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Abstract 
Gout is one of the most painful forms of arthritis characterised by the deposition of 
monosodium urate crystals (MSU) in the joint synovium and the subsequent acute 
influx of circulating leukocytes.  This study investigated the contribution of the 
inflammatory microenvironment in driving recruited monocyte differentiation and 
function in acute gouty inflammation.   
 
Using the murine peritoneal model of MSU-induced inflammation, the 
differentiation and functional phenotypes of MSU-recruited monocytes were 
compared in normal acute inflammation and in an inflammatory environment 
depleted of resident macrophages and infiltrating neutrophils.  In addition, the role of 
the local environment in producing monocyte chemoattractant protein-1 (MCP-1) 
was investigated. Furthermore, the effect of transmigration on the suppressor 
phenotype of recruited monocytes was also explored.   
 
The pro-inflammatory environment was shown to play a key role in the 
differentiation and function of recruited monocytes in MSU-induced acute 
inflammation.  In addition, infiltrating neutrophils suppressed the pro-inflammatory 
abilities of recruited monocytes, which may contribute to the resolution of 
inflammation.  Using both whole peritoneal membrane preparations and in vitro 
culture techniques, results showed that mesothelial cells lining the peritoneal 
membrane were a source of MCP-1 production, which contributed to monocyte 
recruitment. Finally no differences were observed in either the differentiation or 
functional phenotypes of MSU-recruited monocytes isolated from Glatiramer acetate 
(GA) treated or non-treated mice.   
 
These findings suggest that the inflammatory microenvironment plays a key role in 
driving the recruitment, differentiation and function of circulating monocytes in the 
MSU-induced model of acute inflammation.   
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General Introduction 
 
Chapter 1.0: General Introduction 2 
1.1 Gout  
Gout is one of the most painful forms of arthritis and has a recorded history stretching back 
several thousand years.  It has captured the attention of numerous brilliant physicians over 
the ages, including the Egyptian Imhotep around 2640BC, and Hippocrates (400BC) whom 
referred to it as podagara, or “the unwalkable disease” (1).   
 
Originally a disease associated with the wealthy and those of high society (1), the 
prevalence of gout now strikes across the full range of socio-economic groups, 
highlighting its emergence as a common disease in western society.  The prevalence of 
gout in New Zealanders of European decent has increased dramatically from 3.1/1000 in 
1958 to 29/1000 in 1992 (2, 3).  Although not as dramatic, similar increases have been 
documented in the US where disease prevalence has risen from 2.9/1000 in 1990 to 
5.2/1000 in 1999 (4).  These statistics emphasize that the incidence of gout is on the rise 
worldwide.   
 
1.2 Acute gout 
The deposition of monosodium urate (MSU) crystals in one or more joints causes an acute 
inflammatory response within the joint synovium resulting in swelling, redness and pain 
(Diagram 1.1A).  These symptoms result from increases in vascular permeability and an 
intense influx of leukocytes into the local area.  Abrupt onset and spontaneous resolution 
are key characteristics of acute gouty attacks (5) and 60% of individuals who experience 
their first gout attack will also experience a second within one year (6).     
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Diagram 1.1: Acute and chronic gouty inflammation.  Joints from patients with A. acute gout 
and B. chronic gout.  The arrow indicates the formation of tophi around the joint that have ruptured and 
caused ulceration through the skin.  Photos used with permission from PHARMAC, NZ.   
 
1.3 Chronic gout 
Poor management of gout may push the disease into a chronic stage.  This is characterised 
by the formation of tophi, masses of MSU crystals and immune cells, which have 
accumulated in the joints or soft tissue (Diagram 1.1B).  These formations around the 
joints leads to polyarticular bone erosions and deformations (7).  Chronic gout is often 
debilitating with some individuals experiencing periodic attacks of inflammation, known 
as “gout flares” for the rest of their lives (8).   
 
1.4 Monosodium urate crystals 
MSU crystals were confirmed as the inducing agent in a gout attack in the 1960s when 
Faires and McCarty injected synthetically prepared crystals into the synovial cavities of 
their own knees.  The result was a full-fledged gout attack (9). 
 
MSU crystals range in size from 10 to 25µm in length, are needle-like in shape and have 
the ability to polarize light, a quality known as birefringence (Diagram 1.2). Once 
precipitated, MSU crystals take a long time to be redissolved by the body and have been 
identified in the extracted synovial fluid of gout patients even in the absence of clinical 
inflammation (10, 11).   
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Diagram 1.2: Monosodium urate crystals.  Monosodium urate crystals as visualised under a 
microscope in A. normal and B. polarized light fields.  Diagram 1.1 was provided by Dr Willy-John Martin.   
 
1.5 Uric acid is a risk factor for gout 
Uric acid is a normal by-product of purine breakdown.  Proteins, enzymes, and energy 
carrying molecules (such as NADP and ATP) all require purines as essential building 
blocks.  In humans, renal excretion accounts for approximately 70% of uric acid excretion 
and 30% is removed through the intestine into the faeces (12).  
 
Uricase is an enzyme responsible for the breakdown of uric acid to the more soluble 
molecule allantoin.  The human gene encoding the enzyme was thought to be inactivated 
due to a mutation sometime during evolution (13, 14).  Other mammals with functional 
uricase have significantly lower levels of serum uric acid compared with humans (14), and 
explains why gout is mainly a human disease.  
 
A range of environmental, genetic and gender factors affect serum uric acid levels, the 
main predictor of gout risk and development.  Normal uric acid levels fall into the range of 
2.4 – 6.0mg/dL in women and 3.4 – 7.0mg/dL in men (15).  Hyperuricemia is clinically 
diagnosed when concentrations exceed 7mg/dL.  Previous studies have shown that when 
uric acid levels approach this concentration, individuals are at risk of MSU crystallization 
and the onset of gout (16). 
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1.6 Gout risk factors  
 
1.6.1 Hyperuricemia 
Even though serum uric acid concentration is thought to be the main predictor of a gout 
attack, only 25% of individuals with hyperuricemia develop gout (16).  Some individuals 
can be in a state of asymptomatic hyperuricemia for years without suffering a gout attack.  
MSU crystals can also be precipitated within the joints between attacks without eliciting an 
inflammatory response (17).  The reasons for these phenomena remain unknown. 
 
1.6.2 Gender 
Gout is a predominantly male disease with adult men (particularly those aged over 40) 
being four times more likely than women to develop the disease (18, 19).  It is believed 
that the uricosuric effects of estrogen protects women from gout, and is consistent with the 
observation that women rarely suffer gout attacks prior to menopause (20).  Testosterone 
has also been shown to increase the expression of URAT1, a protein key in urate 
reabsorption (21).   
 
1.6.3 Diet 
Intake of purine rich foods (such as seafood, red meat and mushrooms) remains a 
significant contributor to serum uric acid levels and a major risk factor in gout (22, 23).  
Other foods associated with increased risk include high fructose beverages (such as soft 
drink and fruit juices), which interfere with ATP recycling, degrading it to uric acid rather 
than to ADP then ATP (24, 25).  Alcoholic beverages also cause an increase in the rate of 
purine synthesis within the liver during the metabolism of ethanol (26, 27).   
 
1.6.4 Co-morbid diseases 
Previous studies have made associations between hyperuricemia to not only hypertension 
but a wide variety of other diseases such as type II diabetes, obesity and cardiovascular 
diseases (28), collectively known as the metabolic syndrome (29).   
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1.6.5 Genetics 
In humans, genetic mutations causing an overproduction of purines are rare (30); therefore 
increased genetic risks are more likely due to differences in renal excretion.  Recent studies 
have identified two genes linked to urate reabsorption that have a strong influence on the 
regulation of serum urate: URAT1 and GLUT9.  Polymorphisms in the gene encoding 
URAT1 have been associated with both hyperuricemia and hypouricemia (31-33).  
Particular alleles of GLUT9 have been associated with reduced serum urate levels in 
various populations (34, 35).  
 
1.7 Treatment and management of gout 
There are three main approaches for management of gout.  Glucocorticoids and non-
steroidal anti-inflammatory drugs (NSAIDs) can be used to alleviate the immediate 
inflammatory symptoms associated with an acute gouty attack.  Uricostatic drugs (such as 
allopurinol) elicit their effects by lowering the production of uric acid, while uricosuric 
drugs (such as benzbromarone) increase renal excretion; both can be used as a long-term 
treatment for hyperuricemia.  However, the easiest approach is a change in lifestyle; more 
specifically, a moderation of purine rich food intake.   
 
1.7.1 Diet 
Previous studies have recommended limiting the intake of purine-rich foods and uric acid-
promoting beverages (such as alcohol) to prevent increasing serum uric acid levels and the 
risk of precipitation of MSU crystals (26, 36).  Other studies have shown that a diet 
including low-fat dairy products (36), cherries (37), vitamin C (38) and even long-term 
coffee consumption (39) have been associated with small reductions in serum uric acid 
concentrations.     
 
1.8 Initiation of gouty inflammation 
When MSU crystals are deposited within the joint synovium, resident cells recognize and 
are subsequently activated to initiate an acute inflammatory response.  Mast cells, 
macrophages and epithelial cells have been shown to produce pro-inflammatory molecules 
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(such as IL-1β, TNFα, IL-8, IL-6 and S100 proteins) after MSU-activation (40-43).  
Complement proteins and various other chemoattractants (such as MCP-1) present in the 
serum are thought to be involved in the activation and recruitment of circulating 
inflammatory cells (44).  These inflammatory mediators upregulate adhesion molecules on 
both local the epithelial cells and responding leukocytes, resulting in the recruitment of 
circulating leukocytes into the joint synovial space.   
 
Neutrophils, once recruited into the synovium during the early phases of an inflammatory 
response, have been shown to phagocytose MSU crystals, resulting in the production of IL-
8 and S100 proteins, which leads to further recruitment of leukocytes (45).  Other studies 
have also shown that neutrophils are able to produce destructive reactive oxygen species 
upon contact with MSU crystals as a part of their programmed responsibilities in the innate 
immune response (46).  
 
1.8.1 Recognition of MSU crystals as “danger signals” by immune 
cells 
Most antigens are poorly- or non-immunogenic by themselves and will not elicit a strong 
immune response.  Therefore an adjuvant or “danger signal” must be present with the 
foreign particle in order to induce the production of cytokines from resident cells and 
enhance the overall inflammatory response (47).  While lipopolysaccharide (LPS) from 
Gram-negative bacteria is a well-known danger signal mediated through the Toll-like 
receptor-4 (TLR4) pathway (48), cell death is also known to trigger adjuvant effects (49, 
50).  Previous studies have shown that uric acid released from dead cells is associated with 
causing adjuvant effects and that this process was dependent on MSU crystal formation 
(51).  These results point to uric acid and/or MSU crystals as key endogenous 
adjuvant/danger signals in the initiation of acute inflammation.   
 
1.8.2 Innate cell recognition of MSU crystals  
In order for inflammation to occur, innate cells must recognize the MSU crystals. Studies 
have shown previously that in the joints of complement-deficient rabbits, resident 
macrophages fail to recognize MSU crystals, resulting in decreased production of the 
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neutrophil chemokine kertinocyte-derived chemokine (KC), after urate crystal stimulation 
(52).  In addition, precoating MSU crystals with IgG caused an increase in superoxide 
production in human polymorphonuclear leukocytes in vitro (46).  These results indicate 
that the recognition of complement proteins on the surface of MSU crystals can lead to the 
activation of both resident macrophages and infiltrating neutrophils.  However, this may 
not be the only method of recognition, as in the absence of serum, MSU crystals are still 
able to activate immune cells to produce pro-inflammatory molecules, indicating a more 
direct recognition of MSU crystals by innate cells (44).   
 
Although the receptors for MSU crystals are not definitively known, there is evidence to 
support a role for CD14 in crystal recognition.  Terkeltaub and colleagues have shown that 
bone marrow-derived macrophages (BMDMs) from TLR2 and TLR4 knockout mice 
exhibit impaired recognition and uptake of MSU crystals in vitro (53).  Recognition of 
MSU crystals by the TLR2/TLR4 pathways was also indicated with evidence showing that 
the TLR4 co-receptor CD14 could bind directly to MSU crystals in vitro (54).  In the same 
study, Liu-Bryan and colleagues showed that the absence of CD14 results in a drastic 
reduction in both neutrophil recruitment and IL-1β production after MSU crystal 
stimulation (54).   
 
Contrary to the in vitro data above, Rock and colleagues have shown using a panel of 
TLR-, IL-1R- and MyD88-deficient mice that the MSU-induced inflammatory response is 
mediated by IL-1R and the MyD88 pathway but not the TLRs (55).  This suggests that 
although CD14 plays a role in crystal recognition by macrophages, CD14-dependent 
signalling via the MyD88 pathway rather than TLRs is required for eliciting the production 
of pro-inflammatory cytokines in response to MSU stimulation.  More recently, studies 
have also shown that macrophage phagocytosis of MSU crystals and subsequent rupturing 
of intracellular phagosomes is responsible for MSU-induced IL-1β production (56).  
Therefore these findings indicate that MSU-induced inflammation might occur through 
more than one pathway.  Nevertheless, with the identification of the importance of MSU 
crystals in the initiation of innate inflammation, the recognition processes for crystals 
remain the focus of extensive research.   
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1.8.3 Macrophages and the NALP3 inflammasome 
Macrophages are the linchpin of innate immunity and are found throughout the tissues of 
the body, including Kupffer cells of the liver, alveolar macrophages of the lung, serosal 
macrophages of the peritoneum, type A cells in the joint synovium, and microglia of the 
central nervous system (CNS) (57).  They play an important role in the clearance of 
pathogens through their phagocytic ability.  Upon stimulation with MSU crystals in vitro, 
resident macrophages produce pro-inflammatory cytokines (including IL-1β, TNFα, IL-
18) and iNOS (55, 58-60).  Previous studies have shown that the blockade of IL-1β 
abrogates inflammation, highlighting a key role for IL-1β in gouty inflammation (55).   
 
The cleaving of preformed intracellular stores of pro-IL-1β into activated IL-1β requires 
the assembly of the NACHT-LRR-PYD-containing protein-3 (NALP3) inflammasome 
(61).  This multi-protein complex is comprised of the intracellular pattern recognition 
receptor NALP3, the accessory protein ASC, and procaspase-1 (60).  Following activation, 
NALP3 oligomerises and recruits ASC, then binds to procaspase-1 resulting in 
autocatalytic processing and activation (62).  Caspase-1 activation leads to pro-IL-1β 
cleavage and the release tof mature pro-inflammatory IL-1β from the cell (61).   
 
Chen and colleagues have shown previously that IL-1β production and IL-1β receptor (IL-
1R) activation are essential for neutrophil recruitment and MSU-induced inflammation, 
using a panel of knockout mice with deficiencies in the inflammasome (such as ASC, 
caspase-1 and NALP3) and the IL-1R (55).  In addition, the blockade of IL-1R resulted in 
the resolution of gout symptoms in patients treated with anakinra – a recombinant version 
of IL-1 receptor antagonist.  Together, these findings indicate the importance of the 
inflammasome and of IL-1β in gout.   
 
1.8.4 The profile of cytokines/chemokines in MSU-induced 
inflammation 
Previous studies in our group have shown that administration of MSU crystals via 
intraperitoneal injection induces the production of IL-1β, IL-6, TNFα and MCP-1 (also 
known as CCL2) from activated resident macrophages (58).  In addition MSU-elicited 
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leukocyte recruitment peaked at 18 hours after MSU administration, with the monocytes 
recruited at a slower rate and in smaller numbers compared to the infiltrating neutrophils 
(58).   
 
In humans, neutrophils recruited into inflamed tissue produce large amounts of the 
chemokine IL-8, resulting in neutrophil priming and further recruitment via the IL-8 
receptor (CXCR-2) (63, 64).  As mice do not have the gene that encodes IL-8 (65), 
previous studies of animal models of gout have shown a requirement for the neutrophil 
chemokine KC, which is also known as chemokine ligand 1 (CXCL1), and IL-1β (55, 60) 
for neutrophil recruitment while other molecules such as TNFα, GM-CSF (66), S100A9 
and S100A9 (67) and complement proteins (44) are believed to supplement immune cell 
recruitment.  MSU-activated monocytes have been shown to produce mediators such as 
TNFα and IL-1β to upregulate adhesion molecules E-selectin, ICAM-1 and VCAM-1 on 
human endothelial cells, allowing circulating neutrophils to adhere to the endothelium in 
vitro (68).  These studies indicate that the recruitment of neutrophils is dependent on a 
number of cell types that collectively contribute to the neutrophil response in MSU-
induced acute inflammation.   
 
While the monocyte chemoattractant MCP-1 was thought previously to be produced by 
macrophages (69), our studies have shown that depletion of macrophages prior to MSU 
administration significantly abrogated neutrophil but not monocyte recruitment (58).  This 
indicated that while macrophages play a key role in neutrophil recruitment via the 
production of the chemokine KC, other resident cells regulate the production of MCP-1.  It 
has been shown previously that MCP-1 can be detected within the synovium of rabbit 
joints after MSU administration (70).  Furthermore, in the same study, MCP-1 was 
detected in synovial lining cells using immunohistochemistry (70).  Therefore, further 
research is required to investigate whether the local membrane cells are responsible for 
MCP-1 production and monocyte recruitment.   
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1.9 Leukocyte migration 
Monocyte and neutrophil recruitment is a key characteristic of acute inflammation in gout.  
The movement of leukocytes from the bloodstream to sites of inflammation is a strictly 
controlled process involving regulated steps collectively known as the adhesion cascade 
(71) (Diagram 1.3).   
 
Leukocyte rolling is mediated by various selectins (such as L-selectin on leukocytes and E-
selectin on inflamed endothelial cells) interacting with P-selectin glycoprotein ligand-1 
(PSGL1) and other co-molecules that are expressed on endothelial cells (72).  Binding of 
PSGL1 and selectins causes leukocyte adherence to inflamed endothelium in a pulse like 
fashion, with exceptionally high on- and off-rates of adherence which determines the speed 
at which leukocytes are ‘rolling’ (71).   
 
Chemokines are a group of small molecules expressed by endothelial cells, which are 
responsible for initiating the arrest of ‘rolling’ leukocytes within the adhesion cascade.  
Monocyte chemoattractant protein-1 (MCP-1) is one such molecule and has been 
associated with the recruitment of monocytes through the endothelium in rheumatoid 
arthritis (73).  MCP-1 binds with high affinity to specific G-protein transmembrane 
receptors on rolling monocytes, which results in rapid activation of phospholipase C 
(PLC), leading to an increase in intracellular Ca2+ and generation of inositol-1,4,5-
trisphosphate (InsP3) and diacylglycerol (DAG) which are all required to initiate cell arrest 
(74).  Previous findings have shown that the binding of leukocyte integrins to 
transmembrane proteins such as intercellular adhesion molecule-1 (ICAM1) and vascular 
cell-adhesion molecule-1 (VCAM1) (75, 76) are responsible for cell arrest and contribute 
to the strengthening of adhesion prior to migration from the blood vessels (74).   
 
Three key mechanisms have been identified by which leukocytes may transmigrate 
through the endothelium; crawling, paracellular and transcellular migration (71).  Crawling 
is performed by leukocytes seeking preferred sites of transmigration. This process involves 
the extension of leukocyte membrane protrusions into the endothelial cell body and 
triggering the ligation of ICAM1 by macrophage antigen-1 (MAC1). Eventually this leads 
to enhanced endothelial cell contraction and opening of inter-endothelial contacts (77).  
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Paracellular migration involves the ligation of endothelial-cell adhesion molecules leading 
to reduced inter-endothelial contacts and therefore allowing the migration of leukocytes 
through endothelial cell-junctions.  This process is facilitated by a gauntlet of interactions 
between leukocyte membrane compartments containing platelet/endothelial-cell adhesion 
molecules and cell junctions on the endothelium (77).  The transcellular route is believed 
to occur in thin endothelium such as the central nervous system (CNS) (78) whereby 
leukocytes transmigrate through an intracellular channel within the endothelial cell 
mediated by ICAM1 ligation (79).   
 
 
Diagram 1.3: Schematic representation of the leukocyte adhesion cascade.  Rolling is 
mediated by selectins, activation is mediated by chemokines, and arrest, is mediated by integrins.  
Transmembrane migration can be separated into crawling, paracellular and transcellular migration.  Diagram 
1.3 was adapted from (71). 
 
1.10 Neutrophils in gout 
Neutrophils, also known as polymorphonuclear leukocytes (PMNs), comprise 40 – 70% of 
circulating leukocytes in humans.  Under homeostatic conditions, following release from 
the bone marrow, neutrophils undergo apoptosis within 6 – 10 hours (80, 81) and are 
cleared from the circulation by the liver and splenic macrophages (82).   
 
Neutrophils are a part of the host’s innate immune defence and are among the first 
leukocytes recruited into inflamed tissues.  Once recruited to a site, their role involves the 
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uptake of infectious matter, pathogens and debris, and production of hazardous molecules 
to kill and digest foreign organisms and remove damaged tissue (83).   
 
Studies have shown previously that neutrophil recognition of foreign particles, bacteria or 
other inflammatory agents is mediated through pattern recognition receptors (such as 
TLRs) (84).  Furthermore, foreign agents may become opsonised with antibodies and 
complement factors, which may be detected and phagocytosed by neutrophils through 
interactions with Fc and complement receptors (85). 
 
Neutrophil recognition and phagocytosis of inflammatory particles activates the respiratory 
burst enzyme, NADPH oxidase which leads to the production of extracellular superoxide 
from the cell that can lead to further bactericidal activity and tissue damage (86).  In 
addition, neutrophils are able to produce pro-inflammatory cytokines (such as IL-8 (87) 
and S110A8/A9 (67)), which induces further neutrophil recruitment and amplifies the 
inflammatory response.   
 
Within the inflamed tissue, exposure to cytokines (such as IL-1β, TNFα and IFNγ), growth 
factors (such as G-CSF and GM-CSF) and MSU crystals have been shown to activate and 
subsequently prolong the half-life of recruited neutrophils from hours to days in vitro (88).  
This may result in an accumulation of normally short-lived neutrophils within the inflamed 
environment in order to induce a prolonged pro-inflammatory response.   
 
In gout, neutrophils have been shown to be one of the main recruited leukocytes after 
MSU-crystal deposition within the joint (58) and play a key part in inducing the overall 
acute inflammatory response.   
 
1.11 Monocytes in gout 
 
1.11.1 Monocyte subpopulations 
In C57Bl/6J mice, circulating monocytes are primarily identified by their expression of 
CD11b, low levels of F4/80, and intermediate levels of Gr-1 (Ly6C- and Ly6G+) (89).  To 
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date, two circulating monocyte subpopulations (expressing either Gr-1low or Gr-1hi) have 
been shown to reside in the blood (90).  In mice, the former is further characterised as 
resident CX3CR1hiCCR2-Gr1- monocytes due to their ability to remain within the 
bloodstream during homeostasis, and take-up a “patrolling” role (90, 91).  Under steady-
state conditions, this subpopulation migrates between the bloodstream and the local tissue 
through the endothelium and “samples” the environment for danger signals (90).  Further 
studies have found this migratory observation to be dependent on Fractalkine (CX3CL1), a 
transmembrane chemokine expressed on endothelial cells, the ligand for CX3CR1 (91).  
Adoptive transfer studies have shown previously that Gr-1- monocytes migrate into tissues 
under homeostatic conditions and are believed to replenish resident cell populations under 
steady state conditions (91).   
 
The Gr-1hi circulating “inflammatory” monocytes display a CX3CR1lowCCR2+ phenotype 
and are recruited to inflamed peripheral tissue by MCP-1, the ligand for CCR2 (57, 90, 
91).  Although inflammatory monocytes can differentiate into both macrophages and 
dendritic cells (DCs) in vitro, Auffray and colleagues has shown that inflammatory 
monocytes are predisposed to becoming DCs following LPS insult in vivo (90, 92).  
Alternatively, Chazaud and colleagues have shown that after skeletal muscle injury in 
mice, recruited monocytes differentiate into F4/80hi macrophages to support myogenesis 
(93).  Together, these findings indicate that the fate of differentiation of this particular 
subset of circulating monocytes is dependent on the type of stimulus and the inflammatory 
environment into which they are recruited. 
 
1.11.2 Monocyte differentiation 
Monocytes are phagocytic mononuclear cells that comprise approximately 2 – 10% of 
white blood cells in circulation in humans.  Although they have been shown previously to 
produce pro-inflammatory mediators such as IL-8, TNFα and IL-6 after LPS stimulation in 
vitro, they are considered to be an undifferentiated myeloid precursor cell (94).  Once 
monocytes are recruited from the bloodstream into peripheral tissues, they have the 
capacity to differentiate into a number of cell types depending on the soluble mediators 
present within the local environment.  The influence of the inflammatory environment on 
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the differentiation of recruited monocytes has been shown in a wide variety of disease 
models.  For example, mononuclear precursors recruited into a tumour environment 
containing anti-inflammatory molecules (such as glucocorticoid hormones, IL-4, IL-13 and 
IL-10) are programmed to differentiate into alternatively activated macrophages, also 
known as tumour associated macrophages (TAMs) (57, 95, 96).  TAMs have been shown 
to produce anti-inflammatory cytokines (such as IL-10 (97) and TGF-β (98)) and 
contribute to immune-tolerance and tumour angiogenesis (98).  Alternatively, in the central 
nervous system (CNS) of experimental autoimmune encephalomyelitis (EAE) mice rich in 
IFN-γ, TNFα (99) and IL-17 (100, 101), recruited myeloid precursors have been shown to 
develop macrophage-like phenotypes (102) and produce reactive oxygen species (ROS) 
and other pro-inflammatory cytokines (103), leading to demyelination and axonal damage 
(104).   
  
Granulocyte/macrophage-stimulating factor (GM-CSF, also known as CSF2) and 
macrophage-stimulating factor (M-CSF, also known as CSF1) are haematopoietic-cell 
growth factors defined by their abilities to generate colonies of mature myeloid cells from 
bone-marrow precursor cells in vitro.  Warren and Vogel have shown that while 
monocytes cultured in M-CSF predominantly differentiate into macrophages (105), 
monocytes cultured in GM-CSF and IL-4 become dendritic cells (DCs) (106).  
Furthermore, monocytes cultured with RANKL and M-CSF differentiate into osteoclasts in 
vitro (107).  More recently, M-CSF and IL-10 in the tumour environment have been 
proposed to programme the differentiation of recruited monocytes into TAMs by blocking 
their differentiation into DCs (96, 108).  Higher concentrations of GM-CSF detected 
within bronchoalveolar lavage fluid have also been proposed to generate an unique 
population of DC-like macrophages in vivo (109).  Together, these findings indicate a role 
for colony stimulating factors (CSFs) in determining the fate of recruited myeloid 
precursor cells.   
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1.11.3 Monocyte activation  
The activation of monocytes and macrophages can induce differential responses depending 
on the stimulus (57).  Three common activation responses have been identified, based on 
in vitro activation of macrophages with different stimuli.   
 
Classical activation occurs by the triggering of inflammatory responses by stimuli such as 
TLR ligands.  Classically activated macrophages activated by pathogen-associated 
molecular patterns (PAMPs) such as LPS produce large amounts of pro-inflammatory 
cytokines (such as IFN-γ, IL-6 and TNFα) and reactive oxygen species (ROS); have an 
enhanced capacity for antigen presentation and increased microbicidal activity (57, 89, 95).  
Alternative activation by anti-inflammatory cytokines (i.e. in the presence of IL-4 and IL-
13) results in the promotion of tissue repair, low level production of anti-inflammatory 
cytokines (such as TGFβ) and increased parasite killing (57, 95).  In addition, type II 
activation of macrophages by immune complexes (e.g. Ig-opsonised antigens) drives the 
production of high levels of IL-10, increased nitric oxide (NO) production and enhanced 
presentation of antigens (95).   
 
Monocyte activation appears to also depend on environmental stimuli; LPS-activated 
monocytes exhibit a similar pro-inflammatory profile to classically activated macrophages 
by their production of pro-inflammatory cytokines (such as IFNγ and IL-6) via the MyD88 
pathway (55).  The differentiation of monocytes into macrophages in vivo may be 
associated with different types of activation. 
 
1.11.4 Resolution of gout 
Although the mechanism behind the spontaneous resolution of gout is not definitively 
known, there is evidence to indicate that mononuclear phagocytes mediate resolution of 
acute inflammation via the production of anti-inflammatory cytokines (such as TGF-β).   
 
Barin and colleagues have shown previously that recombinant human transforming growth 
factor-β (TGF-β) was able to suppress the inflammatory response induced by MSU 
administration, in a rat subcutaneous air pouch model (110).  However, while showing that 
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TGF-β has an inhibitory effect on MSU-induced inflammation, this study did not identify a 
potential source of TGF-β production.   
 
Experiments by the Haskard group have shown using a panel of murine 
monocyte/macrophage cell lines that monocyte-like cells produced the pro-inflammatory 
cytokine TNFα after MSU stimulation in vitro, while mature macrophage-like cells were 
non-inflammatory when exposed to MSU crystals (111).  In a followup experiment by the 
same group using human peripheral blood monocytes, differentiated by adherence in vitro 
over 1 – 7 days, Haskard and colleagues showed that undifferentiated blood monocytes 
produced IL-6, IL-1β and TNF-α in response to MSU stimulation in vitro, while mature 
macrophages showed reduced levels of these pro-inflammatory cytokines and instead 
produced large amounts of TGF-β (112, 113).  While these studies showed the importance 
of the stage of monocyte/macrophage differentiate in the production of “pro”- or “anti”-
inflammatory cytokines after MSU stimulation in vitro, the relevance of these findings 
relative to the inflammatory environment in vivo is not clear.   
 
Further studies on the phagocytosis of apoptotic neutrophils by macrophages have 
indicated a role in the production of anti-inflammatory cytokines, contributing to the 
resolution of inflammation.  Terkeltaub and colleagues have shown in TG2-/- mice that are 
defective in the ability to phagocytosis apoptotic cells, that MSU administration i.p. 
exhibited a prolonged and more intense neutrophil infiltration compared with wild-type 
mice.  This indicated that failed uptake of neutrophils by macrophages resulted in 
unresolved acute inflammation.  Finally, in a previous study, human monocyte-derived 
macrophages that ingested apoptotic neutrophils produced anti-inflammatory mediators 
(including TGF-β) after LPS stimulation, while downregulating pro-inflammatory 
cytokines (such as TNFα) in vitro.  
  
Although these studies together establish a model of resolution that incorporates 
macrophages switching to an anti-inflammatory phenotype after phagocytosis of apoptotic 
neutrophils and the involvement of TGF-β as a suppressive cytokine, whether these 
mechanisms actually occur in gout has yet to be determined in vivo.   
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A clear limitation of the in vitro studies is that they do not account for the functional 
changes that occur during cellular recruitment.  As circulating monocytes transmigrate 
through the endothelium, ligand interactions result in an increase in the expression of 
several genes (including MMP-1, MCP-1, TG2 caveolin-1 and CD4) (114).  Therefore, the 
in vitro conditions (using only M-CSF, GM-CSF or by adherence to culture plates) used in 
previous studies are completely different to the inflammatory environment (consisting of a 
complex mixture of cytokines/chemokines, serum, cells, and tissues) into which monocytes 
are recruited in vivo (115). 
 
1.11.5 Monocyte investigation 
Since recruited monocytes play an important role in both the “pro”- and “anti”- phases of 
inflammation, the mechanism that drives their differentiation and function has been a 
subject of interest in gout research.  Common research approaches include the use of 
immortalized murine monocyte/macrophage cell lines or the differentiation of human 
peripheral blood monocytes in vitro, yet monocytes are never isolated during an 
inflammatory response.  Therefore, a major area of investigation is how monocytes fit into 
the network of responses during an inflammatory response, working in concert and 
cooperation with other environmental/cellular mediators, such as neutrophils.   
 
1.12 Interactions between the innate and adaptive immune 
systems 
The innate and adaptive immune systems have been traditionally considered as separate 
but complementary mechanisms of defence against pathogenic challenges.  However, 
advances in the understanding of the nature and functions of TLRs have sparked new 
appreciation of the interdependence and cross-talk that occurs in an immune response and 
has given rise to renewed interest in the interactions between the innate and adaptive 
branches of the immune network.   
 
The common explanation for the death of lymphocyte-deficient hosts would be their lack 
of an adaptive immune response to effectively clear pathogens and therefore avoid acute 
infection (116).  However, Fu and colleagues have shown that an un-regulated innate 
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immune response in the form of a cytokine storm can also be a direct cause of death, after 
viral infection in T-cell- and lymphocyte- deficient mice (117).   In addition, studies have 
shown recently that both effector and memory CD4+ T cells suppressed macrophage 
inflammasome-mediated caspase-1 activation and subsequent IL-1β release, using a 
variety of murine peritonitis models (including MSU crystals, alum and asbestos) (118).  
Furthermore, myeloid-derived suppressor cells (MDSCs) have been shown to inhibit T cell 
responses in tumour models (119), which may be an exacerbated phenotype of the baseline 
suppressive mechanism mediated by MDSCs during homeostasis.  Nevertheless these 
findings may indicate a cross-regulatory role between the innate and adaptive systems, 
which may be necessary to temper immune responses and potentially control non-specific 
activation.   
 
1.12.1 Spontaneous activation of T lymphocytes 
The cellular branch of adaptive immunity is mediated by T cells, which express antigen 
specific receptors (TCRs) and combat mostly intracellular pathogens (120).  Circulating T 
cells can be activated by antigen presenting cells (APCs) (such as DCs) in lymphoid 
organs and differentiate into effector T cells.   Based on T cell function and surface marker 
expression, they can be categorized into cytotoxic T lymphocytes (CTL also known as 
CD8 T cells) and T helper cells (TH cells or CD4 T cells).  CD8 T cells are responsible for 
inducing the apoptosis of infected host cells through granzymes or Fas-FasL interactions 
(120).  CD4 T cells produce pro-inflammatory cytokines that can potentiate CTL responses 
or promote humoral immunity (121). 
 
Studies have shown previously that spontaneous T cell proliferation can occur when naïve 
CD4 T cells are transferred into lymphopenic mice (122).  In the same study, Paul and 
colleagues were able to show that “homeostatic proliferation” can occur by two 
distinguishable mechanisms, which they proposed might indicate fundamentally distinct 
roles in the maintenance of CD4 T cell homeostasis (122).  In addition, spontaneous 
lymphocyte proliferation was observed in isolated CD4 and CD8 T cells from patients 
infected with T-cell lymphotropic virus type I (123, 124).  These findings may indicate a 
possible non-antigen specific, spontaneous proliferation of resident T cells, which is only 
Chapter 1.0: General Introduction 20 
highlighted in an immune-compromised or artificial setting.  Whether cells of the innate 
immune system play a role in the regulation of this background spontaneous T cell 
proliferation warrants further research.   
 
1.13 Research models of gout 
Research models of disease are essential in order to study acute gout or any other form of 
inflammatory disease.  Faires and McCarty developed the first gout animal model that 
resulted in significant observations, whereby they injected synthetic MSU crystals into dog 
knees (9).  The authors were able to replicate the same inflammatory symptoms that they 
observed when they self-administered MSU crystals into their own knees, such as pain, 
swelling and redness (9).  
 
Since then, mouse and rat models have been developed in order to study gouty 
inflammation.  As the sizes of murine joints are too small to make intrasynovial injections 
of MSU crystals, within murine models, alternative tissue sites are used to mimic the joint 
synovium.   
 
1.13.1 The murine peritoneal model of gout 
The peritoneal model of gout was first used in research by Getting and colleagues (42).  
The peritoneal cavity contains cell subsets in vivo similar to those in the joint synovium, 
including macrophages, epithelial cells, mast cells, fibroblasts and lymphocytes.  Similar to 
the inflammatory response in gout, the injection of MSU crystals into the peritoneum 
induces a robust leukocyte infiltration (including neutrophils and monocytes), as well as 
the production of cytokines and chemokines.  Limitations of this model include the 
absence of certain cell types such as osteoclasts and chondrocytes specific to the bone 
niches, as well as tissue extracellular matrixes such as cartilage and bone, which are more 
relevant for models of chronic gout.  The peritoneal model is also limited by its relatively 
large size, with the cavity lacking the mechanically induced algesia due to oedema 
normally accompanied during a gout attack.  Despite the disadvantages above, outcomes 
observed from this model has been used extensively through to clinical studies of the 
disease, confirming its usefulness and relevance in gouty inflammation.     
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1.13.2 Murine air pouch model 
The murine air pouch model is another research model of acute gout.  A subcutaneous 
injection of sterile air on the back of rats (or mice) is performed in order to produce an air 
sac.  With the air pouch mimicking the joint synovium, an MSU challenge induces the 
recruitment of leukocytes.  This model has been used as an MSU-induced recruitment 
model of acute gout in previous studies (125). 
 
The limitations of this particular model are similar to the peritoneal model; with an 
absence of cell subtypes normally found in the bone niche.  In addition, the initial 
inflammation caused by the formation of the air pouch may cause an inflammatory 
background of altered cell numbers or cell phenotype, which may modify changes 
observed in subsequent inflammatory changes.   
 
Therefore, the MSU-induced peritoneal inflammatory model was chosen for this research.  
It induces an un-altered inflammatory background with cellular infiltration, which mimics 
clinical gout.  It is supported by the model’s use in literature and relevancy in clinical 
translational experiments.   
 
1.14 Objectives of this study 
The research introduced has summarised the roles of infiltrating neutrophils, monocytes 
and macrophages in acute gout.  My thesis aims to assess the effect of the recruiting 
inflammatory environment as well as the changes in the differentiation and functions of 
monocytes recruited into the peritoneum by MSU-induced inflammation.   
 
The objectives of this study were: 
 
Aim 1:  To profile changes in recruited monocyte differentiation and   
  functionality after the depletion of resident macrophages in MSU-  
  induced inflammation. 
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Aim 2:  To investigate the impact of leukocyte transmigration on the   
  suppressor phenotype of recruited monocytes. 
 
Aim 3:  To identify the cell subset responsible for the production of MCP-1  
  during MSU-induced inflammation.   
 23 
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Materials and Methods 
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2.1 Chemicals and reagents 
Chemicals were purchased from the following companies as listed in section 2.2: 
BDH Chemicals, NZ 
Invitrogen, NZ 
Merck , Australia 
PAA, Austria 
Roche, NZ 
Sigma-Aldrich, NZ 
 
2.2 Buffers and solutions 
 
2.2.1 Buffers and media for tissue preparation and cell culture 
Complete RPMI-1640 (cRPMI) media 
Foetal Bovine Serum (FBS)  10% (v/v)   Sigma-Aldrich,  
         Invitrogen 
Glutamax    2mM    Invitrogen 
Penicillin-streptomycin  100U/mL   Invitrogen 
In sterile RPMI-1640 (Invitrogen).  Stored at 4°C and used sterile.   
 
Collagenase II/DNase I solution 
Collagenase Type II   1mg/mL   Invitrogen  
DNase I    0.2mg/mL   Roche 
In sterile cRPMI.  Filter sterilized using 32mm syringe filters with 0.2µm Supor® 
membrane (Pall Corporation, Newquay, Cornwall, UK), stored at 4°C and used sterile.   
 
Peritoneal Mesothelial Cell (PMC) growth media 
Epidermal Growth Factor  20ng/mL   Roche 
FBS     10% (v/v)   Sigma-Aldrich,  
         Invitrogen 
Glutamax    2mM    Invitrogen 
Hydrocortisone   5µM    Sigma-Aldrich 
Chapter 2.0: Materials and Methods 25 
Penicillin-streptomycin  100U/mL   Invitrogen 
In sterile RPMI-1640 (Invitrogen).  Stored at 4°C and used sterile.   
 
Dulbecco’s Phosphate Buffered Saline (D-PBS) in-house 
D-PBS powder   95.5g/package   Invitrogen 
Made up to 10 litres in MilliQ water (Q-Grad® 1 Purification Pack, Millipore Corp., 
Billerica, MA, USA), pH adjusted to 7.1.  Filter sterilized using 0.22µm vacuum driven 
disposable bottle top filters (SteritopTM Millipore Corp., Billerica, MA, USA), stored at 
4°C and used sterile.  This D-PBS was used for procedures that did not require D-PBS to 
be endotoxin free.   
 
Red Blood Cell (RBC) lysis buffer 
Solution 1 
NH4Cl     0.16M    Merck  
Solution 2 
Tris     0.17M    Invitrogen 
In MilliQ water.  Autoclave sterilized, stored at room temperature (RT) and used sterile. 
Working RBC lysis buffer was prepared by mixing Solutions 1 and 2 at a 9:1 ratio 
immediately before use. 
 
Serum-free RPMI-1640 media 
Glutamax    2mM    Invitrogen 
Penicillin-streptomycin  100U/mL   Invitrogen 
In sterile RPMI-1640.  Stored at 4°C and used sterile. 
 
2.2.2 Buffers for cell purification 
autoMACSTM rinsing buffer 
EDTA     2mM    Invitrogen 
In Dulbecco’s Phosphate Buffered Saline (D-PBS, Invitrogen).  Autoclave sterilized, 
stored at 4°C and used sterile.   
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autoMACSTM running buffer 
FBS     1% (v/v)   PAA 
EDTA     2mM    Invitrogen 
In D-PBS. Autoclave sterilized, FCS added after sterilization stored at 4°C and used 
sterile. 
 
Flow CompTM isolation buffer 
FBS     2% (v/v)   PAA 
EDTA     1mM    Invitrogen 
In sterile D-PBS.  Stored at 4°C and used sterile. 
 
2.2.3 Buffers for flow cytometry 
Annexin-V binding buffer 
HEPES    10mM    Sigma-Aldrich 
NaCl     140mM   BDH 
CaCl2     2.5mM   BDH 
In D-PBS (in-house), pH adjusted to 7.4.  Stored at 4°C, used within one month of 
preparation.   
 
FACS buffer 
Bovine serums albumin (BSA) 0.1% (w/v)   Invitrogen 
Sodium azide    0.01% (v/v)   Sigma-Aldrich 
In D-PBS (in-house).  Stored at 4°C.   
 
2.2.4 Solutions for preparation of clodronate liposomes 
Cholesterol stock solution 
Cholesterol    20mg/mL   Sigma-Aldrich 
In chloroform (Merck).  Stored at -20°C. 
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Dichloromethlene diphophonate (Cl2MDP) solution 
Cl2MDP     0.7M    Sigma-Aldrich 
In MilliQ water, pH adjusted to 7.1.  Stored at -20°C.   
 
Phosphatidylcholine stock solution 
L-α-phosphatidylcholine  100mg/mL   Sigma-Aldrich 
In chloroform (Merck).  Stored at -20°C. 
 
2.2.5 Solutions for immunohistochemistry 
Blocking buffer 
Saponin     0.1% (w/v)   Sigma-Aldrich 
BSA     0.1% (w/v)   Invitrogen 
Sodium azide    0.01% (v/v)   Sigma-Aldrich 
FBS     10% (v/v)   Sigma-Aldrich, 
         Invitrogen 
In D-PBS (in-house).  Stored at 4°C. 
 
2.2.6 Buffers for protein or antibody labelling 
Sodium bicarbonate (NaHCO3 buffer) 
NaHCO3    0.1M    Sigma-Aldrich 
In MilliQ water.  Prepared fresh before each use.   
 
Tris buffer 
Tris     0.1M    Invitrogen 
In MilliQ water, pH adjusted to 8.5.  Stored at RT.   
 
2.3 Proteins and copolymers 
Glatiramer Acetate (GA, Copaxone®) 
Purchased from Teva pharmaceutical Industries Ltd. (Petach Tikva, Israel). 
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2.4 Kits 
Biotin/Avidin blocking kit     Invitrogen 
Bioplex bead array kit (IL-6, KC, MCP-1)   Bio-Rad,  
        Hercules, CA, USA 
Diff-Quik kit       Dade Behring,   
        Newark, USA 
IL-1β ELISA kit      R&D Systems,   
        Minneapolis, USA 
Limulus amebocyte lysate kit     Associates of    
        Cape Cod, Inc., 
        Falmouth, MA, USA 
Murine GM-CSF ELISA kit     PeproTech Inc., 
        Rocky Hill, NJ, USA 
Murine M-CSF ELISA kit     PeproTech Inc., 
        Rocky Hill, NJ, USA 
TNFα ELISA kit      BD Bioscience,  
        San Diego, CA, USA 
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Table 2.1: Antibodies used for flow cytometry and immunofluorescent histology. 
 
All antibodies for use in flow cytometry or immunofluorescent histology were titrated 
before use to determine the ideal concentration for use.   
 
Antigen Clone Source Isotype Fluorophore 
Annexin-V  Pharmingen  FITC 
CD3a 2C11 eBioscience Hamster IgG SA-APCb 
CD28a 37.51 homemade Hamster IgG  
CD4 RM4-5 Pharmingen Rat IgG2a, κ PerCP 
CD8a 2.43 homemade Rat IgG2b, κ PE 
CD11b M1/70 Pharmingen, 
eBioscience, 
BioLegend 
Rat IgG2b, κ APC, FITC, PE, 
PerCP-Cy5.5 
CD14c Sa2-8  
(unlabelled) 
Sa14-2 
eBioscience 
BioLegend 
Rat IgG2a, κ PerCP-Cy5.5  
αrat-Alexa555c 
αrat-Alexa488c 
CD206 MR5D3 SeroTec Rat IgG2a PE 
Cytokeratin Polyclonal 
(unlabelled) 
abcam Rabbit IgG αrabbit-FITCc 
αrabbit-Alexa594c 
F4/80 BM8 
CI:A3-1 
eBioscience Rat IgG2a, κ PE, PerCP 
FcRa 24G.2 homemade Rat IgG2b, κ  
Gr-1 RB6-8C5 Pharmingen Rat IgG2b, κ APC 
Ly-6G 1A8 Pharmingen Rat IgG2a, κ PE 
MCP-1 4E2 eBioscience Hamster 
IgG1, κ 
FITC c 
Neutrophils 7/4 SeroTec IgG2a FITC 
PI  Pharmingen   
a Purified antibody was kindly provided by Dr Thomas Backström from the Malaghan Institute of Medical Research. 
b Biotinylated antibodies were treated with an appropriate streptavidin-fluorophore conjugate. 
c Unlabelled antibodies were treated with an appropriate secondary antibody.   
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2.5 Preparation of monosodium urate crystals 
A supersaturated solution of uric acid (Sigma-Aldrich), adjusted to mildly basic conditions, 
was prepared to allow for the crystallization of MSU crystals.  Briefly, 250mg uric acid 
was added to 45mL of MilliQ water containing 300µL of 5M NaOH (Sigma-Aldrich) and 
the solution was boiled until the uric acid dissolved.  The solution was filter sterilized 
using 0.22µm vacuum driven disposable bottle top filters, following which, 1mL of 5M 
NaCl (BDH) was added to the hot solution, and the solution stored at 26°C to allow 
crystallization.  After seven days the MSU crystals were washed with ethanol (BDH) and 
acetone (BDH) over a buchner flask then placed under sterile conditions and allowed to air 
dry.  Physical characteristics typically displayed by MSU crystals include, a needle-like 
shape, lengths between 5 – 20µm and displaying optical birefringence under the 
microscope.  MSU crystals were confirmed as endotoxin-free by LAL assay (<0.01 
EU/10mg).   
 
2.6 Endotoxin levels 
As endotoxin can activate innate immune cells, reagents and glassware used were tested to 
ensure the cell cultures were not only sterile but also free from endotoxins.  All plasticware 
were explicitly pyrogen (endotoxin)-free.  Reagents used were either certified as low 
endotoxin or tested by LAL assay for endotoxin levels.   
 
2.6.1 Limulus amebocyte lysate (LAL) assay test 
The following were tested for endotoxin levels by LAL assay kit.  The kit was run 
according to manufacturer’s instructions. 
 
MSU crystals       <0.01 EU/10mg 
MilliQ water       <0.01 EU/mL 
Cleaned and autoclaved glassware    <0.01 EU/mL 
(The inside of a 250mL piece of glassware was rinsed with 10mL of water provided in the 
LAL kit and tested).   
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2.6.2 Purchased reagents 
5M NaCl    Sigma-Aldrich <0.3 EU/mL 
D-PBS     Invitrogen  <0.03 EU/mL 
RPMI-1640    Invitrogen  <0.03 EU/mL 
Puregene RBC lysis buffer  QIAGEN,  <0.03 EU/mL 
     Valencia, CA, USA 
Fetal bovine serum   Invitrogen  <0.08 EU/mL 
     Sigma-Aldrich <0.13 EU/mL 
 
2.7 Animal studies 
 
2.7.1 Maintenance and ethic approvals 
All mice were bred and housed at the Biomedical Research Unit of the Malaghan Institute 
of Medical Research, based at Victoria University of Wellington, New Zealand.  All 
experimental procedures were approved by the Victoria University Animal Ethics 
Committee in accordance with their guidelines, under the license codes 2005R7M 
(Inflammatory immune profiling of neutrophil mouse models of inflammation) or 
2006R19 (The use of mouse tissues for multiple research projects).   
 
2.7.2 Mice 
C57Bl/6J mice were originally purchased from Jackson Laboratory (Bar Harbour, ME, 
USA).  All animals used for experiments were male, aged between 8 – 11 weeks.   
 
2.7.3 Murine peritoneal model of MSU-induced inflammation 
Mice were administered with an intraperitoneal (i.p.) injection of 3mg MSU crystals 
suspended in 0.5mL D-PBS.  At different time-points, mice were euthanased by carbon 
dioxide asphyxiation followed by cervical dislocation.   
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Blood was then harvested by cardiac puncture into sterile 10mL tubes (SARSTEDT, 
Australia Pty Ltd., Australia) containing 600µL volume of 125U/mL heparin (Wellington 
Hospital, NZ) in D-PBS stored on ice. 
 
Peritoneal leukocytes were harvested by peritoneal lavage.  Mice were dowsed with 70% 
ethanol and the skin covering the peritoneum carefully removed without disturbing the 
peritoneal membrane.  D-PBS (3mL) containing 25U/mL heparin was injected into the 
peritoneal cavity.  The inguinal fat pads were used as sites of injection to allow the 
injection hole to re-seal upon extraction of syringe needle.  The peritoneum was then 
massaged for 20 seconds following which the heparin/D-PBS (containing peritoneal 
exudates cells) was extracted using the same syringe used for injection.  The peritoneal 
lavage fluid was kept in the syringe to maintain sterility and then placed immediately on 
ice.     
 
2.7.4 Fluorescent staining of murine CD11b+ blood cells in vivo 
C57Bl/6J mice were administered with a 200µL i.v. tail injection of 7µg/mL fluorescent-
labelled protein (section 2.3), then left naïve or treated with MSU crystals (section 2.5).  At 
different time-points, mice were euthanased by carbon dioxide asphyxiation followed by 
cervical dislocation.  Blood and peritoneal exudates cells (PECs) were harvested as 
described for MSU crystal-induced inflammation above. 
 
2.8 Cell harvest and processing 
 
2.8.1 Preparation of cells from peritoneal lavage 
PECs were harvested from naïve or treated mice at different time-points as described in 
2.8.3.  Under sterile conditions, the peritoneal lavage was expelled into a 15mL sterile tube 
(Falcon BD Labware, Franklin Lakes, NJ, USA) containing 200µL FBS.  Cells were 
pelleted by centrifugation with a Heraeus Megafuge 2.0R (DJB Labcare, 
Buckinghamshire, England) for five minutes at 500 x g (RT) and the lavage fluid stored for 
cytokine/chemokine analysis (section 2.4).  Pelleted cells were washed three times in room 
temperature D-PBS before further culture or staining with fluorescent-labelled antibodies. 
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Cytospin samples of the cells were prepared, stained with Diff-Quik (section 2.4) and 
differential cell counts performed (section 2.12.1).  For counting PECs, 10µL of cell 
suspension was mixed with 90µL of 0.4% Trypan Blue Stain (Invitrogen).  The mixture 
was placed on a haemocytometer and the viable cells that excluded the dye were counted 
under 10x magnification with an Olympus BX40 (Olympus, Central Valley, PA, USA) 
microscope. 
 
2.8.2 Preparation of cells from mouse blood 
Blood was collected by cardiac puncture or by tail-bleeding from naïve or treated mice at 
different time-points.  Under sterile conditions, RBCs were pelleted by centrifugation for 
five minutes at 500 x g (RT) and the serum stored for cytokine/chemokine analysis 
(section 2.4).  Pelleted cells were gently resuspended in 5 – 10mL of Puregene RBC lysis 
buffer (QIAGEN, Valencia, CA, USA) and incubated with atmospheric air and 5% CO2 in 
a HERAcell 240 tissue culture incubator (Thermo Scientific, Cheshire, UK) for 15 minutes 
at 37°C.  Cells were then washed twice in D-PBS before further culture or antibody 
staining for analysis by flow cytometry (section 2.11).  If RBC lysis was incomplete, the 
process was repeated.   
 
2.8.3 Preparation of cells from spleens and lymph nodes 
Mice from naïve or treated groups were euthanased by carbon dioxide asphyxiation 
followed by cervical dislocation.  Mice were dowsed with 70% ethanol and the peritoneal 
cavity was carefully opened.  The inguinal, mesenteric lymph nodes or spleens were 
removed as required.  The lymph nodes and spleens were placed in Collagenase II/DNase I 
solution (section 2.2.1) on ice until further use.   
 
For investigating total cell populations in lymphoid tissues, spleens were injected with 1 – 
2mL of Collagenase II/DNase I solution and the flow-through collected in 24 well plates 
(Falcon BD Labware, Franklin Lakes, NJ, USA).  The spleens were then placed in the 
collected solution and incubated for 30 minutes at 37°C.  Harvested lymph nodes were 
placed directly in 1mL Collagenase II/DNase I solution in 24 well plates and incubated as 
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above.  For the isolation of lymphocytes from spleens and lymph nodes, Collagenase 
II/DNase I digestion was excluded. 
  
Following incubation, lymph nodes and spleens were disrupted with the back of the 
plunger from 1mL syringes (BD, Singapore) and flushed with cRPMI through 40µm nylon 
cell strainers (Falcon BD Labware, Franklin Lakes, NJ, USA) into 50mL tubes (Falcon BD 
Labware, Franklin Lakes, NJ, USA).  Suspensions were then centrifuged for five minutes 
at 800 x g (RT) and contaminating RBCs lysed with Puregene RBC lysis buffer as 
described (section 2.8.2).  Cells were washed once and resuspended in cRPMI, filtered 
though 40µm cell strainers and placed on ice until further use.  Cell counts were performed 
as described for PECs (section 2.8.1). 
 
2.8.4 Preparation of primary mouse peritoneal mesothelial cells 
Harvesting and culturing of primary mouse PMCs was performed as previously described 
(126, 127).  Naïve C57Bl/6J mice were euthanased by carbon dioxide asphyxiation 
followed by cervical dislocation.  In a safety cabinet (class II, type A2) under sterile 
conditions, mice were sprayed with 70% ethanol and the skin and fur covering the 
peritoneum carefully separated without puncturing the peritoneal lining.  Resident 
peritoneal leukocytes were removed by injecting 5mL of 25U/mL heparin in D-PBS into 
the peritoneal cavity, injecting near the inguinal fat pads to allow resealing and minimal 
leakage of the injection site upon needle extraction.  After gently massaging the inflated 
peritoneum, the heparin/D-PBS (containing resident leukocytes) was extracted with a 
syringe, and the lavage repeated.  5mL of 0.25% Trypsin/EDTA (Invitrogen) pre-warmed 
to 37°C was injected into the peritoneal cavity and allowed to sit for 15 minutes under a 
heat lamp with occasional massaging.  The outside of the peritoneum was kept moist with 
D-PBS.  The Trypsin/EDTA was extracted and transferred to a sterile 50mL tube 
containing 200µL FBS.  The peritoneum was then washed twice with cRPMI and the 
extracted cells expelled into the same 50mL collection tube.   
 
The harvested cells were pelleted by centrifugation for five minutes at 500 x g (20°C), 
washed twice in D-PBS.  The final cell pellet was resuspended in peritoneal mesothelial  
cell (PMC) growth media (section 2.2.1) and cultured in 75cm2 collagen-coated culture 
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flasks (Falcon BD Labware, Franklin Lakes, NJ, USA).  Cells were grown out to the third 
passage (section 2.8.5) before use in experiments. Cells were confirmed as mesothelial by 
a squamous cobble stone appearance and positive immunofluorescence staining (section 
2.12.2) with a fluorescent-labelled anti-cytokeratin antibody.   
 
2.8.5 Culturing peritoneal mesothelial cells 
Primary mouse PMCs were harvested and cultured in 75cm2 collagen-coated culture flasks 
(section 2.8.4).  Just prior to cell confluence, the media was removed and the cells gently 
rinsed with D-PBS warmed to 37°C.  10% Trypsin/EDTA in D-PBS was added to cover 
the bottom of the flask, and the solution incubated at 37°C.  After two minutes, cells 
detachment was inspected using an Olympus CK2 inverted microscope (Olympus, Central 
Valley, PA, USA).  With gentle tapping, mesothelial cells detached from the culture flask 
while any contaminating macrophages remained adherent.  The activity of Trypsin/EDTA 
was terminated by the addition of cRPMI (2mL) to the flask.  The harvested mesothelial 
cells were pelleted from the solution by centrifugation for five minutes at 500 x g (RT) 
then resuspended in D-PBS and washed twice before further culture or preparation for 
immunofluorescent histology (section 2.12.2).  Cells were counted as described for PECs 
(section 2.8.1).   
 
2.9 Cell purification 
 
2.9.1 Enrichment of mouse monocytes and neutrophils  
Monocytes were isolated from PECs or peripheral blood from mice treated with MSU as 
described in sections 2.8.1 and 2.8.2 respectively.  Individual samples were pooled in 
sterile 50mL tubes, washed twice in D-PBS and resuspended in 5mL D-PBS.  4mL of 
Lympholyte®-M cell separation media (Cedarlane Laboratories Ltd., Hornby, Canada) was 
added below the cell suspension using sterile pasteur pipettes (Volac, Bacto Laboratories 
Pty Ltd., NSW, Australia).  The cells were centrifuged for 20 minutes at 1200 x g (RT).  
Enriched monocytes formed a buffy layer above the gradient medium (Diagram 2.1).  
Monocytes were collected and transferred to fresh 50mL tubes using transfer pipettes 
(Samco Scientific, San Fernando, CA, USA), washed twice, resuspended in cRPMI and 
Chapter 2.0: Materials and Methods 36 
placed on ice until further use.. This procedure resulted in a cell preparation that was 
greater than 75% monocytes. 
 
Neutrophils were also isolated from PECs using Lympholyte®-M cell density gradients as 
described for monocytes above.  In contrast to monocytes, the neutrophil-rich fraction 
pelleted to the bottom of the gradient (Diagram 2.1).  The supernatant was carefully 
removed by decanting, and the cells washed twice in D-PBS, then resuspended in cRPMI 
and placed on ice until further use.  This procedure resulted in a preparation what was 
greater that 80% neutrophils. 
 
 
Diagram 2.1: Schematic representation of cell purification by Lympholyte®-M 
density gradient.  After centrifugation for 20 minutes at 1200 x g (RT) monocytes from blood or 
peritoneal exudate cells formed a buffy layer directly above the gradient medium.  Neutrophils were pelleted 
at the bottom of the tube. 
 
2.9.2 Magnetic sorting of CD11b+ cells 
Monocytes were isolated from the blood using Lympholyte®-M cell density gradients as 
described (section 2.9.1).  The autoMACSTM cell separation system (Miltenyi Biotec, 
Bergisch Gladbach, Germany) was used for CD11b+ cell isolation.  The cells were 
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resuspended in 2mL autoMACS running buffer (section 2.2.2) and filtered through 30µm 
pre-separation filters (Miltenyi Biotec, Bergisch Gladbach, Germany).  To remove dead 
cells and debris, a positive selection was performed using an autoMACS separator 
(program “possel”, Miltenyi).  The negative fraction was collected, washed once and 
resuspended in 200µL running buffer.  PE-conjugated antibody specific for CD11b (Table 
2.1) was added to a dilution factor of 1 : 2,000µL and the cells incubated for 15 minutes on 
ice.  The cells were then washed twice in 50mL running buffer and resuspended in 200µL.  
Anti-PE beads ((Miltenyi Biotec, Bergisch Gladbach, Germany) were added to a dilution 
factor of 1 : 20µL, and the cells incubated for 30 minutes at 4°C under rotation.  Cells were 
then washed and resuspended in 2mL and separated using the autoMACS separator as 
above.  The positive fraction contained the CD11b+ purified cells (>80% CD11b+).  The 
suspensions were then washed once and resuspended in cRPMI for cell culture.   
 
2.10 In vitro assays 
 
2.10.1 Restimulation assay 
Harvested PECs from naïve, MSU- or thioglycollate- treated mice were purified by density 
gradient (section 2.9.1) and cultured in cRPMI at 5x105 cells/mL, 200µL per well in 96 
well flat-bottom plates (Falcon BD Labware, Franklin Lakes, NJ, USA).  Cells were either 
left unstimulated, treated with 500µg/mL MSU crystals, or with 100ng/mL 
Lipopolysccharide, E.coli 0111:B4 (LPS, Biolab Scientific, Australia) and incubated for 
eight hours at 37°C.  Supernatants were then harvested and stored at -20°C until analysis 
for cytokines and chemokines (section 2.4).   
 
2.10.2 Phagocytic assay 
PECs were harvested from naïve or MSU treated mice and purified by density gradient 
(section 2.9.1).  Cells were resuspended in cRMPI at 5x105 cells/mL and 2mL of cell 
suspension was placed into sterile 10mL tubes.  FluoSpheres® fluorescent microspheres 
(2% solids, Invitrogen) were diluted in D-PBS and 50µL of the diluted beads were added 
to the cells with a final dilution factor of 1:20,000 of the original 2% solids solution.  The 
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cell suspensions with added beads were then placed on a rotator (200rpm, 15mm radius) 
and incubated for 30 minutes at 37°C.  FBS at a volume of 1mL was then added below the 
cell suspension using sterile pasteur pipettes and centrifuged for five minutes at 800 x g 
(RT).  This pelleted the cells while separating non-phagocytosed beads at the serum-
medium interface.  The supernatant was then removed and the cells washed twice in FACS 
buffer, stained for the appropriate cell surface markers and analysed by flow cytometry 
(section 2.11).   
 
2.10.3 Proliferation assay 
Lymphocytes or splenocytes were isolated from naïve or treated mice as described (section 
2.8.3).  Cells were resuspended in cRPMI at 1x106 cells/mL and 50µL of cell suspension 
were added to 96 well round-bottom plates.  DynaBead® mouse CD3/CD28 T cell 
expander beads (Invitrogen) in D-PBS were added to the wells at a final concentration of 
2.5x104 beads/well.  The cultures were then incubated for 20 hours at 37°C.   
 
Alternatively, antibody-coated plates were used instead of expander beads.  To coat 96-
well plates, anti-mouse CD3 antibody (Table 2.1) and anti-mouse CD28 (Table 2.1) were 
diluted to 2µg/mL and 3µg/mL respectively in D-PBS and incubated in the wells overnight 
at 37°C.  Lymphocytes were then added as described above and incubated for 20 hours at 
37°C.   
 
After incubation, 25µL [3H]-thymidine (GE Healthcare, Buckinghamshire, UK) diluted 
1:100 in cRMPI (final concentration 0.5mCi) was added to each well and the cultures 
incubated for a further eight hours.  At different time points, cells were harvested from the 
culture plates onto printed glass fibre filter mats (PerkinElmer Lifesciences Inc., Boston, 
MA, USA) using a Tomtec automatic 96 well plate harvester (Tomtec, Hamden, CT, 
USA).  Filter mats were dried in a microwave oven, placed into plastic sample bags 
(PerkinElmer, Lifesciences Inc., Boston, MA, USA) and scintillated with Beta Scint liquid 
scintillation cocktail (Wallac, Turku, Finland).  The sample bags were sealed with a heat 
sealer (Wallac, Turku, Finland) and [3H]-thymidine incorporation was analysed using a 
1459 Microbeta Plus liquid scintillation counter (Wallac, Turku, Finland).   
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2.10.4 Suppression assay 
Monocytes from PECs or CD11b+ cells from blood were purified as described (section 
2.9.1/2.9.2 respectively).  Cells were resuspended in cRPMI at 5x105 cells/mL and 50µL of 
serial diluted (2x) cell suspensions were added to the appropriate wells containing 
lymphocytes or splenocytes and a proliferation assay carried out as described in section 
2.11.3.  
 
2.10.5 Peritoneal mesothelial cell stimulation assay 
Cultured PMCs (section 2.8.5) were suspended in cRPMI at 1x105 cells/mL and 200µL of 
cell suspension was placed into a sterile 96 well flat-bottom plate.  Cells were incubated 
for six hours, after which the culture medium was replaced with fresh cRPMI.  Anti-mouse 
CD14 blocking antibody (Table 2.1) was added to the appropriate wells at a final 
concentration of 20µg/mL and incubated for one hour at 37°C.  After incubation, cells 
were either left unstimulated or treated with 500µg/mL MSU crystals, or 100ng/mL LPS 
and incubated for six hours at 37°C.  Supernatants were then harvested and stored at -20°C 
until analysed for cytokine and chemokine production (section 2.4). 
 
2.10.6 Peritoneal membrane stimulation assay 
Naïve mice were sacrificed by carbon dioxide asphyxiation followed by cervical 
dislocation.  Mice were sprayed with 70% ethanol and under sterile conditions the skin and 
fur covering the peritoneum was carefully separated without puncturing the peritoneal 
lining.  The ventral tissue covering the peritoneal cavity was excised in approximately 
1.5cm2 pieces and placed into cRPMI in 24 well plates, on ice.  In a 96 well round-bottom 
plate, with the appropriate wells containing 200µL cRPMI, wells were either left untreated, 
or added with 500µg/mL MSU crystals or 100ng/mL LPS.  The visceral side of the excised 
peritoneal tissue was placed face down over the top of the wells and then the lid of the 96-
well plate placed over the top so as to form a seal between the tissue and the well. 
  
Alternatively, for CD14 blocking permutations, a final concentration of 20µg/mL of anti-
mouse CD14 antibody was added to the wells and incubated with the appropriate 
peritoneal tissue for one hour at 37°C prior to the addition of stimulants.  The plate was 
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then inverted to allow the media containing stimulants to contact the peritoneal tissue.  
Tissues were then incubated for six hours at 37°C, following which the supernatants were 
collected and assayed for cytokines/chemokines by ELISA and cytokine bead array 
(section 2.4).   
 
2.10.7 Preparation of neutrophil secretion 
Neutrophils were harvested from mice 18 hours after MSU administration and purified 
from PECs using Lympholyte®-M cell density gradients as described (section 2.9.1).  
Control neutrophils were cultured in cRPMI to give a high level of neutrophil viability 
over the period of incubation.  Neutrophils were suspended at 1x106 cells/mL and 2mL of 
cell suspension was placed into each well of sterile 24 well plates.  Cells were either left 
unstimulated or treated with 500µg/mL MSU crystals and incubated for eight hours at 
37°C.  Supernatants were then harvested and stored at -20°C until being assayed for 
cytokines and chemokines (section 2.4).   
  
To induce apoptosis in neutrophils, neutrophils starved of serum by being cultured in 
serum-free cRPMI (section 2.2.1).  Neutrophils were suspended at 1x106 cells/mL and 
2mL of cell suspension was placed into a sterile 50mL tube.  Cells were then placed on a 
rotator (200rpm, 15mm radius) and incubated for eight hours at 37°C.  Supernatants were 
harvested and stored at -20°C until being assayed for cytokines and chemokines (section 
2.4).  The percentage of apoptotic neutrophils was determined by annexin-V/PI double 
staining (section 2.14.1) together with the appropriate fluorescent-labelled antibodies 
(Table 2.1) and analysed by flow cytometry (section2.12).   
2.10.8 Culturing of monocytes with neutrophil secretions 
Mixed PECs or purified monocyte populations (5x105 cells/mL, 200µL per well) were 
suspended in either fresh cRPMI, cRPMI containing secretions from viable neutrophils 
(section 2.10.7), RPMI containing secretions from apoptotic neutrophils (section 2.10.7) 
with 10% FBS added to the monocyte culture (v/v), or untreated neutrophil secretions.  
Cells were either left unstimulated, treated with 500µg/mL MSU crystals, or with 
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100ng/mL LPS and incubated for eight hours at 37°C.  Supernatants were then harvested 
and stored at -20°C until analysis for cytokines and chemokines (section 2.4).   
 
2.11 Flow cytometry 
Cell suspensions from various preparations were transferred in a volume of 200µL to a 96 
well round-bottom plate.  The cells were centrifuged for one minute at 1800 x g (RT), the 
supernatant flicked off and the cells resuspended and washed again in 200µL FACS buffer.  
The cells were incubated with anti-mouse FcR antibody (Table 2.1) in 50µL FACS buffer 
for 10 minutes at RT.  After incubation, cells were washed in FACS buffer, and 
subsequently incubated with the appropriate 50µL master mix of fluorophore-labelled 
antibodies (Table 2.1) for 10 minutes on ice.  Cells were then washed in 200µL FACS 
buffer, filtered through gauze and transferred to Titertube® micro tubes (Bio-Rad, 
Hercules, CA, USA) . 
 
Flow cytometric analysis was performed on a BD FACSort (BD, San Jose, CA, USA) or 
BD FACSCalibur (BD, San Jose, CA, USA).  Unstained samples were used to distinguish 
between debris and living cells by their forward scatter (FSC) and side scatter (SSC) 
properties.  Unstained samples were also used to adjust the voltage corresponding to all 
four channels and samples stained with single fluorescent conjugated antibodies were used 
to compensate for overflow of fluorescence into other channels.  Data acquisition was 
carried out using the CellQuestTM Pro software (BD, San Jose, CA, USA) and the data 
analysed using the FlowJo software (tree Star Inc., Ashland, OR, USA).   
 
2.12 Histology 
 
2.12.1 Morphological histology for differential cell counts 
Cell samples in a volume of 100µL (1x106 cells/mL) were centrifuged for five minutes at 
800rpm (RT) onto glass slides (LabServ, Auckland, NZ) using a Shandon Cytospin 4 
cytocentrifuge (Thermo Scientific, Cheshire, UK) and were allowed to air-dry.  Cells were 
then fixed for five seconds in Diff-Quik Fixative (1.8mg/mL Triarylmethane dye methyl 
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alcohol), stained for ten seconds in Diff-Quik Solution I (1g/L Xanthine dye) and then 
stained for seven seconds in Diff-Quik Solution II (0.625g/L Azure A, 0.625g/L Methylene 
blue).  For differential cell counts, 200 cells were counted per sample.   
 
2.12.2 Immunofluorescent histology   
Immunoflourescent histology was performed as previously described (128).  In brief, 
resident macrophages or PMCs (section 2.9.5) from naïve mice were suspended in cRPMI 
at 1x105 cell/mL and 200µL placed in 8 chamber tissue culture glass slides (Falcon BD 
Labware, Franklin Lakes, NJ, USA).  After incubation for one hour at 37°C, GolgiStop 
(BD Biosciences, Mississauga, On, Canada) was added to the appropriate wells at a 
dilution factor of 1:1500.  Cells were then either left unstimulated, treated with 500µg/mL 
MSU crystals, or 100ng/mL LPS and incubated for four hours at 37°C. 
  
Following incubation, supernatants were removed and cells fixed and permeabilized with 
200µL ice-cold methanol and placed into the freezer at -20°C.  After ten minutes, cells 
were washed once with in-house D-PBS (section 2.2.1).  Non-specific antibody binding 
sites were blocked by incubation with block buffer (section 2.2.5) for 30 minutes at 37°C.  
After incubation, chambers were washed once with D-PBS and the primary antibodies 
anti-mouse cytokeratin (Table 2.1), anti-mouse MCP-1 (Table 2.1) or anti-mouse CD14-
A555 (section 2.14) suspended in block buffer were added to the appropriate wells and 
incubated at 37°C.  After one hour, chambers were washed three times with D-PBS, and 
fluorophore conjugated secondary antibodies suspended in block buffer were added to the 
appropriate wells and incubated for 30 minutes at 37°C.  Cells were then washed three 
times and fixed with 4% formalin for ten minutes at RT.  Cells were washed three times, 
the chambers removed, a drop of ProLong Gold anti-fade with DAPI (Invitrogen) applied 
and the slide mounted with a cover slip (Paul Marienfeld GmbH & Co., Lauda-
Königshofen, Germany).  Slides were examined using an Olympus BX51 fluorescent 
microscope (Olympus, Central Valley, PA, USA) and images visualized using software as 
described (section 2.16).   
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2.13 Preparation of clodronate liposomes 
Preparation of clodronate liposomes was performed as previously described (129).  In 
brief, 1.51mL of phosphatidylcholine stock solution (section 2.2.3) was added to 0.7mL 
cholesterol stock solution (section 2.2.3) in a 500mL round bottom flask.  The solvent was 
removed by placing the flask onto a rotary evaporator at 120mbar minimum (Vacuum 
controller V-850, Büchi) and 150rpm rotation (Rotavapor R-210, Büchi Labortechnik AG, 
Flawil, Switzerland).  A thin milky-white phospholipid film formed against the inside of 
the flask.  17.5mL of 0.7M clodronate solution (section 2.2.3) was added and then the film 
dispersed by gentle rotation (150rpm) at RT for 10 minutes.  The resulting suspension was 
held under nitrogen gas for two hours at RT and then gently shaken and sonicated in a 
waterbath at 40kHz (Ultrasonic cleaner FXP8M, Unisonics, Manly Vale, NSW, Australia) 
for three minutes.  The suspension was held under nitrogen gas overnight at 4°C.   
  
The liposome suspension was transferred to a 50mL tube and centrifuged for 40 minutes at 
1800 x g (10°C) with the brakes off.  Liposome-encapsulated clodronate (1 – 2% of the 
clodronate is encapsulated (129)) formed a white band at the top of the suspension.  The 
non-encapsulated clodronate solution, which sat under the white band of clodronate 
liposomes, was carefully removed with a syringe.  The clodronate solution was filtered 
through a 32mm syringe filter with 0.2µm Supor® membrane and stored at -20°C for 
repeated use (up to three times).  The clodronate liposomes were then washed twice with 
10mL D-PBS (20 minutes at 1200 x g, 10°C) and resuspended to a final volume of 7mL D-
PBS.  Liposomes were stored at 4°C and used within three days of preparation.   
 
2.13.1 In vivo depletion of resident macrophages  
Mice were either left untreated or injected i.p. with 200µL clodronate liposomes (section 
2.13).  Three days following the first injection, both untreated and treated mice were 
challenged with an i.p. injection of 3mgMSU crystals suspended in 0.5mL D-PBS 
following which PECs were harvested by lavage (section 2.8.1).  Immediately before 
transfer to syringes and before injections, the clodronate liposome suspension was gently 
shaken to ensure even dispersion.   
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2.14 Fluorophore labelling of antibodies and proteins 
AlexaFluor-488 (Invitrogen), -555 (Invitrogen) or -647 (Invitrogen) were dissolved in 
Dimethlsulfoxide (DMSO, Sigma-Aldrich) at 20mg/mL, and stored at -20°C in 10µL 
aliquots.  Proteins (section 2.3) at 0.5mg/mL or antibodies (Table 2.1) at 1mg/mL were 
resuspended in freshly made 0.1M NaHCO3 buffer (section 2.2.6), placed into Vivaspin 
500 exclusion columns (Sartorius, AG, Göttingen, Germany) and centrifuged using a IEC 
Micromax microcentrifuge (Thermo Scientific, Waltham, MA, USA) at 10,000 rpm for ten 
minutes, this process was then repeated.  Proteins or antibodies were transferred to 1.5mL 
eppendorf tubes (Axygen, Union City, CA, USA) and resuspended to 1.5mg/mL in 0.1M 
NaHCO3 buffer.  While vortexing, 10µg of fluorescent dye was added per 50µg of protein 
or 100µg of antibody.  The samples were then incubated for ten minutes at RT, transferred 
to Vivapsin 500 exclusion columns and washed with 0.1M Tris buffer (section 2.2.6) at 
10,000 rpm for ten minutes.  Samples were then washed twice with D-PBS until the flow-
through became transparent.  Labelling of proteins or antibodies was validated by flow 
cytometry.    
 
2.14.1 Annexin-V and propidium iodide (PI) double staining 
Purified neutrophils (section 2.9) were washed and stained with FITC-labelled annexin-V  
(5µL/100µL cells) and 10µg/mL PI in annexin-V binding buffer (section 2.2.3).  Staining 
was then determined by flow cytometry.  Double negatives indicate viable cells, annexin-V 
single positive indicate early apoptotic cells.  PI single positives are necrotic cells, while 
annexin-V/PI double positives are late stage dying and dead cells.   
 
2.15 Image analysis and editing 
Microscope images of cells were acquired and optimised using AnalySIS Life Imaging 
Software (Olympus Soft Imaging Solutions GmbH, Münster, Germany).  Photoshop 
software (Adobe Systems Inc., San Jose, CA, USA) was used on microscopic images to 
remove debris from acquired images.   
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2.16 Statistical analysis 
To determine statistical significance when there were two treatment groups within an 
experiment, the Student’s T-test was used.  The one-way ANOVA and Tukey multiple 
comparison tests were used in experiments for which there were two or more groups.  
Statistical significance was determined when P < 0.05.  All statistical analysis were carried 
out with the software GraphPad Prism (GraphPad Software Inc., San Diego, CA, USA).
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3.1 Introduction 
A key characteristic of mononuclear phagocytes is their plasticity, making it a challenge to 
clearly identify myeloid lineage-defined cell subsets.  It is becoming increasingly clear that 
microenvironmental signals can influence the heterogeneity of monocyte-macrophage 
subsets.  Examples of how the local inflammatory environment is capable of altering the 
monocyte/macrophage phenotype can be observed in a variety of disease conditions such 
as tumours, autoimmunity and acute inflammation.   
 
3.1.1 The inflammatory environment in tumours 
During inflammation, mononuclear precursors are recruited into a variety of local 
environments that influence cellular differentiation and function.  For example, anti-
inflammatory molecules (such as glucocorticoid hormones, IL-4, IL-13 and IL-10) present 
within the tumour environment generate a population of tumour-associated macrophages 
(TAMs) (57, 95, 96).  These resident cells are responsible for the production of anti-
inflammatory cytokines TGF-β (98) and IL-10 (97) and contribute to over-suppression of 
the immune response, leading to tumour angiogenesis (98). 
 
Both the anti-inflammatory cytokine IL-10 released by resident TAMs and macrophage-
colony stimulating factor (M-CSF) present in the tumour environment play a prominent 
role in driving the differentiation of recruited monocyte precursors into TAMs by blocking 
their differentiation into DCs (96, 108).  This reprogramming of monocyte differentiation 
is thought to be an important determinant of the proportion of TAMs versus tumour-
associated DCs (TADCs) and their relative distribution in different tumours (130). 
 
Colony-stimulating factors (such as M-CSF) generated during tumour growth are also 
thought to play a role in the development of an immature myeloid cell population or 
myeloid-derived suppressor cells (MDSCs) (96, 131, 132).  MDSCs are potent suppressors 
of T-cell responses, especially CD8+ T cells, and have been associated with tumour 
expansion in both tumour-bearing mice and cancer patients (133-135).   
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3.1.2 The inflammatory environment in multiple sclerosis 
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous 
system (CNS).  Experimental autoimmune encephalomyelitis (EAE) is a murine model of 
this disease extensively used in research.  In the CNS of EAE mice, CD11b+ Ly6Chi 
myeloid precursor cells (136) are recruited into a local environment rich in IFN-γ, TNFα 
(99) and IL-17 (100, 101).  In these surroundings, recruited monocytes differentiate into 
macrophages (102) that can escalate disease symptoms through the production of reactive 
oxygen species and pro-inflammatory cytokines (103), leading to demyelination and 
axonal damage (104).  The same subset of circulating myeloid precursor cells identified in 
the EAE model have also be found in the spleen and have been shown to suppress CD4+ T 
cell proliferation ex vivo (137).  These myeloid cells with altered functions have been 
characterised as MDSCs (119, 137, 138) and may have displayed differential functions 
simply because of the differences in recruitment environments (between the CNS and 
spleen in the EAE model).     
 
3.1.3 Monocyte recruitment in an MSU-induced inflammatory 
environment  
Gout is characterized by the deposition of needle-like MSU crystals within the joint 
synovium (139, 140).  Using the murine model of gout, recent findings by other members 
of our group have shown that the initiation of MSU-induced acute inflammation is 
mediated by activated resident macrophages (58).  The early inflammatory profile of gout 
involves a peak of pro-inflammatory cytokines (predominantly IL-1β, IL-6, and TNFα) 
within the local environment, which resolves within 4 – 6 hours (58).  Chemoattractants 
(such as MCP-1 and KC) have been shown to be responsible for the rapid influx of 
leukocytes into the peritoneum, peaking at approximately 18 – 24 hours after stimulation. 
 
Unlike tumour or EAE models, in MSU-induced inflammation circulating monocytes are 
recruited into a highly pro-inflammatory environment (IL-1β, IL-6 and TNFα).  Previous 
studies have proposed that following infiltration, MSU-recruited monocytes play a pro-
inflammatory role through the production of cytokines such as IL-6 and TNFα (40, 41, 
43), and then become non-inflammatory as they differentiate into macrophages (111, 113).  
However, the results of these in vitro and ex vivo studies were based on immortalised cells 
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expressing monocyte- and macrophage-like phenotypes.  Recent ex vivo studies within our 
group indicate that MSU-recruited monocytes are non-responsive to MSU crystal 
restimulation and only become pro-inflammatory once they have acquired more 
macrophage-like characteristics (58).  This indicates a different monocyte/macrophage 
phenotype generated in an acute inflammatory environment, which has not been previously 
investigated in vivo.   
 
3.1.4 The inflammatory monocyte subpopulation 
In C57Bl/6J mice, circulating monocytes are primarily identified by their expression of 
CD11b, low levels of F4/80, and intermediate levels of Gr-1 (Ly6C- and Ly6G+) (57).  The 
Gr1-1hi circulating monocytes, displaying a CX3CR1lowCCR2+ phenotype, are recruited to 
inflamed peripheral tissue by MCP-1, the ligand for CCR2 (57, 90, 91).  Consequently, 
these monocytes are more commonly referred to as inflammatory monocytes (90).  Recent 
findings have shown that these particular subpopulations of circulating monocytes display 
a tendency to “home” to sites of inflammation and differentiate into F4/80hi macrophages 
(57, 141).   
 
3.1.5 Effects of neutrophils on the inflammatory environment 
As previously described, infiltrating neutrophils appear to contribute to the acute pro-
inflammatory environment through the production of IL-8, superoxide and S100A8/A9 
proteins (67, 87, 103).  This has the effect of recruiting more neutrophils and amplifies the 
overall inflammatory response.  Neutrophils may also have a direct effect on the 
monocyte/macrophage phenotype.  The phagocytosis of apoptotic neutrophils has been 
shown previously to drive monocyte/macrophage switching from a “pro”- to “anti”- 
inflammatory phenotype (113, 142, 143).  This process is a common mechanism in the 
resolution of acute inflammation and may also serve to limit the degree of tissue damage.   
 
3.1.6 Effects of resident macrophage depletion on cellular 
recruitment  
Previous studies within our group have shown that in a macrophage-depleted environment, 
monocyte recruitment is unaffected, whilst neutrophil infiltration is significantly abrogated 
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(58).  Using MSU crystal stimulation as an in vivo method of monocyte recruitment, this 
provides an opportunity to examine the impact of a less pro-inflammatory environment (in 
the absence of resident macrophages and infiltrating neutrophils) on the differentiation and 
function of MSU-recruited monocytes.  
 
3.1.7 Objectives 
The aim of this chapter was to determine the effect of different acute inflammatory 
environments on MSU-recruited monocyte differentiation and function, using a mouse 
model of MSU-induced peritoneal inflammation.  To achieve this, the differentiation 
pathway of MSU-recruited monocytes in normal C57Bl/6J mice was profiled, and 
compared to the differentiation pathway in macrophage-depleted mice.  In addition, the 
functional phenotype of MSU-recruited monocytes from normal and macrophage-depleted 
mice was compared during MSU-induced inflammation.   
 
3.2 Results 
 
3.2.1 Profiling the cell subsets observed in MSU-induced 
inflammation  
To profile the recruited leukocytes involved in MSU-induced inflammation, methods were 
established to distinguish the different cell populations morphologically.  Peritoneal 
lavages were carried out on naïve or MSU-treated mice and the cells centrifuged onto glass 
slides, fixed with a DiffQuik staining kit and examined under a microscope.  Compared to 
the resident macrophages from naïve mice (Figure 3.1A), MSU-recruited monocytes were 
distinguishable by their smaller, less foamy, bean shaped nuclei (Figure 3.2B).  While 
infiltrating neutrophils contained ‘multi-lobular’-like nuclei typical of polymorphonuclear 
cells (Figure 3.1B).    
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Figure 3.1: Morphology of cells involved in the peritoneal model of MSU-induced 
inflammation.  C57Bl/6J mice were administered with an i.p. injection of MSU crystals (3mg/0.5mL).  
After 18 hours, peritoneal exudate cells were harvested by lavage.  Cells were resuspended in cRMPI 100µl 
of cell suspension centrifuged onto glass slides using a cytocentrifuge.  Cells were then fixed with a DiffQuik 
staining kit and examined under a microscope.  A. Resident macrophages B. MSU-recruited monocytes 
(white arrow) and neutrophils (black arrow).  Original magnification 100x.  Scale bar represents 50µm.  
Results are representative of three independent experiments. 
 
Although cell morphology showed an obvious distinction between newly recruited 
monocytes and fully mature macrophages, clear identification of phenotypic changes at 
different stages of cell differentiation can be difficult.  Therefore, further examination of 
cell surface markers using flow cytometry was also used in order to distinguish between 
different cell populations, and more accurately identify the different stages of monocyte to 
macrophage differentiation in MSU-induced inflammation. 
 
To develop a flow cytometry gating strategy to identify different monocytes/macrophage 
populations, C57Bl/6J mice were administered with an i.p. injection of MSU crystals 
(3mg/0.5mL).  After four hours, PECs were harvested and stained for the murine 
macrophage marker F4/80 and the myeloid antigens Gr-1 and 7/4.  Monocyte and 
neutrophil populations could then be distinguished from each other based on their relative 
expression of Gr-1 and 7/4, with monocytes expressing Gr-1int, 7/4hi  (Figure 3.2A, R1) 
and neutrophils displaying Gr-1hi, 7/4hi (Figure 3.2A, R2).  In addition, the two subsets 
could be further characterised by their F4/80 expression, with monocytes staining F4/80int 
(Figure 3.2A, R3), and neutrophils staining F4/80- (Figure 3.2A, R4).   
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Resident macrophages were also harvested from naïve C57Bl/6J mice by peritoneal lavage 
and stained with the same cell surface markers in order to distinguish them from MSU-
recruited monocytes.  Resident macrophages expressed high levels of F4/80 (Figure 3.2B, 
gate R5) and stained negative for both Gr-1 and 7/4 (Figure 3.2B, gate R6).   
 
 
Figure 3.2: Identification of cell types involved in MSU-induced inflammation in vivo.  
C57Bl/6J mice were administered with an i.p. injection of MSU crystals (3mg/0.5mL).  After four hours, 
peritoneal exudate cells were harvested, stained for cell surface antigen Gr-1, 7/4 and F4/80 and samples of 
individual mice analysed by flow cytometry.  A. Monocytes were identified as Gr-1int, 7/4hi (gate R1) and 
F4/80int (gate R3) while neutrophils were Gr-1hi, 7/4hi (gate R2) and F4/80- (gate R4).   B. F4/80hi resident 
macrophages (gate R5) were 7/4- and Gr-1- (gate R6) was identified in naïve mice.  Results are representative 
of at least three independent experiments. 
 
Therefore, from the analysis of cell surface marker expression, the staining strategies 
applied were: monocytes (Gr-1int, 7/4hi, F4/80int), neutrophils (Gr-1hi, 7/4hi, F4/80-) and 
macrophages (Gr-1-, 7/4-, F4/80hi). 
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3.2.2 Depletion of peritoneal resident macrophages with clodronate 
liposomes 
To investigate the influence of the inflammatory environment on MSU-recruited 
monocytes, we sought to deplete the resident peritoneal macrophage population using 
clodronate liposomes (129, 141).  This process removed the predominant initiators of acute 
inflammation prior to MSU crystal administration, thereby altering the inflammatory 
environment into which monocytes were recruited.  Encapsulated clodronate (Diagram 
3.1A) has been previously used in experimental models to deplete phagocytes both in the 
blood (141, 144) and in local tissues (145).  Upon phagocytosis, intracellular lysosomal 
phospholipases disrupt the phospholipid bilayers of the vesicles, release the drug (Diagram 
3.1B) and elicit apoptosis (146-149).  Non-specific depletion of cells with limited 
phagocytic abilities (such as neutrophils and epithelial cells) does not occur as they do not 
have the necessary intracellular biochemical machinery required to sequester toxic levels 
of intracellular clodronate (150). 
 
 
Diagram 3.1: Schematic representation of clodronate liposome uptake by phagocytic 
cells.  A. Liposomes are artificially prepared fatty vesicles, constructed from phospholipid bilayers 
separated by aqueous compartments.  Hydrophilic molecules such as clodronate dispersed in water are 
encapsulated during the formation of the liposomes.  B. Clodronate encapsulated liposomes (squares) are 
phagocytosed by macrophages via endocytosis.  Fusion with lysosomes (L) results in the disruption of the 
liposome bilayers by phospholipases (diamonds).  Increased amounts of clodronate are released as more 
concentric bilayers are disrupted.  (N = macrophage nucleus).  Diagram 3.1 was modified from (129). 
 
Preliminary experiments were conducted to determine the time-course and efficiency of 
the depletion process.  Naïve C57Bl/6J mice were injected intraperitoneally with a 200µL 
(0.7M) solution of clodronate-encapsulated liposomes.  As shown in Figure 3.3, liposome 
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treatment depleted over 95% of resident F4/80+ cells three days after liposome 
administration as previously described (141).  The small proportion of remaining F4/80int 
cells observed represented a small number (5%) of migrating monocytes (Figure 3.3B). 
 
 
Figure 3.3: Clodronate liposome depletion of peritoneal resident macrophages.  
C57Bl/6J mice were either A. left untreated or B. injected intraperitoneally with 200µL of clodronate 
liposomes.  After three days, peritoneal exudate cells were harvested by peritoneal lavage, stained for cell 
surface antigens Gr-1 and F4/80 and samples of individual mice analysed by flow cytometry.  Arrow 
represents a small population (5%) of migrating F4/80int cells.  Plots are gated on Gr1- and F4/80hi 
macrophages.  Results are representative of at least three independent experiments.   
 
Therefore, to induce acute inflammation after depleting the resident macrophages, MSU 
crystal administration was given at three days post intraperitoneal treatment; this 
represented the time of maximum macrophage depletion.   
 
3.2.3 Effect of macrophage depletion on MSU-induced leukocyte 
recruitment  
As the previous depletion experiment was conducted for a single time-point only, we 
subsequently sought to investigate the effects of macrophage depletion on cell recruitment 
over the course of an entire MSU-induced inflammatory response.   
 
C57Bl/6J mice were either left untreated or injected intraperitoneally with clodronate 
liposomes.  Three days post-liposome treatment, mice were injected i.p. with 3mg/0.5mL 
Chapter 3.0: The Impact of the Inflammatory Environment on the Differentiation and 
Function of Recruited Monocytes in MSU-induced inflammation 
55 
of MSU crystals.  At different time-points, PECs were recovered and the total number of 
viable cells determined using trypan blue exclusion.  In the conventional MSU-induced 
inflammatory model, total cell infiltration peaked at 18 hours after MSU administration 
and began to resolve after 24 hours (Figure 3.4).  However, after the depletion of resident 
macrophages, the peak of MSU-induced cellular recruitment was significantly abrogated 
(Figure 3.4).     
 
 
Figure 3.4: Total cell infiltration after clodronate liposome depletion of resident 
macrophages.  C57Bl/6J mice were either left untreated or administered with an i.p. injection of 200µL 
clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  At 
different time-points, peritoneal exudate cells were harvested and total cell numbers determined by mixing 
10µL of cell suspension with 90µL of Trypan Blue Stain.  The mixture was placed on a hemocytometer and 
viable cells that excluded the dye were counted under a microscope.  Values represent mean ± S.E.M.  * = P 
< 0.05 as determined by two-tailed unpaired Student t-test.  Results are representative of two independent 
experiments with four mice per group.  
 
We next asked the question: whether the change in total cell numbers was due to a general 
reduction in cell infiltration or a decrease in the recruitment of a specific cell type?  
 
In MSU-induced inflammation, cellular infiltration is largely comprised of monocytes and 
neutrophils; with the latter been shown to migrate in greater numbers compared to 
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monocytes (58).  To determine the profile of different infiltrating cells after MSU 
stimulation, PECs slides were prepared, fixed with DiffQuik staining kit and differential 
counts performed based on cell morphology as previously described (section 3.2.1).  
Analysis of recruited leukocyte populations showed that depletion of resident macrophages 
significantly abrogated neutrophil infiltration into the peritoneum (Figure 3.5). 
 
 
Figure 3.5: Neutrophil recruitment after resident macrophage depletion in MSU-
induced inflammation.  C57Bl/6J mice were either left untreated or administered with an i.p. injection 
of 200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  
At different time-points, peritoneal exudate cells were harvested and 100µl of cell suspension centrifuged 
onto glass slides using a cytocentrifuge.  Cells were then fixed with a DiffQuik staining kit and differential 
cell counts performed, 200 cells were counted per sample. Values represent mean ± S.E.M.  * = P < 0.05 ** 
= P < 0.005 as determined by two-tailed unpaired Student t-test.  Results are representative of two 
independent experiments with four mice per group. 
 
Whilst infiltrating neutrophil numbers were significantly reduced after macrophage 
depletion, the total number of monocytes recruited remained unaffected in vivo (Figure 
3.6).  The profile of monocyte recruitment was similar between normal and macrophage-
depleted mice across the entire inflammatory response (Figure 3.6).   
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Figure 3.6: Monocyte recruitment after resident macrophage depletion in MSU-
induced inflammation.  C57Bl/6J mice were either left untreated or administered with an i.p. injection 
of 200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  
At different time-points, peritoneal exudate cells were harvested and 100µl of cell suspension centrifuged 
onto glass slides using a cytocentrifuge.  Cells were then fixed with a DiffQuik staining kit and differential 
cell counts performed, 200 cells were counted per sample. Values represent mean ± S.E.M.  Results are 
representative of two independent experiments with four mice per group. 
 
These results were also consistent with our group’s previous findings that macrophage 
activation is responsible for neutrophil but not monocyte recruitment (58). 
 
3.2.4 Effect of macrophage depletion on the production of MSU-
induced cytokines and chemokines 
We next investigated the impact of resident macrophage depletion on the 
cytokine/chemokine milieu within the peritoneum after MSU stimulation.  Analysis of the 
levels of pro-inflammatory cytokines in the supernatants within the PBS lavage fluid in 
normal MSU-treated mice showed that IL-1β and IL-6 levels in the peritoneum all peaked 
within four hours of MSU administration, returning to normal within 24 hours (Figure 
3.7A and Figure 3.7B).  TNFα showed a biphasic pattern over the course of the 
inflammatory response (Figure 3.7C).   
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Depletion of resident macrophages prior to MSU administration significantly decreased 
IL-6 and IL-1β production compared to the normal (Figure 3.7A and Figure 3.7B).  There 
were no significant differences in TNFα levels detected between the macrophage-depleted 
and non-depleted groups (Figure 3.7C).  
 
 
Figure 3.7: Pro-inflammatory cytokines in the peritoneum after MSU administration.  
C57Bl/6J mice were either left untreated or administered with an i.p. injection of 200µL clodronate 
liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  At different time-
points, peritoneal lavages were performed and samples centrifuged.  Supernatants from each sample were 
collected and levels of IL-1β, IL-6 and TNFα determined by ELISA or Bioplex bead array. Values represent 
mean ± S.E.M.  * = P < 0.05 ** = P < 0.005 as determined by two-tailed unpaired Student t test.  Results are 
representative of two independent experiments with four mice per group. 
 
As the depletion of resident macrophages decreased neutrophil infiltration in response to 
MSU stimulation but left monocyte recruitment unaffected, we next looked at the 
chemokine levels detected in the peritoneal lavage fluid.   
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Recruitment of neutrophils into the peritoneum during MSU-induced inflammation is 
associated with the production of the neutrophil chemokine KC (the mouse ortholog to the 
gene encoding human IL-8 (65)), whereas monocyte infiltration is mediated by the 
chemoattractant MCP-1.  Like the pro-inflammatory cytokines, MCP-1 and KC levels in 
the peritoneum of normal MSU-treated mice also peaked within four hours of MSU 
administration, and returned to normal levels within 24 hours (Figure 3.8A and Figure 
3.8B). 
 
Following depletion of resident macrophages MSU crystal administration significantly 
abrogated MCP-1 and KC production in vivo (Figure 3.8A and Figure 3.8B).  
 
 
Figure 3.8: Pro-inflammatory chemokines in the peritoneum after MSU 
administration.  C57Bl/6J mice were either left untreated or administered with an i.p. injection of 200µL 
clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  At 
different time-points, peritoneal lavages were performed and samples centrifuged.  Supernatants from each 
sample were collected and levels of MCP-1 and KC determined by Bioplex bead array.  Values represent 
mean ± S.E.M.  * = P < 0.05 ** = P < 0.005 as determined by two-tailed unpaired Student t test.  Results are 
representative of two independent experiments.  Results are representative of two independent experiments 
with four mice per group. 
 
Together these results showed that macrophage depletion abrogates MSU-induced 
neutrophil infiltration without affecting monocyte recruitment and confirmed that 
monocytes recruited by MSU-stimulation in the absence of resident macrophages migrate 
into a significantly less inflammatory environment.  This led to the question: do the 
monocytes migrating into the abrogated inflammatory environment differentiate or 
function differently to those recruited into a normal inflammatory environment? 
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3.2.5 Cell morphology of MSU-recruited monocytes in normal versus 
macrophage-depleted mice 
To investigate whether the MSU-recruited monocytes from normal and macrophage-
depleted mice exhibited variations in differentiation, normal and clodronate liposome-
treated C57Bl/6J mice were injected with MSU crystals (3mg/0.5mL) and the PECs 
harvested at different time-points.  The different recruited monocyte populations were then 
characterised based on morphology, cell surface marker expression and functional 
phenotype.   
 
After four hours, infiltrating monocytes from both normal and macrophage-depleted mice 
displayed similar cell morphologies (Figure 3.9).  However, at 24 hours, monocytes from 
untreated mice displayed larger cytoplasmic volume compared to monocytes from 
macrophage-depleted mice (Figure 3.9).  One week after MSU administration, monocytes 
recruited in macrophage-depleted mice were clearly smaller in size than monocytes 
recruited into a normal MSU-induced inflammatory environment (Figure 3.9).   
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Figure 3.9: Morphology of recruited monocytes during the course of an MSU-induced 
inflammatory response.  C57Bl/6J mice were either left untreated or administered with an i.p. 
injection of 200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals 
(3mg/0.5mL).  At different time-points, peritoneal exudate cells were harvested and 100µl of cell suspension 
centrifuged onto glass slides using a cytocentrifuge.  Cells were then fixed with a DiffQuik staining kit and 
analysed under a microscope. Original magnification 100x.  Scale bar represents 50µm.  Results are 
representative of three independent experiments. 
 
The cell morphologies shown above indicated a delay in MSU-recruited monocyte to 
macrophage differentiation in macrophage-depleted compared to normal mice.   
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3.2.6 Effects of monocyte transmigration on surface marker 
expression 
We next sought to investigate whether cell surface markers associated with differentiation 
correlated with the observed variations in cell morphology.   
 
Before investigating the expression of MSU-recruited monocyte differentiation markers at 
different time-points along the inflammatory response, the expression of key 
monocyte/macrophage cell surface antigens on both blood and (4-hour) MSU-recruited 
monocytes was first studied.   
 
F4/80 is a key macrophage cell surface marker used to distinguish between the different 
stages of monocyte differentiation.  This provides an additional marker in conjunction with 
other cell surface antigens such as 7/4 and Gr-1 (hemopoietic markers), CD206 (mannose 
receptor) and CD14 (TLR4 complement molecule) to profile the stages of monocyte to 
macrophage differentiation after MSU-induced recruitment.    
 
Naïve C57Bl/6J mice were tail-bled and the RBCs lysed with ACT lysis buffer.  Cell 
suspensions were then stained with fluorescent antibodies for the monocyte surface 
antigens Gr-1, 7/4, and CD11b, and also for macrophage differentiation markers F4/80, 
CD14 and CD206, and analysed by flow cytometry.  The same staining protocol was 
utilized for PECs harvested from mice administered with MSU crystals i.p. for four hours.   
 
MSU-recruited monocytes showed no decrease in the hemopoietic cell marker Gr-1; 
however, 7/4 was significantly downregulated (Figure 3.10).   In terms of the 
differentiation markers, F4/80 expression on monocytes was unaltered following 
recruitment whilst CD14 expression increased and CD11b expression decreased (Figure 
3.10).  CD206 expression was barely detectable on both blood and recruited monocytes 
(Figure 3.10).  These data indicated that the process of recruitment alone alters 
inflammatory monocyte surface phenotype.   
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Figure 3.10: The process of migrating from the bloodstream through the endothelium 
alters inflammatory monocyte surface marker expression.  C57Bl/6J mice were tail-bled 
prior to being administered with an i.p. injection of MSU crystals (3mg/0.5mL).  After four hours, peritoneal 
exudate cells were harvested, stained for cell surface antigens and samples of individual mice analysed by 
flow cytometry.  Plots are gated on Gr1in and F4/80int monocytes. Values represent mean ± S.E.M. * = P < 
0.05 ** = P < 0.005 *** = P < 0.0005 as determined by two tailed unpaired Student t-test.  Results are 
representative of at least three independent experiments with three mice per group.   
 
3.2.7 Changes in surface marker expression of monocytes recruited 
into a macrophage-depleted environment 
In order to further compare the profile of MSU-recruited monocytes from normal and 
macrophage-depleted mice, PECs were isolated from normal and macrophage-depleted 
mice at different time-points and the surface phenotypes compared.  In the normal MSU-
induced inflammation model, recruited F4/80int monocytes rapidly downregulated 
hemopoietic cell surface markers Gr-1 and 7/4 within 24 – 72 hours after recruitment 
(Figure 3.11).  Monocytes recruited into a macrophage-depleted environment showed a 
trend towards a delay in the downregulation of these surface antigens (Figure 3.11).   
 
As observed previously in section 3.2.2, the small proportion of F4/80int monocytes (5%) 
present in the peritoneum of macrophage-depleted mice at 0-hours was also observed 
during flow cytometry analysis.  
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Figure 3.11: Hemopoietic cell surface markers of monocytes recruited into a 
macrophage-depleted environment.  C57Bl/6J mice were either left untreated or administered with 
an i.p. injection of 200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals 
(3mg/0.5mL).  At different time-points, peritoneal exudate cells were harvested,stained for cell surface 
antigens Gr-1 and 7/4 and samples of individual mice analysed by flow cytometry.  Arrows represent a small 
population (5%) of migrating F4/80int cells.  Plots are gated on Gr1in and F4/80int monocytes.  Values 
represent mean ± S.E.M.  * = P < 0.05 as determined by two tailed unpaired Student t-test.  Results are 
representative of two independent experiments with four mice per group. 
 
Following MSU-administration, infiltrating monocytes were analysed for their expression 
of common macrophage differentiation markers (F4/80, CD14, CD11b and CD206).  
Resident macrophages were used as a positive control (F4/80hi, CD14hi, CD11bhi and 
CD206hi) (Figure 3.12, 0h).  MSU-recruited monocytes from both normal and 
macrophage-depleted mice increased surface expression of F4/80, and CD11b as well as 
the mannose receptor CD206 and the TLR4 complement molecule CD14 over-time with 
no significant differences between the two profiles (Figure 3.12).   
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Figure 3.12: Differentiation cell surface markers of monocytes recruited into a 
macrophage-depleted environment.  C57Bl/6J mice were either left untreated or administered with 
an i.p. injection of 200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals 
(3mg/0.5mL).  At different time-points, peritoneal exudate cells were harvested, stained for cell surface 
antigens F4/80, CD14, CD11b and CD206 and samples of individual mice analysed by flow cytometry.  
Plots are gated on Gr1in and F4/80int monocytes.  Values represent mean ± S.E.M.  Results are representative 
of two independent experiments with four mice per group. 
 
In summary, MSU-recruited monocytes entering a macrophage-depleted environment 
showed no significant trends towards delayed surface marker expression associated with 
monocyte to macrophage differentiation.   
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3.2.8 The effect of macrophage depletion on MSU-recruited 
monocyte function 
We next sought to investigate whether MSU-induced recruitment of monocytes into a 
normal compared to a macrophage-depleted environment altered monocyte function.     
 
Normal or macrophage-depleted mice were administered MSU i.p. and at different time-
points PECs were harvested.  Recruited monocytes were purified using a Lympholyte®-M 
density gradient (>75% monocytes based on flow cytometry analysis of F4/80int Gr-1hi 
population).  Purified MSU-recruited monocytes were then cultured ex vivo in the presence 
of MSU crystals (500µg/mL) or LPS (100ng/mL), and the supernatant analysed for pro-
inflammatory cytokines by ELISA or Bioplex bead array.  As a positive control, resident 
macrophages were harvested from naïve mice and stimulated with MSU crystals or LPS 
(Figure 3.13A and Figure 3.13B, 0h). 
 
MSU-recruited monocytes from normal mice at the early stages of inflammation (4 hours) 
did not produce pro-inflammatory cytokines after MSU restimulation. However, as the 
inflammatory response progressed (8 hours onwards), MSU-recruited monocytes increased 
their capacity to produce IL-1β and IL-6 (Figure 3.13A and Figure 3.13B).  Similar trends 
were observed for LPS restimulation.   
 
Monocytes recruited into a macrophage-depleted environment did not produce IL-1β and 
IL-6 after MSU restimulation until time-points 24 hours to 1 week (Figure 3.13A and 
Figure 3.13B).   
 
While there was no significant difference in LPS elicited IL-1β production by recruited 
monocytes from macrophage-depleted mice compared to normal mice (Figure 3.13A). 
Recruited monocytes from macrophage-depleted mice produced significantly less IL-6 
following restimulation 18 hours after MSU administration (Figure 3.13A).  
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Figure 3.13: Production of pro-inflammatory cytokines by recruited monocytes after 
restimulation.  C57Bl/6J mice were either left untreated or administered with an i.p. injection of 200µL 
clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  At 
different time-points, peritoneal exudate cells were harvested and purified by Lympholyte®-M density 
gradient (>75% monocytes).  Cells were resuspended at 5x105 cells/mL in cRPMI and 200µL was cultured in 
the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  After the incubation period, levels of 
IL-1β and IL-6 were determined by ELISA and Bioplex bead array.  Negative controls for IL-1β (1-5pg/mL) 
and IL-6 (5-15pg/mL) were omitted from the graph.  Measurements performed in quadruplicate.  Values 
represent mean ± S.E.M.  * = P < 0.05 ** = P < 0.005 as determined by one-way ANOVA and Tukey 
multiple comparison test.  Results are representative of the accumulated data from two independent 
experiments with eight mice per group.   
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The capacity of recruited monocytes to produce the chemoattractants MCP-1 and KC after 
restimulation with MSU crystals or LPS was next analyzed.   Again as a positive control, 
resident macrophages were shown to produce large amounts of both MCP-1 and KC after 
stimulation with MSU crystals or LPS (Figure 3.14A and Figure 3.14B, 0h).   
 
Monocytes recruited into a normal MSU-induced inflammatory environment did not 
respond to MSU or LPS restimulation immediately after migration into the peritoneum.  
However, as the inflammatory response progressed, recruited monocytes produced both 
MCP-1 and KC in response to MSU crystal and LPS restimulation; this ability to produce 
MCP-1 was lost after one week.   
 
Monocytes recruited into a macrophage-depleted environment produced lower levels of 
MCP-1 and KC in response to MSU restimulation compared to monocytes recruited into a 
normal MSU-induced inflammatory environment (Figure 3.14A and Figure 3.14B).   
 
Exposure of early (4-hour) recruited-monocytes from macrophage-depleted mice to LPS 
elicited low levels of MCP-1 compared to normal mice, however this ability was regained 
at later time-points during the inflammatory response  (Figure 3.14A).  Production of KC 
by MSU-recruited monocytes from macrophage-depleted mice restimulated with LPS was 
significantly abrogated 18 hours after MSU stimulation (Figure 3.14B).  
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Figure 3.14: Production of pro-inflammatory chemokines by recruited monocytes 
after restimulation.  C57Bl/6J mice were either left untreated or administered with an i.p. injection of 
200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  At 
different time-points, peritoneal exudate cells were harvested and purified by Lympholyte®-M density 
gradient (>75% monocytes).  Cells were resuspended at 5x105 cells/mL in cRPMI and 200µL was cultured in 
the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  After the incubation period, levels of 
MCP-1 and KC were determined by Bioplex bead array.  Negative controls for MCP-1 (20-80pg/mL) and 
KC (20-70pg/mL) were omitted from the graph.  Measurements performed in quadruplicate.  Values 
represent mean ± S.E.M.  ** = P < 0.005 *** = P < 0.0005 as determined one-way ANOVA and Tukey 
multiple comparison test. Results are representative of the accumulated data from two independent 
experiments with eight mice per group. 
 
In summary, these results demonstrated that purified MSU-recruited monocytes from 
normal mice had increased ability to produce pro-inflammatory cytokines over time and 
transiently produced MCP-1 and KC.  Recruited monocytes from the macrophage-depleted 
model displayed an abrogated ability to produce cytokine/chemokines in response to MSU 
restimulation.  In addition, there were fundamental differences in the functional responses 
of recruited monocytes depending on the stimulus (MSU crystals or LPS).   
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3.2.9 Changes in phagocytic function of monocytes recruited into an 
abrogated inflammatory environment 
The development of phagocytic ability is an important characteristic of 
monocyte/macrophage differentiation.  Expression of the receptor CD206 is a commonly 
used determinant of phagocytic ability.  However, as CD206 is a receptor used to 
recognize mannose sugars on bacterial cell walls rather than crystals and was not 
upregulated on MSU-recruited monocytes, a more relevant method of measuring 
phagocytosis was deemed necessary.  Fluorescent bead uptake was therefore used as an 
alternative approach to determine phagocytic function.  
 
PECs were recovered at different time-points after MSU administration and monocytes 
isolated by density gradient separation.  Purified MSU-recruited monocytes were incubated 
with fluorescent beads for 30 minutes then stained for the surface marker F4/80 and 
analysed by flow cytometry.  Phagocytic ability was measured as the percentage of F4/80+ 
bead+ cells in culture.  In Figure 3.15 and Figure 3.16 (0h) F4/80hi resident macrophages 
were used as a positive control (43% bead+).   
 
 
Figure 3.15: Phagocytosis of fluorescent beads by monocytes/macrophages.  Naïve 
resident macrophages were harvested by peritoneal lavage from C57Bl/6J mice. Cells were resuspended at 
5x105 cells/mL and 2mL of the suspension was incubated with fluorescent beads for 30 minutes.  Excess 
beads were washed off, cells were stained for the cell surface antigen F4/80 and samples of individual mice 
analysed by flow cytometry.  Results are representative of one experiment with four mice per group. 
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As shown in Figure 3.16, approximately 30% of MSU-recruited F4/80int monocytes (at 4-
hours) isolated from normal mice displayed bead uptake, increasing to almost 50% bead+ 
after 24-hours.   
 
MSU-recruited monocytes purified from macrophage-depleted mice exhibited slightly 
lower and slower induction of phagocytic ability compared to monocytes from untreated 
mice, only beginning to show increased uptake of fluorescent beads between 18 – 24 hours 
(Figure 3.16).   
 
 
Figure 3.16: MSU-recruited monocytes from macrophage-depleted mice display 
reduced phagocytic ability.  C57Bl/6J mice were either left untreated or administered with an i.p. 
injection of 200µL clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals 
(3mg/0.5mL).  At different time-points, peritoneal exudate cells were harvested and purified by 
Lympholyte®-M density gradient (>75% monocytes).  Cells were resuspended at 5x105 cells/mL and 2mL of 
the suspension was incubated with fluorescent beads for 30 minutes.  Excess beads were washed off, cells 
were stained for the cell surface antigen F4/80 and samples of individual mice analysed by flow cytometry. 
Values are representative of pooled samples.  Plots are gated on F4/80int monocytes.  Results are 
representative of one experiment with four mice per group. 
 
Upon observing a delay in phagocytic ability, the capacity of recruited monocyte 
phagocytosis i.e. the percentage of phagocytic cells to take up more than one fluorescent 
bead was subsequently exammed.  This involved gating on the bead+ population and then 
sub-gating on subpopulations displaying a second fluorescent spike.  In resident 
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macrophages, 52% of F4/80+ bead+ cells were able to phagocytose multiple beads (Figure 
3.17 and Figure 3.18, 0h).  
 
Figure 3.17: Phagocytic capacity of monocytes/macrophages.  Naïve resident macrophages 
were harvested by peritoneal lavage from C57Bl/6J mice. Cells were resuspended at 5x105 cells/mL and 2mL 
of the suspension was incubated with fluorescent beads for 30 minutes.  Excess beads were washed off, cells 
were stained for the cell surface antigen F4/80 and samples of individual mice analysed by flow cytometry.  
Plots are gated on F4/80+ Bead+ macrophages.  Results are representative of one experiment with four mice 
per group. 
 
Compared with monocytes isolated from the normal MSU-induced inflammatory response, 
F4/80int bead+ monocytes from macrophage-depleted mice displayed a delayed 
development of the ability to take up multiple fluorescent beads at 18-hours, only reaching 
similar phagocytic capacities to MSU-recruited monocytes from normal mice after 24-
hours (Figure 3.18).     
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Figure 3.18: Development of the capacity to phagocytose multiple fluorescent beads 
by monocytes recruited into a macrophage-depleted environment.  Total F4/80+ and Bead+ 
cells in Figure 3.16 were analysed for their ability to phagocytose more than one bead using histogram peaks 
in flow cytometry.  Measurements were performed in duplicate.  Values are representative of pooled 
samples.  Results are representative of one experiment with four mice per group. 
 
In summary, in normal mice MSU-recruited monocytes increased phagocytic function with 
time but, this profile was delayed for recruited monocytes from macrophage-depleted mice    
 
3.2.10 Changes in growth factors detected in the local environment 
after depletion of resident macrophages   
The next approach was to investigate the possible mechanisms responsible for the 
observed delay in recruited monocyte differentiation.  Colony-stimulating factors (CSFs) 
such as granulocyte/macrophage colony-stimulating factor (GM-CSF) and macrophage 
colony-stimulating factor (M-CSF) are critical haematopoietic-cell growth factors.  They 
are defined by their ability to generate in vitro colonies of mature myeloid cells from bone-
marrow precursors; both granulocytic and macrophage colonies in the case of GM-CSF 
and macrophages alone for M-CSF (151).  This lead to the question: were CSF levels 
altered in the macrophage depletion model?  
 
To answer this question, GM-CSF and M-CSF levels were measured in the peritoneal 
lavage and different time-points after MSU administration in normal and macrophage-
depleted mice.  In the normal MSU-induced inflammatory model, M-CSF peaked at four 
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hours and returned to normal levels within three days (Figure 3.19).  Interestingly, the 
depletion of resident macrophages caused elevated levels of background M-CSF before 
MSU administration (Figure 3.19, 0h).  Four hours after MSU-administration, M-CSF 
levels dropped in macrophage-depleted mice and increased again at eight hours before 
slowly returning to baseline levels (Figure 3.19).   
 
 
Figure 3.19: Macrophage-Colony Stimulating Factor levels in macrophage-
depleted/non-depleted mice during MSU-induced inflammation.  C57Bl/6J mice were 
either left untreated or administered with an i.p. injection of 200µL clodronate liposomes.  After three days, 
mice were injected i.p. with MSU crystals (3mg/0.5mL).  At different time-points, peritoneal lavages were 
performed and samples centrifuged.  Supernatants from each sample were collected and levels of GM-CSF 
determined by ELISA.  Plates were read after 25 minutes.  Values represent mean ± S.E.M. Values represent 
mean ± S.E.M.  * = P < 0.05 ** = P  < 0.005 as determined by two tailed unpaired Student t-test.  Results are 
representative of one experiment with four mice per group.   ELISA was conducted by Dr Mischa Walton. 
 
In normal mice, GM-CSF levels decreased over 24 hours following MSU administration 
and slowly increased again over the course of one week (Figure 3.20).  In macrophage-
depleted mice, GM-CSF levels were significantly lower following MSU administration (4- 
and 8-hours) compared to normal mice, but showed a similar pattern of recovery during 
latter stages of the inflammatory response (Figure 3.20).   
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Figure 3.20: Granulocyte-Macrophage-Colony Stimulating Factor levels in 
macrophage-depleted/non-depleted mice during MSU-induced inflammation.  C57Bl/6J 
mice were either left untreated or administered with an i.p. injection of 200µL clodronate liposomes.  After 
three days, mice were injected i.p. with MSU crystals (3mg/0.5mL).  At different time-points, peritoneal 
lavages were performed and samples centrifuged.  Supernatants from each sample were collected and levels 
of M-CSF determined by ELISA.  Plates were read after 25 minutes.  Values represent mean ± S.E.M.  * = P  
< 0.05 ** = P < 0.005 as determined by two tailed unpaired Student t-test.  Results are representative of one 
experiment with four mice per group.  ELISA was conducted by Dr Mischa Walton.   
 
These results indicated that the depletion of resident macrophages significantly altered the 
profiles of CSFs, which may have contributed to the observed patterns of monocyte 
differentiation.  Macrophage-depletion not only abrogated the inflammatory environment 
during MSU-induced inflammation, but also increased the background levels of M-CSF 
while significantly decreasing GM-CSF levels during the acute phase of inflammation.   
 
3.2.11 Infiltrating neutrophils contribute to inflammation in MSU-
treated mice 
As shown in section 3.2.3, the depletion of resident macrophages also significantly 
inhibited neutrophil infiltration after MSU stimulation in vivo.  Neutrophils play a key role 
in establishing the acute inflammatory microenvironment during the early stages of MSU-
induced inflammation by potentiating further neutrophil recruitment through IL-8 
production (87) and decreasing inflammation by inducing TGF-β production from 
phagocytes after their apoptosis (142).  Therefore it was possible that the absence of 
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infiltrating neutrophils in macrophage-depleted mice contributed to delayed MSU-
recruited monocyte differentiation and function.   
 
To determine the effect of neutrophils on recruited monocyte function, MSU-recruited 
cells were harvested from mice eight hours and one week after i.p. MSU administration.  
PECs were either left as a heterogenous population or the recruited monocytes purified 
using a density gradient.  Both the mixed cell and monocyte preparations were then 
restimulated with either MSU crystals or LPS and incubated for eight hours (as described 
in section 3.2.8).  Supernatants from the different cell culture systems were analysed for 
levels of IL-1β, IL-6, MCP-1 and KC by ELISA and Bioplex bead array.  Cytokine levels 
were then normalized to the number of monocytes present in each culture, as calculated by 
flow cytometry analysis (% of F4/80int Gr-1+ x total cell number).   
 
Eight hours after MSU administration in vivo, purified monocytes restimulated with MSU 
crystals produced higher amounts of IL-1β but not IL-6 compared to the mixed cell 
population (Figure 3.21A and Figure 3.21B).  One week after MSU administration in vivo, 
(purified recruited-monocytes/macrophages) co-cultured with MSU crystals produced 
higher levels of pro-inflammatory cytokines IL-1β and IL-6 compared to the mixed cell 
population (Figure 3.21A and Figure 3.21B).  However, it is important to note that at one-
week background levels of IL-6 also increased, possibly due to non-specific activation 
resulting from the isolation process.   
 
Interestingly, after LPS restimulation, purified monocytes produced significantly higher 
levels of IL-1β compared to mixed cell cultures following re-exposure to MSU crystals 
(Figure 3.21A).  Also, while recruited monocytes isolated at eight hours after MSU 
administration produced increased levels of IL-6, both purified and mixed cell populations 
isolated one week after MSU administration produced similar levels of IL-16 after LPS 
restimulation ex vivo (Figure 3.21B). 
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Figure 3.21: Co-incubation of neutrophils abrogates monocyte production of pro-
inflammatory cytokines.  C57Bl/6J mice were administered with an i.p. injection of 200µL clodronate 
liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL) for eight hours and one 
week. Peritoneal exudate cells were harvested and either left in a heterogenous population or purified by 
Lympholyte®-M density gradient (>75% monocytes).  Cells were resuspended at 5x105 cells/mL in cRPMI 
and 200µL was cultured in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  After the 
incubation period, levels of IL-1β and IL-6 were determined by ELISA or Bioplex bead array.  Cytokine 
levels were then normalized for the percentage of monocytes presented within the cultures, determined from 
flow cytometry analysis.  Measurements performed in duplicate.  Values represent mean ± S.E.M.  * = P  < 
0.05 ** = P < 0.005 as determined by one-way ANOVA and Tukey multiple comparison test.  Results are 
representative of two independent experiments with five mice per group.     
 
Chemokine levels were also determined by Bioplex bead array from supernatants obtained 
from the above assays.   
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Recruited monocytes purified eight hours after MSU administration increased their 
capacity to produce both MCP-1 and KC after MSU restimulation compared to mixed cell 
cultures (Figure 3.22A and Figure 3.22B).  There were no significant differences between 
the purified and mixed cell cultures harvested one week after MSU stimulation in vivo in 
the production of either MCP-1 or KC (Figure 3.22A and Figure 3.22B).  It should be 
noted that background levels of MCP-1 detected were quite high at both the eight and one 
week time-points.   
 
Restimulation of purified monocytes harvested eight hours post MSU administration in 
vivo showed increased production of MCP-1 and KC compared to the mixed cell cultures 
(Figure 3.22A and Figure 3.22B).  However, there were no significant differences in MCP-
1 or KC production between either the purified or mixed populations harvested one week 
after MSU-administration (Figure 3.22A and Figure 3.22B).   
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Figure 3.22: Co-incubation of neutrophils abrogates monocyte production of pro-
inflammatory chemokines.  C57Bl/6J mice were administered with an i.p. injection of 200µL 
clodronate liposomes.  After three days, mice were injected i.p. with MSU crystals (3mg/0.5mL) for eight 
hours and one week. Peritoneal exudate cells were harvested and either left in a heterogenous population or 
purified by Lympholyte®-M density gradient (>75% monocytes).  Cells were resuspended at 5x105 cells/mL 
in cRPMI and 200µL was cultured in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  
After the incubation period, levels of MCP-1 and KC were determined by Bioplex bead array.  Cytokine 
levels were then normalized for the percentage of monocytes presented within the cultures, determined from 
flow cytometry analysis.  Measurements performed in duplicate.  Values represent mean ± S.E.M.  ** = P  < 
0.005 *** = P < 0.0005 as determined by one-way ANOVA and Tukey multiple comparison test.  Results 
are representative of two independent experiments with five mice per group. 
 
In summary, these results suggested that infiltrating neutrophils might exert a suppressive 
effect on the pro-inflammatory abilities of recruited monocytes during MSU-induced 
inflammation.  Whether this phenomenon was the result of neutrophil phagocytosis or a 
soluble factor secreted by neutrophils was then investigated. 
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3.2.12 Soluble factors produced by infiltrating neutrophils suppress 
recruited-monocyte activity   
Previous studies have shown that phagocytosis of apoptotic neutrophils is a common 
mechanism of resolution in acute inflammation (143, 152).  Therefore, uptake of apoptotic 
neutrophils by MSU-recruited monocytes could have been the reason for the lower pro-
inflammatory cytokines/chemokines detected in mixed cell cultures.  However, infiltrating 
neutrophils have also been shown to produce soluble factors that can influence 
mononuclear phagocyte function (153) and these secreted molecules could exert a 
suppressive effect on recruited monocytes.   
 
To determine whether neutrophil secreted soluble factors were responsible for the 
decreased cytokine/chemokine production in mixed cell populations compared to purified 
monocytes following MSU restimulation, the effects of different conditioned supernatants 
from purified neutrophil cultures on isolated recruited-monocytes restimulated with MSU 
crystals were investigated.   
 
Neutrophils were purified by running PECs harvested from mice administered with MSU 
i.p. for 18 hours through a density gradient and collecting the resultant cell pellet (>80% 
neutrophils).  The purified neutrophils were divided and either apoptosed (cultured in 
serum free RPMI), activated (cultured with 500µg/mL MSU crystals in cRPMI), or left 
untreated (cultured in cRPMI) and incubated for eight hours.  The conditioned neutrophil 
culture supernatants were then stored at -20°C until further use.   
 
C57Bl/6J mice were given an i.p. injection of MSU crystals and left for eight hours and 
one week.  MSU-recruited monocytes were purified using Lympholyte®-M density 
gradient.  The purified monocytes were then resuspended in either cRPMI or the 
conditioned supernatants from apoptotic or activated neutrophils.  The purified monocytes 
were then restimulated with either MSU crystals (500µg/mL) or LPS (100ng/mL) ex vivo 
and incubated for eight hours.  Supernatants from the co-cultures were analysed for levels 
of IL-1β, IL-6, MCP-1 and KC by ELISA and/or Bioplex bead array.  Cytokines were then 
normalized to the number of monocytes present within the cultures (described in section 
3.2.11).   
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As shown in Figure 3.23A and Figure 3.23B, early recruited monocytes did not show any 
differences in their production of IL-1β or IL-6 when in the presence of neutrophil 
conditioned supernatants.  However, exposure to neutrophil supernatants significantly 
decreased IL-1β and IL-6 production by purified MSU-recruited monocytes harvested one-
week post MSU-stimulation. 
 
LPS restimulation elicited increased IL-1β and IL-6 levels from purified monocytes 
compared to unstimulated control (Figure 3.23A and Figure 3.23B).  However, there were 
no significant differences from purified monocyte populations co-incubated with 
neutrophil-conditioned medium and restimulated with LPS compared with monocytes in 
cRPMI alone (Figure 3.23A and Figure 3.23B).   
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Figure 3.23: Pro-inflammatory cytokine production by restimulated monocytes is 
abrogated by co-incubation with neutrophil-conditioned medium.  C57Bl/6J mice were 
administered with an i.p. injection of MSU crystals (3mg/0.5mL) for 18 hours.  Peritoneal exudate cells were 
harvested and purified by Lympholyte®-M density gradient (>80% neutrophils).  Neutrophils (2x106/2mL) 
were then either apoptosed (incubated with serum free RPMI), activated (incubated with 500µg/mL MSU 
crystals in cRPMI), or left nave (incubated in cRPMI) for eight hours.  The supernatants were then collected 
and stored at -20°C.  Another group of C57Bl/6J mice were then administered with an i.p. injection of MSU 
crystals (3mg/0.5mL) for eight hours and one week. Peritoneal exudate cells were harvested and either left in 
a heterogenous population or purified by Lympholyte®-M density gradient (>75% monocytes).  Cells were 
resuspended at 5x105 cells/mL in either cRPMI or prepared neutrophil supernatant and 200µL was cultured 
in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  After the incubation period, levels 
of IL-1β and IL-6 were determined by ELISA or Bioplex bead array.  Cytokine levels were then normalized 
for the percentage of monocytes present within the cultures determined from flow cytometry analysis. 
Measurements performed in triplicate.  Arrows represent unstimulated control.  Values represent mean ± 
S.E.M.  *** = P < 0.0001 as determined by one-way ANOVA and Tukey multiple comparison test.  Results 
are representative of one experiment with ten mice per group. 
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Co-incubation of purified monocytes with neutrophil-conditioned supernatants 
significantly decreased MCP-1 and KC levels detected in culture one week after MSU-
induced inflammation (Figure 3.24A and Figure 3.24B).   
 
Whilst LPS restimulation induced increases in MCP-1 and KC production from purified 
monocytes compared to unstimulated control (Figure 3.24A and Figure 3.24B), there were 
no significant differences in MCP-1 or KC production from monocytes co-incubated with 
neutrophil-conditioned medium and restimulated with LPS compared with monocytes in 
cRMPI alone (Figure 3.24A and Figure 3.24B). 
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Figure 3.24: Pro-inflammatory chemokine production by restimulated monocytes is 
abrogated by co-incubation with neutrophil-conditioned medium.  C57Bl/6J mice were 
administered with an i.p. injection of MSU crystals (3mg/0.5mL) for 18 hours.  Peritoneal exudate cells were 
harvested and purified by Lympholyte®-M density gradient (>80% neutrophils).  Neutrophils (2x106/2mL) 
were then either apoptosed (incubated with serum free RPMI), activated (incubated with 500µg/mL MSU 
crystals in cRPMI), or left nave (incubated in cRPMI) for eight hours.  The supernatants were then collected 
and stored at -20°C.  Another group of C57Bl/6J mice were then administered with an i.p. injection of MSU 
crystals (3mg/0.5mL) for eight hours and one week. Peritoneal exudate cells were harvested and either left in 
a heterogenous population or purified by Lympholyte®-M density gradient (>75% monocytes).  Cells were 
resuspended at 5x105 cells/mL in either cRPMI or prepared neutrophil supernatant and 200µL was cultured 
in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  After the incubation period, levels 
of MCP-1 and KC were determined by Bioplex bead array.  Cytokine levels were then normalized for the 
percentage of monocytes presented within the cultures, determined from flow cytometry analysis.  
Measurements performed in triplicate. Values represent mean ± S.E.M.   *** = P < 0.0001 as determined by 
one-way ANOVA and Tukey multiple comparison test.  Results are representative of one experiment with 
ten mice per group. 
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These results indicated that neutrophil-secreted soluble factors might play a role in the 
suppression of pro-inflammatory cytokines/chemokines produced by MSU-recruited 
monocytes.  However, whether one specific agent or a combination of molecules within 
the conditioned supernatants mediated the observed suppression was unclear.   
 
3.2.13 TGF-β  secreted by infiltrating neutrophils may play a role in 
suppressing recruited monocyte activity   
TGF-β is a powerful pleiotropic anti-inflammatory cytokine.  Although the cause of 
resolution in gout still remains unclear, some studies have suggested a role played for 
TGF-β (142).  Neutrophils have been shown to release a wide range of soluble molecules, 
including superoxide, HBP proteins and small amounts of TGF-β (153).  
 
To determine if blocking TGF-β would affect monocyte/macrophage production of pro-
inflammatory cytokines/chemokines in response to MSU stimulation, mice were 
administered i.p. with MSU crystals (3mg/0.5mL) for four hours and one week and the 
recruited PECs collected.  Harvested PECs were left in a heterogenous population in 
cRPMI and restimulated with either MSU crystals or LPS in the presence or absence of 
αTGF-β blocking antibody and incubated for eight hours.  Supernatants from the co-
cultures were analysed for IL-1β, IL-6, MCP-1 and KC by ELISA and Bioplex bead array.   
 
Early (4-hours) infiltrating PECs did not produce IL-1β or IL-6 in response to MSU 
restimulation with or without the TGF-β blockade (Figure 3.25A and Figure 3.25B).    
However, IL-1β and IL-6 production were increased in the one-week mixed cell cultures 
after MSU restimulation in the presence of TGF-β blocking antibody (Figure 3.25A and 
3.25B).   
 
There were no statistically significant differences between levels of IL-1β and IL-6 with or 
without the blockade of TGF-β produced by either early or later-stage MSU-recruited 
leukocytes after LPS restimulation (Figure 3.25A and Figure 3.25B).  Interestingly, in the 
absence of stimulating agents, TGF-β antibody treatment alone resulted in elevated IL-6 
but not IL-1β production.   
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Figure 3.25: TGF-β  suppresses pro-inflammatory cytokine production by recruited 
monocytes during later stages of MSU-induced inflammation only.  C57Bl/6J mice were 
administered with an i.p. injection of MSU crystals (3mg/0.5mL) for four hours and one week. Peritoneal 
exudate cells were resuspended at 5x105 cells/mL in cRPMI 200µL was cultured with or without αTGF-β 
blocking antibody (32µg/mL) in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  
After the incubation period, levels of IL-1β and IL-6 were determined by ELISA or Bioplex bead array.  
Measurements performed in triplicate. Values represent mean ± S.E.M.   * = P < 0.05 *** = P < 0.0001 as 
determined by one-way ANOVA and Tukey multiple comparison test.  Results are representative of one 
experiment with ten mice per group. 
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Blocking TGF-β did not affect the levels of pro-inflammatory chemokines produced after 
MSU crystal restimulation by mixed recruited leukocyte cultures harvested at the early 
stages of MSU-induced inflammation (Figure 3.26A and Figure 3.26B).  However in later 
stages, blockade of TGF-β significantly increased the levels of MCP-1 and KC produced 
after restimulation with MSU (Figure 3.26A and Figure 3.26B).   
 
As shown in Figure 3.26A and Figure 3.26B, mixed cell cultures harvested during the early 
stages of MSU-induced inflammation incubated with TGF-β and restimulated with LPS 
produced similar levels of MCP-1 and KC.  While the former was unaffected with TGF-β 
blockade (Figure 3.26A), production of KC was significantly increased after LPS 
restimulation (Figure 3.26B). 
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Figure 3.26: TGF-β  suppresses pro-inflammatory chemokine production by recruited 
monocytes during later stages of MSU-induced inflammation only.   C57Bl/6J mice were 
administered with an i.p. injection of MSU crystals (3mg/0.5mL) for four hours and one week. Peritoneal 
exudate cells were resuspended at 5x105 cells/mL in cRPMI 200µL was cultured with or without αTGF-β 
blocking antibody (32µg/mL) in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  
After the incubation period, levels of MCP-1 and KC were determined by Bioplex bead array.  
Measurements performed in triplicate. Values represent mean ± S.E.M.   ** = P < 0.001 *** = P < 0.0001 as 
determined by one-way ANOVA and Tukey multiple comparison test.  Results are representative of one 
experiment with ten mice per group. 
 
 
 
Chapter 3.0: The Impact of the Inflammatory Environment on the Differentiation and 
Function of Recruited Monocytes in MSU-induced inflammation 
89 
These results indicated that the anti-inflammatory cytokine TGF-β did not affect the 
production of pro-inflammatory molecules by early-recruited leukocytes after MSU or LPS 
restimulation.  However, blocking TGF-β and restimulating with MSU increased the levels 
of IL-1β, MCP-1 and KC produced by leukocytes harvested at the later stages of the 
inflammatory response.  While restimulation with LPS in the presence of αTGF-β 
antibody induced an increase in KC production by PECs, blocking TGF-β did not affect 
IL-1β, IL-6 or MCP-1 production.   
 
3.3 Discussion 
MSU-induced peritoneal inflammation is a commonly used murine model of the acute and 
highly pro-inflammatory environment that occurs during a gout attack. Mononuclear 
phagocytes are highly plastic cells capable of differentiating into various subsets with 
completely different roles depending on the programming signals.  The findings presented 
within this chapter give insight into the impact of resident macrophages, infiltrating 
neutrophils, and the inflammatory microenvironment in general on the differentiation and 
function of MSU-recruited monocytes. 
 
3.3.1 MSU-induced monocyte recruitment in normal and 
macrophage-depleted mice 
The depletion of resident macrophages decreased the levels of monocyte chemoattractant 
MCP-1 detected within the peritoneum during early inflammation after MSU 
administration (section 3.2.4).  However, the low MCP-1 levels did not correspond with a 
decrease in the number of monocytes recruited into the local environment (section 3.2.3).  
This may be attributed to a MCP-1 threshold which once reached allows for optimum 
monocyte infiltration into the peritoneal cavity.  Alternatively, another mediator (such as 
MIPs (154) or M-CSF (155, 156)) other than MCP-1 is produced by resident cells after 
exposure to MSU crystals and is also responsible for the recruitment of monocytes from 
the circulation during acute inflammation.   
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3.3.2 Effect of the inflammatory environment on monocyte 
differentiation and function    
Although macrophage depletion abrogated IL-1β and IL-6 production within the MSU-
induced pro-inflammatory environment (section 3.2.4), TNFα levels remained unaffected.  
This could be attributed to production by epithelial cells (such as endothelial cells (157) 
and fibroblasts (158)), which can maintain the production of TNFα upon stimulation.   
 
The inflammatory environment plays a vital role in driving the differentiation of recruited 
monocytes to macrophages.  Morphologically (section 3.2.5), monocytes recruited into a 
macrophage-depleted environment in response to MSU showed stalled development of 
physiological phenotypes (such as decreased cytoplasmic volume) compared to MSU-
recruited monocytes from normal mice.  Interestingly, this delay in differentiation only 
weakly correlated with changes in the cell surface phenotype.  While the downregulation 
of recruited monocyte hemopoietic markers were notably hampered (section 3.2.7), this 
was not associated with a delay in the upregulation of macrophage markers (section 3.2.8).  
Hence, this serves as a caveat on not solely relying on cell surface markers to distinguish 
differences in cell differentiation, and that fundamental methods, although subjective, can 
sometimes contribute to the overall picture via more basic and unobstructed observations. 
 
During the early stages (4-hour) of MSU-induced inflammation, monocytes recruited into 
a macrophage-depleted inflammatory environment produced pro-inflammatory cytokines 
in response to LPS but not MSU crystal restimulation (section 3.2.8).  Production of IL-1β 
and IL-6 by monocytes isolated from both normal and macrophage-depleted mice in 
response to LPS restimulation indicate that the TLR pathways that mediate responses to 
LPS may only be marginally affected by an abrogation in the acute inflammatory response.  
Whilst the delayed production of pro-inflammatory cytokines by recruited monocytes from 
macrophage-depleted mice after MSU crystal restimulation could be due to impaired 
phagocytic ability (section 3.2.9), Latz and colleagues have shown that the encapsulation 
of MSU crystals leads to damage and subsequent rupture of the intracellular lysosomes in 
phagocytes(56).  Resulting in NALP3 inflammasome activation and the production of IL-
1β by caspase-1 cleavage of pro-IL-1β (60, 159).   
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Consistent with this, impaired uptake of fluorescent beads was also shown (section 3.2.9).  
Therefore it appears that the inflammatory environment plays a role in the development of 
phagocytic function in monocytes, which enables recruited cells to recognize MSU crystals 
and produce pro-inflammatory cytokines.    It is possible that delayed development of 
phagocytic function observed in MSU-recruited monocytes from macrophage-depleted 
mice is responsible for decreased stimulation of monocytes via the classical NALP3 
inflammasome pathway.   
 
3.3.3 The impact of colony-stimulating factors on recruited monocyte 
differentiation 
The depletion of resident macrophages caused an elevation of background levels of M-
CSF (section 3.2.10).  M-CSF has been shown previously to circulate at detectable levels 
at steady state and have been shown previous to give rise to osteoclast lineage cells in 
conjunction with RANKL (receptor activation of NFκB ligand) (160).  Therefore at 
baseline levels, M-CSF may play a role in inducing myeloid differentiation, contributing to 
background tissue growth and healing.  The depletion of resident macrophages may trigger 
secretion of intracellular reservoirs of M-CSF by epithelial resident cells such as 
fibroblasts and endothelial cells (151).  As CSFs have chemotactic properties (155, 156), 
elevated baseline levels of M-CSF may contribute to the recruitment of circulating myeloid 
precursors designed to replenish the depleted resident macrophage population.   
 
In an abrogated inflammatory environment depleted of macrophages, the levels of M-CSF 
and GM-CSF were significantly decreased during the early phases of MSU-induced 
inflammation (section 3.2.10).  Previous studies examining lineage-development has 
shown that GM-CSF and M-CSF can compete with each other to generate different cellular 
phenotypes when co-cultured with myeloid precursor cells (161).  Stimulation of immature 
macrophage-lineage populations with GM-CSF and IL-4 generate a DC-like phenotype 
(162-164), whereas stimulation with both M-CSF and GM-CSF results in a more 
macrophage-like population (161).  In this study, the change in levels of both M-CSF and 
GM-CSF within the inflamed peritoneum of macrophage-depleted mice may have altered 
programming signals required for efficient monocyte to macrophage differentiation.  
Therefore future directions may warrant investigation into the ratios of GM-CSF and M-
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CSF required for monocyte/macrophage differentiation, possibly by using knockout mice 
or antibody depletion.  This may give insight into which CSF plays a more predominant 
role in generating macrophage- or DC-like phenotypes from MSU-recruited monocytes.       
 
3.3.4 Neutrophil suppression of recruited monocyte pro-
inflammatory capacity during MSU-induced inflammation 
During the early stages (8-hours) of MSU-induced inflammation, co-incubation of 
infiltrating neutrophils with recruited monocytes had an immunosuppressive effect on the 
pro-inflammatory capabilities of the monocyte population (section 3.2.11).  Neutrophil 
derived products have been previously shown to regulate monocyte/macrophage activity 
(165).  However, as co-incubation of neutrophil-derived soluble factors did not affect the 
pro-inflammatory capabilities of the early (8-hour) MSU-recruited monocytes (section 
3.2.12), it is possible that infiltrating monocytes may drive resolution of acute 
inflammation via neutrophil uptake and switching to a non-inflammatory phenotype.  This 
finding is consistent with previous studies showing that the uptake of apoptotic neutrophils 
can downregulate the production of pro-inflammatory cytokines from phagocytosing 
mononuclear cells in acute inflammation (142).  In addition, Terkeltaub and colleagues has 
shown that macrophage phagocytosis of apoptotic thymocytes prior to MSU administration 
decreases macrophage responsiveness to stimulation in vivo (166).  Although it is a widely 
accepted phenomenon in macrophages (167), there has been no evidence of the 
phagocytosis of apoptotic neutrophils switching recruited monocytes from a “pro”- to 
“non”- inflammatory phenotype.   
 
At the later (1-week) time-point of MSU-induced inflammation, neutrophil-derived soluble 
factors were able to suppress the production of pro-inflammatory cytokines by purified 
monocytes/macrophages after MSU but not LPS restimulation (section 3.2.12).  It is 
possible that neutrophil-derived products may limit the inflammatory response by 
suppressing differentiated monocytes/macrophages from being reactivated by MSU 
crystals still deposited within the peritoneal cavity.  As neutrophils have been previously 
shown to produce TGF-β (168), administering TGF-β antibody in conjunction with MSU 
crystals in the rat air pouch model inhibited the overall acute inflammatory response (110).  
In this study, adding anti-TGF-β blocking antibody to mixed PEC cultures inhibited the 
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suppressive effects of neutrophil-secreted TGF-β and increased monocyte production of 
cytokines/chemokines after MSU restimulation (section 3.2.13).  Hence, this indicates that 
neutrophil-derived soluble factors (including TGF-β) can suppress recruited 
monocyte/macrophage responsiveness to MSU crystal restimulation, which may contribute 
to the resolution of MSU-induced inflammation.   
 
An interesting finding of this study was that the purification of MSU-recruited monocytes 
resulted in increased background levels of cytokines/chemokines.  This could be possibly 
due to the isolation of recruited monocytes from a suppressive effect of other 
cells/molecules (such as neutrophil TGF-β) released from the local environment as an 
inflammatory regulator.  Another possibility for the elevated background levels could be 
due to non-specific activation of monocytes from the density gradient purification 
procedure.  While the specific cause remains currently unclear, the density gradient 
purification process is a better method than AutoMACs or cell sorting in providing an 
isolated monocyte population from PECs while limiting non-specific cellular activation.  
Nevertheless, these data indicate the importance of investigating cell function in “natural” 
mixed cell environments.  When investigating purified cell populations as the ex vivo 
mixed population results differ significantly from earlier in vitro data, using isolated cell 
populations.  
 
In summary, this study showed that depletion of resident macrophages abrogated the 
inflammatory environment into which monocytes were recruited in response to MSU 
stimulation.  Over the course of the MSU-induced inflammation, recruited monocytes from 
macrophage-depleted mice displayed delayed differentiation into macrophages.  This 
phenotypic change in differentiation correlated with stalled development of phagocytic 
function.  Despite developing the ability to produce pro-inflammatory cytokines and 
chemokines in response to LPS, these altered monocytes do not show the same sensitivity 
to MSU restimulation, indicating that the inflammatory environment can alter the 
development of MSU recognition pathways independent of TLR signalling.  The uptake of 
neutrophils by recruited monocytes may be the key mechanism in initiating resolution in 
MSU-induced inflammation.  In addition, TGF-β may play a role in suppressing the MSU-
induced inflammatory response and help maintain homeostatic regulatory control.   
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4.1 Monocyte recruitment by peritoneal mesothelial cells in 
MSU-induced inflammation 
 
4.1.1 Leukocyte migration 
Leukocyte recruitment from the bloodstream to the site of inflammation occurs through a 
strictly regulated pathway known as the adhesion cascade (described in Chapter 1). 
 
In brief, various selectins (such as L- and E- selectins) on circulating leukocytes interact 
with selectins (such as PSGL1) and other co-molecules expressed on endothelial cells 
creating a “rolling” effect along the inner walls of blood vessels (72).  While chemokines 
(such as MCP-1) are responsible for the arrest of the “rolling” leukocytes (71), integrins 
expressed on circulating cells interact with adhesion molecules along the blood vessels 
contributing to further strengthening of adhesion prior to transmigration (74). 
 
Leukocytes transmigrate from the bloodstream through the endothelium and into inflamed 
tissue by three mechanisms; crawling, paracellular and transcellular migration (71).  
Crawling occurs when “rolling” leukocytes are seeking preferred sites of transmigration 
(77).  Paracellular migration occurs when ligands expressed on the leukocytes interact with 
adhesion molecules on the endothelium leading to reduced inter-endothelial contacts and 
allowing migration of cells through the vessel walls (77).  Transcellular migration occurs 
mainly in the thin endothelium within the CNS, whereby cells may transmigrate through 
intracellular channels within the endothelial cells mediated by various ligand-to-adhesion 
molecule interactions (78).     
 
4.1.1.1 Monocyte recruitment in MSU-induced inflammation 
Early inflammation in acute gout is associated with the infiltration of circulating 
monocytes into the joint synovium (125).  In the MSU-induced model of acute gout, 
activated macrophages have been identified as a key cell type involved in the recruitment 
of cells from the bloodstream through the production of monocyte – (MCP-1) and 
neutrophil – (KC) attracting chemokines (69).  Previous studies in our group have shown 
that the depletion of peritoneal resident macrophages significantly abrogated neutrophil 
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infiltration in MSU-induced inflammation, while monocyte infiltration remained 
unchanged (58).  This indicated that monocyte recruitment in gout could be regulated by a 
mechanism independent of activated resident macrophages and that other resident cells 
may orchestrate monocyte recruitment in response to MSU stimulation.   
 
Previously, infiltrating neutrophils have been thought to mediate acute monocyte 
infiltration by releasing chemokines such as IL-8 and MCP-1 into the local environment 
(165, 169).  However, other studies have shown that neither MCP-1 release nor monocyte 
infiltration is affected by a reduction in neutrophil infiltration (170), providing further 
evidence that monocyte recruitment can occur via macrophage and neutrophil independent 
mechanisms.  Consistent with this, synoviocytes have been shown by 
immunohistochemistry to be the predominant producers of MCP-1 in a rabbit model of 
acute inflammation after LPS stimulation (70).  These findings point towards the peritoneal 
membrane potentially playing a key role in monocyte recruitment in the peritoneal model 
of MSU-induced inflammation.   
 
4.1.1.2 Activation of MCP-1 production by peritoneal mesothelial cells in 
MSU-induced inflammation 
The peritoneal model of MSU-induced inflammation utilizes the peritoneal cavity of mice 
as a representation of the joint synovium of humans, into which cells are recruited during 
acute inflammation.  The peritoneal cavity is lined by a serosal membrane covered by a 
monolayer of simple squamous mesothelium (171).  The main purpose of mesothelial cells 
is to provide a lubricating surface that is slippery, non-adhesive and thus decreases friction 
between organs.  In addition, the mesothelium has also been implicated in the trafficking 
of leukocytes in response to pro-inflammatory mediators (171) and therefore provides a 
pseudo-model of the synovial membrane.  Combined with this, cytokines such as IL-1β 
and IFN-γ have been shown to activate human PMCs and induce the production of the 
chemokine MCP-1 in vitro (172).  Recent findings have also shown  significant production 
of MCP-1 from murine PMCs after stimulation with LPS, which was strictly dependent on 
the TLR4 pathway in a model of acute peritonitis (173).  This indicates a potential role for 
TLR4 signalling in MCP-1 production induced by inflammatory stimuli.    
Chapter 4.0: Recruitment and the effects of Glatiramer acetate on Monocytes in MSU-
induced inflammation 
97 
Preliminary studies in our group have shown that whole peritoneal tissue stimulated with 
MSU crystals produces the chemokine MCP-1 but not other pro-inflammatory cytokines 
such as TNFα, IL-1β and IL-6 (unpublished data).  However, several aspects remain 
unknown 1) whether this response was specific to MSU crystals 2) which cell type on the 
peritoneal lining was responsible for MCP-1 production and 3) which pathway(s) might be 
involved in MSU-induced MCP-1 production in the membrane.   
 
4.1.1.3 Objectives 
The aim of this section was to determine whether MCP-1 produced by mesothelial cells 
could be responsible for monocyte recruitment in response to direct MSU crystal 
stimulation.  To address this question, we investigated the production of MCP-1 by both 
the peritoneal membrane and cultured mesothelial cells, and whether the TLR4 pathway 
plays a role.   
 
4.1.2 Results 
 
4.1.2.1 MCP-1 production by the peritoneal membrane after MSU or LPS 
stimulation 
To investigate the phenomenon of macrophage independent MSU-induced MCP-1 
production, excised peritoneal membranes were recovered from naïve C57Bl/6J mice and 
stimulated with MSU crystals or LPS for 6 hours in vitro.  This incubation period 
correlates with acute MCP-1 production in vivo (58).  Separate membrane preparations 
were also stimulated with MSU crystals or LPS in the presence of an anti-CD14 blocking 
antibody in order to determine whether the MCP-1 production was dependent on the TLR4 
pathway.  The culture supernatants were then analysed for MCP-1 levels by Bioplex bead 
array.   
 
Consistent with previous observations by other members of our group, excised peritoneal 
tissues produced significant levels of MCP-1 when exposed to MSU crystals (Figure 4.1).  
This response was also observed after stimulation with LPS.  The production of MCP-1 
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induced by either MSU crystals or LPS was significantly abrogated following blockade of 
CD14.   
 
 
Figure 4.1: MSU-induced MCP-1 production by the peritoneal membrane is 
mediated by CD14.  Peritoneal membranes were excised from naïve C57Bl/6J mice and either left 
untreated or incubated with or without anti-mouse CD14 blocking antibody (20µg/mL) in the presence of 
MSU crystals (500µg/mL) or LPS (100ng/mL).   After six hours incubation, MCP-1 levels were determined 
by Bioplex bead array.  Measurements performed in triplicate.  Values represent mean ± S.E.M.  * = P < 0.05 
*** = P < 0.001 as determined by one-way ANOVA and Tukey multiple comparison test.  Results are 
representative of two independent experiments.   
 
These results showed that the peritoneal membrane could produce MCP-1 in response to 
direct MSU stimulation, in the absence of resident macrophages.  Therefore, this indicated 
that the cells lining the peritoneal membrane may be a key source of the chemoattractant 
MCP-1 responsible for MSU-induced monocyte recruitment. 
 
4.1.2.2 Isolation, identification and culture of peritoneal mesothelial cells 
Mesothelial cells are one of the cell types present on peritoneal membranes.  The first aim 
was to stain the whole peritoneal membrane to identify the presence of cytokeratin+ 
mesothelial cells.  However, the staining antibodies non-specifically bound to collagen 
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fibres covering the membrane resulting in high levels of background fluorescence when 
analysed microscopically.   
 
As an alternative approach we looked at isolating and culturing mesothelial cells for 
subsequent in vitro stimulation with MSU crystals.  In order to harvest PMCs (126, 127), 
the peritoneums of naïve C57Bl/6J mice were first washed with heparin/PBS to remove the 
resident leukocytes.  A second peritoneal lavage was performed using 0.25% 
Trypsin/EDTA (3mL) and left in the peritoneum for 15 minutes and the exudate cells were 
collected.  The process was repeated for a third time using cRPMI to maximise mesothelial 
cell collection.  Mesothelial cells were then resuspended in cRPMI cultured in vitro for six 
to eight days in the presence of epithelial growth factor.  Cells were identified as 
mesothelial cells (Figure 4.2) by their large size (60-80µm in diameter), tendency to form 
monolayers, and cobblestone appearance (126, 174). 
 
 
Figure 4.2: Identification of peritoneal mesothelial cells.  Peritoneal mesothelial cells were 
harvested from naïve C57Bl/6J mice by treatment with 0.25% Trypsin/EDTA in vivo and cultured in vitro.  
A phase contrast picture was taken to identify peritoneal mesothelial cells by the squamous cobble stone 
appearance.  Original magnification 40x.  Scale bar represents 100µm.  Results representative of at least 
three independent experiments.  Figure 4.2 was provided by Dr Willy-John Martin.   
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To confirm the production of MCP-1 by mesothelial cells after stimulation with MSU 
crystals or LPS, cells were stained for the mesothelial cell marker cytokeratin and MCP-1 
and analysed by immunofluorescent histology.  As shown in Figure 4.3, both MSU and 
LPS stimulated cytokeratin+ mesothelial cells to produce MCP-1.   
 
 
Figure 4.3: MCP-1 production by cultured peritoneal mesothelial cells.  Peritoneal 
mesothelial cells were harvested from naïve C57Bl/6J mice by treatment with 0.25% Trypsin/EDTA in vivo 
and cultured in vitro.   A. Cells were either left untreated or B. exposed to MSU (500µg/mL) or C. LPS 
(100ng/mL) in the presence of GolgiStop for four hours.  Production of MCP-1 (green) by cytokeratin 
positive (red) peritoneal mesothelial cells was then determined by fluorescent antibody staining. Original 
magnification 20x, 20x and 40x respectively.  Scale bar represents 100µm.  Results representative of two 
independent experiments.   
 
4.1.2.3 Peritoneal mesothelial cells produce MCP-1 after MSU or LPS 
stimulation 
To confirm whether CD14 was involved in MSU-induced MCP-1 production by 
mesothelial cells, cultured mesothelial cells were activated with MSU or LPS in the 
presence of CD14 blocking antibody, and the MCP-1 levels within the supernatant 
determined.  Consistent with the whole peritoneal tissue experiments, mesothelial cells 
produced significant levels of MCP-1 after stimulation with either MSU or LPS (Figure 
4.4).  However, while MCP-1 elicited by LPS was significantly abrogated following CD14 
blockade, MCP-1 production after MSU crystal stimulation was unaffected. 
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Figure 4.4: MSU-induced MCP-1 production by cultured peritoneal mesothelial cells 
is not mediated by CD14.  Peritoneal mesothelial cells were harvested from naïve C57Bl/6J mice by 
treatment with 0.25% Trypsin/EDTA in vivo and cultured in vitro.  Cells were either left untreated or 
incubated with or without anti-mouse CD14 blocking antibody (20µg/mL) in the presence of MSU crystals 
(500µg/mL) or LPS (100ng/mL).  After six hours incubation, MCP-1 levels were determined by Bioplex 
bead array.  Measurements performed in triplicate.  Values represent mean ± S.E.M.  ** = P < 0.01 *** = P 
< 0.001 as determined by one-way ANOVA and Tukey multiple comparison test.  Results are representative 
of two independent experiments.   
 
4.1.3 Discussion 
Recruitment of pro-inflammatory leukocytes from the bloodstream into the peritoneum is 
considered to be an important aspect of inflammation and resolution in gout (91, 113).  
Therefore, it is especially important to understand the mechanisms involved in their 
recruitment as possible targets to be used in clinical therapy.   
 
Activated macrophages were previously thought to play a role in monocyte recruitment 
(69) however; studies in our group have shown otherwise.  Our observations have shown 
that while activated resident macrophages play a pivotal role in neutrophil recruitment (58) 
(also described in chapter 3), another mechanism is responsible for monocyte migration. 
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The findings presented within this section have shown that the peritoneal membrane was 
responsible for MCP-1 production upon stimulation with MSU crystals in vitro and that 
this process was CD14 dependent.  However, while cytokeratin+ cultured mesothelial cells 
produced MCP-1 after stimulation with MSU crystals or LPS, CD14 antibodies blocked 
only the LPS response.  The differential responses of PMCs to MSU and LPS in vitro 
suggests that the CD14-dependent TLR4 pathway does not mediate the recognition of 
MSU crystals by mesothelial cells.  This was surprising in light of the apparent dependence 
on CD14 for the peritoneal membrane to produce MCP-1.   
 
As culturing cells in vitro may alter the function of primary cells, the mesothelial cells may 
have lost components of the pathways that respond to MSU crystals.  It is also possible that 
the cell culturing process may have selected a population of MSU-crystal-tolerant 
mesothelial cells while leaving the TLR4 pathway untouched.  
 
Another possibility is that another cell population lining the peritoneal membrane (such as 
fibroblasts) is predominantly responsible for MCP-1 production upon stimulation, and is 
mediated by the CD14-dependent TLR4 pathway.  This may explain the observation of 
CD14 blocking the elicited MCP-1 response of the membrane, but not the cultured 
mesothelial cells.   
 
A follow-up experiment to address these questions could be conducted by excising whole 
peritoneal tissue, placing pieces with the visceral side of the membrane face down over the 
top of the culture well already filled with trypsin/EDTA.  The lid is then placed over the 
top in order to provide a seal between the tissue and the well.  This experiment would 
enable the extraction of cells lining the membrane rather than harvesting from the 
peritoneal cavity as a heterogeneous population.   Results should help to confirm whether 
the cells specifically lining the visceral side of the peritoneum membrane and not those 
lining the internal organs are responsible for the production of MCP-1 through the CD14-
dependent TLR4 pathway after stimulation.    
 
Results presented within this section may also warrant a revisit of cytokeratin staining of 
the peritoneal membrane and identification of MCP-1 producing cells.  This would give a 
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further indication of which cell types (other than mesothelial cells) lining the peritoneal 
membrane are capable in producing MCP-1 upon stimulation.   
 
In summary, these findings have shown that MSU crystals can interact directly with 
peritoneal membrane cells to induce MCP-1 production, thereby playing a key role in 
monocyte recruitment during inflammation.  The results also indicate that cultured 
mesothelial cells may be altered in some way or that, although capable of producing MCP-
1, they are not predominantly responsible for CD14-sensitive MCP-1 production observed 
in the whole peritoneal membrane.    
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4.2 The effects of Glatiramer acetate on recruited 
monocytes in MSU-induced inflammation 
 
4.2.1 Monocytes in immunity 
There are many subpopulations of monocytes, however, all are recognized as mononuclear 
leukocytes of the myeloid lineage.  They originate from the bone marrow as myeloid 
progenitors and are subsequently released into the bloodstream (175).  Monocytes either 
remain in circulation or migrate into peripheral tissues under homeostatic conditions or in 
response to inflammatory signals (175).  A key role of monocytes/macrophages is the 
phagocytosis and clearance of pathogens and debris, while also contributing to the 
resolution of inflammation by the production of TGF-β (57, 93). 
 
4.2.1.1 Myeloid-Derived Suppressor Cells 
One phenotype of the recruited inflammatory monocyte/macrophage subset is the myeloid-
derived suppressor cell (MDSC).  MDSCs comprises of a heterogenous population of 
macrophage precursors, granulocytes, DCs and other myeloid cells at early stages of 
differentiation (119, 138).  In murine models of tumours and multiple sclerosis (MS), 
infiltrating MDSCs have been shown to suppress CD4+ T cell expansion (137, 176, 177).  
In addition, recent studies have described circulating MDSCs to be significantly increased 
in tumour-bearing mice and in cancer patients (119, 176).  In mice MDSCs are broadly 
defined as Gr-1+ CD11b+ cells, have been found to accumulate in other models of disease 
such as sepsis, acute and chronic inflammation, autoimmunity and trauma (137, 176-178).  
In tumour models especially, different subsets of MDSCs are exploited by the neoplastic 
tissue to suppress different aspects of the immune system depending on the type of tumour, 
how the cells were differentiated and the target cell population (119, 132).   
 
4.2.1.2 Glatiramer acetate associates with blood monocytes 
Multiple sclerosis is an inflammatory autoimmune disease of the CNS, resulting in various 
neurological deficits such as sensory loss, cognitive defects and paralysis (179).   
Pathologically, recruited monocytes have been identified as a key cell subset responsible 
for the production of pro-inflammatory cytokines within the inflamed CNS (180).   
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Glatiramer acetate (GA) is an effective treatment of multiple sclerosis and has been shown 
to suppress experimental autoimmune encephalomyelitis (EAE), the murine model of MS.  
The drug appears to elicit its effects by altering circulating monocyte functions, which 
leads to the production of anti-inflammatory cytokines such as IL-10, TFG-β or IL-1 
receptor antagonist (181-183).   
 
Intravenous administration of Alexa488-GA in mice by members of our group has 
identified GA+ monocytes in the blood expressing CD11b+ Gr-1+ F4/80int Ly6C- (Appendix 
1).  Once purified, this circulating population was capable of suppressing T cell 
proliferation in vitro (Appendix 2).  This monocyte phenotype is characteristic of the 
MDSCs (119, 184).  However, to distinguish the GA+ monocytes from tumour MDSCs, 
the CD11b+ Gr-1hi cells isolated from the bloodstream in this study will be referred to as 
suppressor monocytes. 
 
4.2.1.3 Objectives 
The aim of this section was to determine if the enhanced T cell suppressive abilities 
exhibited by GA+ blood suppressor monocytes was retained following recruitment into 
inflamed tissues.  To address this question, we sought to compare the differentiation and T 
cell suppressive function between MSU-recruited monocytes from GA-treated and non-
treated mice.   
 
4.2.2 Results 
 
4.2.2.1 T cell suppressive ability of MSU recruited monocytes 
To measure the effect of MSU-recruited monocytes on T cell responses, we chose to set up 
a T cell expansion assay based on thymidine uptake (185, 186).  In this assay, T cell 
activation and proliferation is induced by the binding of anti-CD3 and anti-CD28 ligands 
to their corresponding receptors on the cell surface.  This process induces rapid expansion 
of the T cell population, which can be quantified by the incorporation of [3H]-thymidine 
into the DNA of the dividing cell.  The amount of cell proliferation correlates to the levels 
of radiation that can be measured by a scintillation counter.   
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To investigate if the suppressive ability of blood monocytes is retained following 
recruitment into the peritoneum in MSU-induced inflammation, we first isolated and 
purified MSU-recruited monocytes at different time-points.  C57Bl/6J mice were injected 
intraperitoneally with 3mg/0.5mL MSU crystals.  At different time-points, recruited 
monocytes were isolated from PECs using a Lympholyte®-M density gradient (described 
in chapter 3).  This purified population comprised between 75% to 80% monocytes, as 
determined by Gr-1 and F4/80 surface marker staining and analysis by flow cytometry.   
 
To obtain a T cell population for the suppression assay, spleens from naïve C57Bl/6J mice 
were injected with 1-2mL of Collagenase II/DNase I solution and incubated for 30 
minutes.  Following incubation, spleens were disrupted with the back of a syringe plunger 
and filtered through 40µm cell strainers with cRMPI.  Contaminating RBCs were lysed 
and the remaining splenocytes washed and resuspended in cRMPI.  The suppression assay 
was conducted by co-culture of splenocytes with the purified, recruited monocytes at 
different cell-to-cell ratios in the presence of αCD3/αCD28 coated “expander” beads.   
 
As shown in Figure 4.5, early (4 hours) MSU-recruited monocytes were able to completely 
suppress T cell expansion at 1:1 and 1:2 ratios with decreasing efficacy as the number of 
splenocytes outnumbered the monocytes (1:4 to 1:16).  The recruited monocytes isolated 
later in the inflammatory response (from 16 hours to 48 hours) displayed an ability to 
suppress T cell activation even at 1:8 and 1:16 ratios (Figure 4.5). 
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Figure 4.5: Monocyte suppression of splenocyte proliferation induced by DynaBead® 
expander beads.  C57Bl/6J mice were administered with an i.p. injection of MSU crystals (3mg/0.5mL).  
At different time-points, peritoneal exudate cells were harvested and purified by Lympholyte®-M density 
gradient (>75% monocytes).  The monocytes were co-cultured with 5x104 C57Bl/6J splenocytes at the 
indicated ratios in the presence of DynaBead® CD3/CD28 T cell expander beads in 96 well round-bottom 
plates.  The cells were incubated for 20 hours, and an additional eight hours in the presence of [3H]-
thymidine.  T cell expansion was measured by [3H]-thymidine incorporation.  Measurements performed in 
triplicate.  Values represent mean ± S.E.M.  Results are representative of two independent experiments with 
four mice per group.   
 
In chapter 3 (section 3.2.9), MSU-recruited monocytes were shown to increase phagocytic 
function over time.  Therefore, it was possible that the observed increase in suppressive 
activity by monocytes at later time-points was the result of increased uptake of expander 
beads, thereby decreasing T cell expansion.  To address this issue, a separate proliferation 
assay was set up where anti-CD3/anti-CD28 antibodies were used to coat culture plates 
overnight prior to co-incubation of monocytes and T cells. 
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As shown in Figure 4.6, T cell expansion in response to anti-CD3/anti-CD28 was 
suppressed by MSU-recruited monocytes isolated from mice 16 hours or more after MSU 
administration, compared to 4-hour monocytes in the expander bead assays.  This result 
indicated that phagocytosis of expander beads in the previous assay made a significant 
contribution to the overall level of suppressive activity and particularly for 4- and 8-hour 
monocytes.  
 
Therefore, in all subsequent suppression assays T cell expansion was triggered using anti-
CD3/anti-CD28 coated plates. 
 
 
Figure 4.6: Monocyte suppression of polyclonal T cell proliferation induced by anti-
mouse CD3/CD28 coated plates.  C57Bl/6J mice were administered with an i.p. injection of MSU 
crystals (3mg/0.5mL).  At different time-points, peritoneal exudate cells were harvested and purified by 
Lympholyte®-M density gradient (>75% monocytes).  The monocytes were co-cultured with 5x104 C57Bl/6J 
lymphocytes at the indicated ratios in 96 well round-bottom plates pre-coated with anti-mouse CD3 and 
CD28 antibodies (2µg/mL and 3µg/mL respectively) in D-PBS the night prior.  The cells were incubated for 
20 hours, and an additional eight hours in the presence of [3H]-thymidine.  T cell expansion was measured by 
[3H]-thymidine incorporation.  Measurements performed in triplicate.  Values represent mean ± S.E.M.  
Results are representative of three independent experiments with four mice per group.   
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In addition, to improve the purity of the T cell population, all subsequent suppression 
assays were carried out using T cell preparations from naïve inguinal lymph nodes.  To 
obtain the T cell population, inguinal lymph nodes from naïve C57Bl/6J mice were 
disrupted with the back of a syringe plunger and filtered through 40µm cell strainers with 
cRMPI.  Contaminating RBCs were lysed and the lymphocytes washed and resuspended in 
cRMPI.   
 
As the suppressive ability of recruited monocytes appeared to increase as they 
differentiated to more macrophage-like cells, we next sought to investigate whether 
resident macrophages displayed an innate ability to suppress T cell proliferation.  PECs 
were harvested from naïve C57lBl/6J mice, however they were not put through a density 
gradient as resident macrophages (approximately 50 – 70µm in diameter), due to their 
relatively large size, cannot be separated by this particular method.  As the peritoneal 
lavage normally contains around 50% or more macrophages, the exudate cells were 
washed and co-cultured with T cells from naïve mice in anti-CD3/anti-CD28 pre-coated 
culture plates.  After the overnight incubation, T cell proliferation was measured by [3H]-
thymidine incorporation.  The results showed that resident macrophages displayed an 
ability to suppress T cell proliferation when macrophage and T cell numbers are 
approximately equal (Figure 4.7).  However, the suppressive ability was lost when T cell 
numbers far outnumbered the macrophage population (Figure 4.7).   
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Figure 4.7: Resident macrophage suppression of polyclonal T cell proliferation 
induced by anti-mouse CD3/CD28 coated plates.  Peritoneal exudate cells were harvested from 
naïve C57Bl/6J mice.  The cell suspension (>50% macrophages) was then co-cultured with 5x104 C57Bl/6J 
lymphocytes at the indicated ratios in 96 well round-bottom plates pre-coated with anti-mouse CD3 and 
CD28 antibodies (2µg/mL and 3µg/mL respectively) in D-PBS the night prior.  The cells were incubated for 
20 hours, and an additional eight hours in the presence of [3H]-thymidine.  T cell expansion was measured by 
[3H]-thymidine incorporation.  Measurements performed in duplicate.  Values represent mean ± S.E.M. * = P 
< 0.05 as determined by one-way ANOVA and Tukey multiple comparison test.  Results are representative 
of two independent experiments with five mice per group. 
 
In summary, these results showed that infiltrating monocytes do not retain their T cell 
suppressive abilities immediately after recruitment.  However, at later time-points along 
the inflammatory response they develop the ability to suppress T cell expansion.  This 
indicated that as monocytes differentiate into more macrophage-like cells, they are able to 
non-specifically suppress T cell proliferation.   
 
4.2.2.2 GA labelling of circulating monocytes 
We next set out to determine whether MSU-recruited GA+ monocytes could enhance T cell 
suppressive activity compared to normal MSU-recruited monocytes.   
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Before investigating the effects of GA+ monocytes in the MSU-induced inflammatory 
model, we first confirmed the phenomenon of in vivo labelling of circulating monocytes by 
GA.  C57Bl/6J mice were injected i.v. with GA-Alexa488. After thirty minutes, white 
blood cells were isolated from blood, stained with CD11b FACS antibody and analysed by 
flow cytometry (Figure 4.8).   
 
The GA+ cells in the blood were confirmed as expressing high levels of CD11b (CD11b+) 
and were located to the mononuclear fraction on the side scatter (SSClow).  Studies by other 
members of our group looking at other cell surface antigens further classified these cells as 
Ly6G-, Gr-1+ and F4/80int (Appendix 1), thus confirming GA+ cells as circulating 
inflammatory monocytes rather than neutrophils 
 
 
Figure 4.8: GA binds CD11b+ cell population after i.v. injection.  C57Bl/6J mice were 
either A. left untreated or administered with an i.v. injection of B. Alexa488- or C. Alexa647-labelled GA 
(7µg/mL) in D-PBS.  Cells were recovered 30 minutes after the injections, stained for cell surface antigens 
and samples of individual mice analysed by flow cytometry.  Results are representative of at least three 
independent experiments. 
 
To determine how long GA+ monocytes remained in circulation, Alexa488-GA was 
injected intravenously, and blood cells of individual mice collected at different time-points 
and analysed by flow cytometry. 
 
These results demonstrated that administration of GA-Alexa488 i.v. resulted in the specific 
labelling of 90 – 100% of circulating monocytes and that the GA+ cells remained present in 
the bloodstream for up to 18 hours after injection.  However, the mean fluorescence index 
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(MFI) of GA bound to monocytes began to decline after an hour.  At 48 hours, the number 
of GA+ monocytes was close to undetectable and even then the fluorescence intensity from 
the dye was relatively low.  
 
 
Figure 4.9: GA binding of blood monocytes is stable over 18 hours.  C57Bl/6J mice were 
administered with or without an i.v. injection of GA-Alexa488 (7µg/mL) in D-PBS.  After the injections, 
mice were tail-bled at various time-points and the cells stained for cell surface antigens and samples of 
individual mice analysed by flow cytometry.  Values represent mean ± S.E.M.  Time-courses were split into 
two separate experiments, for time ranges of 20 minutes to six hours and from six hours to 96 hours.  Results 
are representative of four independent experiments (both time-courses each performed twice) with three mice 
per group.   
 
To take full advantage of the period when GA+ cells remained in the bloodstream, GA i.v. 
injections were immediately followed by i.p. MSU administration.  This ensured that 
circulating GA+ cells in circulation were available for MSU-induced recruitment. 
 
4.2.2.3 GA+ monocytes can be recruited into the peritoneum in MSU-
induced inflammation.   
To determine whether the GA+ monocytes could be recruited into the peritoneum by MSU-
induced inflammation, GA-A488 was injected intravenously into C57Bl/6J mice, followed 
immediately by an intraperitoneal injection of MSU crystals.  After 6 hours, cells were 
harvested and stained for CD11b, F4/80 and Gr-1 and analysed by flow cytometry.  FACS 
plots showed that GA-untreated mice did not stain positive for Alexa488 (Figure 4.10A, 
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gate R1) compared to GA-treated mice. GA-treated mice exhibited a distinct population of 
CD11b+ GA-Alexa488+ double positive cells (Figure 4.10B, gate R1).  The CD11b+ GA+ 
population was confirmed as recruited monocytes by their intermediate expression of the 
macrophage marker F4/80 and showed both a Gr-1hi and Gr-1int population (Figure 4.10C, 
gate R1).   This is consistent with the presence of both (Gr-1+) newly recruited monocytes 
and recruited monocytes that have downregulated Gr-1 as they differentiate into 
macrophages observed in chapter 3, section 3.2.7.   
 
 
Figure 4.10: GA bound cells are recruited into the peritoneum after MSU induced 
inflammation.  C57Bl/6J mice were administered with or without an i.v. injection of GA-A488 (7µg/mL) 
in D-PBS.  After 20 minutes, mice were administered with MSU crystals (3mg/0.5mL).  Peritoneal exudate 
cells were then harvested after six hours, stained for CD11b, F4/80 and Gr-1 cell surface antigens and 
analysed by flow cytometry.  A. Peritoneal exudate cells from GA untreated mice were used as negative 
controls (gate R1). B. Peritoneal exudate cells from GA-A488 labelled mice were identified as CD11b+ and 
GA-A488+ (gate R1).  C. Frequency of GA-A488+ cells (gate R1) showing monocyte surface marker 
phenotypes, Gr-1int and F4/80low.  Results are representative of at least three independent experiments.     
 
4.2.2.4 Effects of GA treatment on T cell suppressive ability of MSU 
recruited monocytes 
The results above confirmed that MSU-induced inflammation was able to recruit GA+ 
monocytes from the blood stream into the peritoneum.  We next asked the question; do 
GA+ monocytes recruited from the blood exhibit enhanced T cell suppressive activity?   
 
Mice were given GA i.v. immediately prior to MSU administration i.p and PECs were 
harvested at 6 and 18 hours to align with period of maximum staining of GA-monocytes in 
the bloodstream (Figure 4.9).  The MSU-recruited monocytes were purified using the 
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lympholyte®-M density gradient and tested for their ability to suppress CD3/CD28 induced 
T cell expansion.  As previously described in Figure 4.6, non-GA-treated recruited 
monocytes exhibited suppressive activity at 18 hours but not at 6 hours (Figure 4.11A).  
Interestingly, GA-treatment appeared to exacerbate T cell expansion at both time-points 
(Figure 4.11B 
 
Figure 4.11: GA bound monocytes does not alter their suppressive abilities on 
polyclonal T cell proliferation.  C57Bl/6J mice were administered with or without an i.v. injection of 
GA-A488 (7µg/mL) in D-PBS.  After 20 minutes, mice were administered with MSU crystals (3mg/0.5mL) 
for six and 18 hours.  Peritoneal exudate cells were harvested and purified by Lympholyte®-M density 
gradient (>75% monocytes).  The monocytes were co-cultured with 5x104 C57Bl/6J lymphocytes at the 
indicated ratios in 96 well round-bottom plates pre-coated with anti-mouse CD3 and CD28 antibodies 
(2µg/mL and 3µg/mL respectively) in D-PBS the night prior.  The cells were incubated for 20 hours, and an 
additional eight hours in the presence of [3H]-thymidine.  T cell expansion was measured by [3H]-thymidine 
incorporation.  Measurements performed in triplicate.  Values represent mean ± S.E.M.  Results are 
representative of two independent experiments with four mice per group. 
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4.2.2.5 Effects of GA treatment on MSU recruited monocyte phenotype 
Next we sought to determine if GA altered other phenotypic features on MSU-recruited 
monocytes.  To do this, we compared the differentiation markers of MSU-recruited 
monocytes from GA-treated to untreated mice.  As in the previous experiments, PECs were 
harvested and stained with cell surface markers CD11b, F4/80 and Gr-1 and analysed by 
flow cytometry.  GA bound monocytes displayed no differences in the main differentiation 
cell surface markers compared to non-GA-treated monocytes (Figure 4.12).   
 
 
Figure 4.12: GA bound monocytes do not alter their surface marker differentiation 
profile.  C57Bl/6J mice were administered with or without an i.v. injection of GA-A488 (7µg/mL) in D-
PBS.  After 20 minutes, mice were administered with MSU crystals (3mg/0.5mL) for six and 18 hours.  
Peritoneal exudate cells were harvested and stained for cell surface antigens and samples of individual mice 
analysed by flow cytometry.  Plots are gated on Gr1in and F4/80int monocytes.  Results are representative of 
three independent experiments.   
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4.2.2.6 Effects of GA treatment on MSU recruited monocyte phagocytic 
function 
To determine whether phagocytic function of MSU-recruited monocytes was altered after 
GA treatment, PECs were recovered 6 and 18 hours after MSU administration and 
recruited monocytes purified by density gradient separation.  Monocytes were then 
incubated with fluorescent beads, stained for the cell surface antigen F4/80 (to identify the 
bead+ monocyte population) and analysed by flow cytometry.   
 
As shown in Figure 4.14, the percentages of bead+ monocytes were similar in both GA-
treated and non-treated groups.  This indicated that GA treatment did not alter the 
phagocytic ability of recruited monocytes.  
 
 
Figure 4.13: GA treatment does not alter phagocytic ability of MSU-recruited 
monocytes.  C57Bl/6J mice were administered with or without an i.v. injection of GA-A488 (7µg/mL) in 
D-PBS.  After 20 minutes, mice were administered with MSU crystals (3mg/0.5mL) for six and 18 hours.  
Peritoneal exudate cells were harvested and purified by Lympholyte®-M density gradient (>75% monocytes).  
Cells were resuspended at 5x105 cells/mL and 2mL of the suspension was incubated with fluorescent beads 
for 30 minutes.  Excess beads were washed off and cells were stained for the cell surface antigen F4/80 and 
samples of individual mice analysed by flow cytometry.  Plots are gated on F4/80int monocytes.  Results are 
representative of one experiment with three mice per group.   
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In the same experiment, the capacity of monocytes to take up more than one bead was also 
evaluated (chapter 3, section 3.2.9).  This involved gating on the bead-positive population 
and then sub-gating on the populations displaying a second fluorescent spike.  The ability 
of MSU-recruited GA+ monocytes to phagocytose more than one bead was comparable to 
normal recruited monocytes (Figure 4.14). 
 
 
Figure 4.14: GA treatment does not alter phagocytic capacity of MSU-recruited 
monocytes.  Total F4/80+ and Bead+ cells in Figure 4.11 were analysed for their ability to phagocytose 
more than one bead using histogram peaks in flow cytometry.  Measurements were performed in duplicate. 
Values represent mean ± S.E.M.  Results are representative of one experiment with three mice per group.   
 
4.2.2.7 Effects of GA treatment on recruited monocyte functionality 
We next looked at the effect of GA on the functional response by restimulating recruited 
monocytes with MSU crystals or LPS.  GA-A488 was injected intravenously into naïve 
C57Bl/6J mice followed by an intraperitoneal injection of MSU crystals.  At 6 and 18 
hours, PECs were harvested and purified through a density gradient.  Monocytes were then 
cultured in the presence of LPS or MSU crystals for 8 hours, and the supernatant analysed 
for cytokine/chemokines levels by ELISA or Bioplex bead array.   
 
There were no significant increases in the production of IL-6, MCP-1 or KC after MSU 
crystal or LPS restimulation by MSU-recruited monocytes from GA-treated compared to 
non-GA-treated mice (Figure 4.15).   
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Figure 4.15: GA bound monocytes do not alter their capacity to produce 
cytokines/chemokines after restimulation.  C57Bl/6J mice were administered with or without an 
i.v. injection of GA-A488 (7µg/mL) in D-PBS.  After 20 minutes, mice were administered with MSU 
crystals (3mg/0.5mL) for six and 18 hours.  Peritoneal exudate cells were harvested and purified by 
Lympholyte®-M density gradient (>75% monocytes).  Cells were resuspended at 5x105 cells/mL and 200µL 
was cultured in the presence of MSU (500µg/mL) or LPS (100ng/mL) for eight hours.  After the incubation 
period, the levels of A. IL-6 B. KC C. MCP-1 were determined by ELISA and Bioplex bead array.  
Measurements performed in duplicate. Values represent mean ± S.E.M.  Results are representative of one 
experiment with three mice per group.   
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4.2.3 Discussion 
Purified naïve blood monocytes have been shown previously by other members of our 
group to display an intrinsic ability to suppress expanding polyclonal T cells in vitro.  
While MDSCs also display monocyte-like phenotypes (Gr-1+ CD11b+) and have the ability 
to suppress T cell proliferation, it is a common perception that these are induced by non-
host derived factors, such as tumours (138, 187, 188). 
 
In this study, the importance of choosing the correct in vitro method of activation was 
made clear during the optimisation of the suppression assay.  When purified MSU-
recruited monocytes were co-cultured with T cells in the presence of expander beads, the 
development of monocyte suppressive ability at the different time-points were almost 
methodical.  In fact, the results were artificial effects of increases in monocyte phagocytic 
function, correlating with the differentiation into more macrophage-like cells.  The uptake 
of the expander beads by monocytes blocked T cell expansion giving a false and 
exaggerated profile of T cell suppressive activity.  These observations serve as a technical 
caveat, emphasizing that αCD3/αCD28 expander beads can be used in T cell expansion 
assays with non-phagocytic cells, however when working with phagocytes such as 
monocytes/macrophages, the use of antibody coated plates avoids the possibility of false 
positive results.   
 
During the early stages of MSU-induced inflammation, monocytes migrate into a chaotic 
environment filled with infiltrated neutrophils (189, 190), debris and a mixture of pro-
inflammatory cytokines/chemokines (40, 41, 43) and growth factors (151).  Unlike their 
naïve counterparts in blood, early recruited monocytes do not suppress T cell activation.  
This may be due to the specific inflammatory environment into which monocytes are 
recruited; for example, the tumour environment (IL-17 and TNFα) (191, 192) may support 
or drive the monocyte suppressive phenotype often associated with immune tolerance 
(119, 176, 188).  In the acute MSU-induced inflammatory environment consisting of 
predominately IL-6, IL-1β, TNFα (40, 43) and soluble factors secreted by neutrophils 
(such as IL-8); these pro-inflammatory signals could override the recruited-monocyte T 
cell suppressive functions.  
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Over time MSU-recruited monocytes did regain their suppressive phenotype; this appeared 
to correlate with the loss of hemopoietic markers (such as 7/4 and Gr-1) and increase in 
F4/80 expression as they differentiated into macrophages (chapter 3, section 3.2.7).  While 
the changes in monocyte surface markers indicate gradual development of more 
macrophage-like characteristics, it appears that the acute pro-inflammatory environment 
can induce a state of inactivity from the monocytes until after the acute inflammatory 
response resolves.  This may correlate with the uptake of neutrophils by recruited 
monocytes in order to initiate the resolution of the inflammatory response (described in 
chapter 3).  By holding back the development of the suppressive phenotype, the 
inflammatory response is allowed to run its course before “semi-differentiated” monocytes 
can continue with progression in functionality.   
 
One of the key findings of this study was that MSU-recruited GA+ monocytes did not 
display any T cell suppressive ability but instead exacerbated T cell expansion compared to 
monocytes from non-GA-treated mice.  The monocyte populations from GA-treated and 
non-treated mice did not differ in their differentiation profiles, phagocytic functions or 
capacity to produce IL-6, MCP-1 or KC.  In Chapter 3, I demonstrated that monocytes 
recruited into an MSU-induced acute inflammatory environment are programmed to 
develop macrophage-like phenotypes and pro-inflammatory functions.  This 
microenvironment could, in the process of driving monocyte to macrophage 
differentiation, alter GA’s modulatory effects on its target cell type.  It is possible that the 
modulatory effects of GA on recruited monocytes is specific to the EAE microenvironment 
(IFN-γ and IL-17), which promotes the differentiation of GA+ monocytes to a phenotype 
that can suppress T cell expansion.    Further studies to investigate whether the 
inflammatory environment plays a key role in GA’s modulatory effects on recruited 
monocytes could involve investigating the activity of arginase-1, which has been indicated 
as a mechanism of suppression by MDSCs in EAE (193, 194), and comparing its activity 
between GA+ monocytes in an MSU-induced acute inflammatory and the EAE 
autoimmune environment. 
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Another possible explanation for the loss of function may be a change in GA’s modulatory 
effects on monocytes as they transmigrate through the endothelium.  It has been previously 
shown that interactions with endothelial cells can cause the altered expression of several 
genes (such as MMP-1, MCP-1 and TG2) on human monocytes (114).  A similar 
modification may have occurred with the GA+ monocytes after recruitment into the 
peritoneum resulting in the loss of their abilities to suppress T cell activation.   
 
In summary, the results presented in this section have shown that the T cell suppressive 
activities of MSU-recruited monocytes develop as they differentiate into macrophages.  In 
addition, GA+ monocytes do not suppress and in fact exacerbate T cell expansion in an  
MSU-induced inflammatory environment. 
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General Discussion 
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There have been many studies in different disease models exploring the differentiation and 
functional contributions of recruited monocytes to pathology.  The objectives of this study 
offer insight into the importance of an acute inflammatory environment on the 
differentiation and function of recruited monocytes.  The profiling of monocytes recruited 
into a microenvironment devoid of resident macrophages and infiltrating neutrophils 
provided a means to study monocyte differentiation and function in an attenuated 
inflammatory environment.  
 
5.1 Initiation of MSU-induced leukocyte recruitment 
In the murine model of acute gout, MSU administration elicits activation of resident 
macrophages and induces the recruitment of circulating neutrophils and monocytes into the 
peritoneal cavity.     
 
Infiltrating neutrophils are important potentiators of acute inflammation through the 
production of IL-8 (87) and superoxide (46).  The recruitment of neutrophils from the 
bloodstream was previously believed to be mediated by the production of TNFα by 
macrophages after LPS administration in the air pouch model (195).  However, other 
studies have shown that when resident macrophages are depleted prior to MSU crystal 
stimulation i.p., abrogation of neutrophil recruitment correlated with a similar decrease in 
the chemokine KC while TNFα levels were unaffected (58).  The results presented within 
this study are consistent with the latter finding, showing that depletion of resident 
macrophages in vivo results in abrogated neutrophil recruitment and decreased KC 
production within the peritoneum during MSU-induced inflammation (chapter 3, section 
3.2.3).  This indicates that resident macrophages play a prominent role in neutrophil 
recruitment through the production of KC in the murine peritoneal model of MSU-induced 
acute inflammation.     
 
The mechanisms responsible for MSU-induced monocyte recruitment into inflamed tissues 
are less well understood.  In this study, activation of resident macrophages after MSU 
administration was observed in conjunction with increased levels of the monocyte 
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chemokine MCP-1 in vivo (chapter 3, section 3.2.4).  However, the source of MCP-1 
production was unclear.   
 
Data reported by Olivier and colleagues indicate that murine macrophage cell-lines 
exposed to MSU crystals transiently increase mRNA levels of various chemokines 
(including MCP-1) (69).  Neutropenic mice are also reported to be unable to mobilize 
inflammatory monocytes from the circulation after LPS stimulation in a subcutaneous air 
pouch model (165).  Consistent with this, rabbits made neutropenic following antibody 
administration are also unable to retain recruited monocytes in the alveolar space in a 
model of pulmonary inflammation (169).  Together these data would support a potential 
role for both resident macrophages and infiltrating neutrophils in monocyte recruitment in 
acute MSU-induced inflammation.   
 
However, other in vivo findings have shown that activated macrophages do not produce 
MCP-1 after MSU-stimulation (58) and that in LFA-1-/- mice, neither MCP-1 release nor 
monocyte recruitment is affected by reduced neutrophil migration after thioglycollate 
stimulation (170).  In this study, although the depletion of resident macrophages resulted in 
the abrogation of neutrophil infiltration, monocyte recruitment remained unchanged 
(chapter 3, section 3.2.3).  These findings indicate that a macrophage- and neutrophil-
independent pathway exists to mediate MCP-1 production within the peritoneum during 
MSU-induced inflammation. 
 
A possible source of macrophage-/neutrophil-independent MSU-induced MCP-1 
production in the model is the surrounding membrane.  The role of epithelial cells in 
leukocyte recruitment has been previously investigated in neoplastic tissue, whereby 
stromal production of MCP-1 induces tumour-associated macrophage infiltration and 
contributes to tumour progression (196).  In addition, as mentioned in chapter 4 (section 
4.1.1.1), synoviocytes isolated from rabbit joints have been shown to produce MCP-1 after 
LPS stimulation using immunohistochemistry (70).  These findings indicate that the local 
membrane can potentially contribute to the production of MCP-1 resulting in monocyte 
recruitment during an inflammatory response.  The results of chapter 4 section 4.1.2.1 
demonstrated that the peritoneal membrane was a major source of MCP-1 after direct MSU 
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stimulation.  In addition, the production of MCP-1 appears to be mediated in a CD14-
dependent manner.  In vitro culture of primary PMCs isolated from the peritoneum 
produced high levels of MCP-1 after both MSU crystal and LPS stimulation (chapter 4, 
section 4.1.2.3).  This is consistent with studies by Matsuo and colleagues showing that 
murine PMCs produce MCP-1 through a TLR4/NFκB-dependent mechanism after LPS 
challenge (173).  Interestingly, cultured PMC production of MCP-1 in response to MSU 
crystal stimulation appeared to be mediated by a CD14-independent mechanism.  This may 
indicate that in vitro culture had altered the function of the primary cell, allowing the 
PMCs to lose components of the MSU crystal response pathway.  Alternatively, this may 
suggest that PMCs are not the only source of MCP-1 in vivo.  Future directions may 
involve further characterisation of other MCP-1+ cells isolated from the digested peritoneal 
membrane, or a revisit of direct MCP-1 immunofluorescent histology on whole excised 
peritoneal tissue to identify cells producing CD14-restricted MCP-1. 
 
In this study, MSU-induced monocyte recruitment remained unaffected even in an 
inflammatory environment with decreased levels of MCP-1.  It is possible that within the 
local environment, a threshold MCP-1 concentration exists, which once reached will 
enable the maximum recruitment of circulating monocytes into the peritoneum after MSU 
administration.  Nevertheless, decreased MCP-1 production does indicate a possible role 
for resident macrophages in the augmentation of MCP-1 production by resident membrane 
cells.  Previous studies have shown that murine peritoneal mesothelium express the IL-1 
receptor (197), which may be activated by IL-1β produced by MSU-activated 
macrophages, and may be responsible for augmenting production of the MCP-1 chemokine 
by membrane cells.   
 
Another reason for unaffected monocyte recruitment despite a local decrease in MCP-1 
levels could be that resident cells may produce mediators of monocyte recruitment other 
than MCP-1.  Fibroblasts and endothelial cells are also able to produce the cytokine 
macrophage-stimulating factor (M-CSF) (198-200), which has been shown previously to 
have chemotactic properties (155, 156).  Transient elevation of M-CSF within the 
peritoneum after MSU administration was observed in this study (chapter 3, section 
3.2.10), indicating a possible role for M-CSF in monocyte recruitment in vivo.  In addition, 
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thrombin – an enzyme that participates in fibrin formation, has been shown to stimulate 
production of the chemokine macrophage inflammatory protein-2 (MIP-2) by rat 
glomerular epithelial cells in vitro (201).   
 
5.2 Early recruited monocytes are non-responsive to MSU 
restimulation ex vivo 
Previous in vitro and ex vivo studies have proposed that undifferentiated monocytes are 
key cells involved in the pro-inflammatory phase of MSU-induced inflammation, and 
switch to an anti-inflammatory phenotype as they differentiate into macrophages (111-
113).  These studies have shown using monocyte/macrophage cell lines and differentiated 
human peripheral blood monocytes, that undifferentiated monocytes produce pro-
inflammatory cytokines (such IL-6 and TNFα) in response to MSU crystal stimulation, 
whereas mature macrophages do not produce IL-6 and TNFα (111, 112).  In addition, a 
study mixing leukocyte populations harvested from human blisters has shown a similar 
pattern of switching from a “pro”- to an “anti”-inflammatory response when 
monocytes/macrophages were stimulated with MSU ex vivo (113).  However, as these 
previous studies were based on immortalized murine cells lines and human monocyte-
derived macrophages differentiated over 7 days in vitro, their physiological relevance to 
the in vivo inflammatory environment remains unclear.     
 
In chapter 3 (section 3.2.8), newly recruited monocytes were shown to be unresponsive to 
MSU crystal restimulation ex vivo.  Contrary to previous in vitro studies, the ability of 
recruited monocytes/macrophages to produce pro-inflammatory cytokines/chemokines 
after MSU crystal restimulation developed at later stages of the inflammation profile, 
coinciding with differentiation towards a macrophage-like phenotype. 
 
This indicated that MSU recognition/activation pathways may be compromised in 
recruited monocytes and develop during differentiation to macrophages.  One such 
recognition pathway involves the co-factor CD14, which is believed to be primarily 
responsible for presenting LPS to TLR4 and subsequent initiation of pro-inflammatory 
cytokine production via the NFκB pathway (60, 61, 202).  Recombinant soluble CD14 has 
also been shown to coat the surface of MSU crystals in vitro (54) and appears to facilitate 
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the recognition and uptake of MSU crystals by resident phagocytes.  Liu-Bryan and 
colleagues have shown that soluble CD14-coated MSU crystals were able to restore the 
production of IL-1β in CD14-/- bone marrow-derived macrophages in vitro (54).  
 
The results in chapter 3 (section 3.2.6) demonstrated that newly recruited monocytes 
expressed higher levels of CD14 after transmigration through the endothelium; however, 
these levels were still significantly lower compared to resident macrophages.  This may 
indicate that there are insufficient levels of CD14 on the surface of recruited monocytes to 
enable recognition of MSU crystals, however responsiveness to LPS restimulation 
indicated the level of CD14 expression was adequate for functional engagement with the 
TLR4 pathway.  Alternatively it has been shown recently that there are differential 
requirements for the activation of the NALP3 inflammasome in monocytes and 
macrophages (203).   Therefore, it is possible that CD14 expression is not required for the 
production of pro-inflammatory cytokines in recruited monocytes after MSU crystal 
stimulation but becomes a regulatory component as monocytes differentiate into 
macrophages.   
 
Another possible reason for the lack of response by early recruited monocytes to MSU 
restimulation could be due to the lower initial phagocytic capacity (chapter 3, section 
3.2.9), a function that develops as recruited monocytes differentiate into macrophages.  
Studies by Mossman and Hansen first observed the phenomenon of “frustrated” 
phagocytosis with the inability of alveolar macrophages to efficiently phagocytose long 
thin crystal particles resulting in disrupted plasma membranes and the production of pro-
inflammatory molecules (204).  Recently, studies have shown that phagocytosis of crystal 
structures such as MSU by macrophages results in the subsequent rupture of intracellular 
lysosomes (56).  This process activates the multi-protein complex NALP3 inflammasome 
that in turn binds and activates procaspase-1 (62).  Activated caspase-1 cleaves preformed 
stores of proIL-1β into active IL-1β allowing it to be secreted from the cell (60).  
Therefore, stalled development of phagocytic capability may delay the ability of newly 
recruited monocytes to respond to MSU restimulation. 
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The link between low phagocytic capacity and lack of MSU-induced restimulation of 
newly recruited monocytes may be further supported by the macrophage-depletion model, 
whereby monocytes recruited into a macrophage-depleted environment exhibited a delay 
in the development of phagocytic function compared to MSU-recruited monocytes from 
normal mice.  The length of time that recruited monocytes were un-responsive to MSU 
restimulation correlated with the different rates of development in phagocytic function.  
While recruited monocytes from normal mice gradually increased responsiveness to MSU 
crystals after 24 hours, monocytes from macrophage-depleted mice only began to respond 
after one week.   
 
Future research to confirm the importance of uptake in the recognition of MSU crystals 
could involve the use of a phagocytosis inhibitor on monocyte/macrophage populations, 
which should obstruct their responsiveness to MSU crystals thereby suppressing 
cytokine/chemokine production.  Alternatively, as monocytes differentiate into 
macrophages, the expression and function of the NALP3 inflammasome could be analysed 
to investigate possible differential response mechanisms to MSU crystals.     
 
5.3 Recruited monocyte phagocytosis of apoptotic 
neutrophils and the resolution of MSU-induced 
inflammation. 
A characteristic feature of a gout attack is the spontaneous resolution of inflammation.  
Although the cause is not conclusively known, there is indirect evidence to show that 
mononuclear phagocytes mediate resolution of inflammation in gout through anti-
inflammatory molecules (including TGF-β) (167, 168).     
 
In situations where there is delayed neutrophil apoptosis and clearance by macrophages, an 
accumulation of infiltrating neutrophils within tissues occurs, resulting in recurrent sterile 
inflammatory complications (152).  This has been observed previously in patients with 
chronic granulomatous disease (CGD), who possess circulating neutrophils that are more 
resistant to apoptosis in vitro (152).  In addition, other studies have shown that is there an 
increased and prolonged neutrophil influx in TG2-/- mice – deficient in macrophage uptake 
of apoptotic cells (166).  These studies indicate that dysfunctional macrophage 
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phagocytosis of apoptotic neutrophils can result in unresolved and extended inflammation 
in vivo.  Furthermore, Fadok and colleagues have shown that human monocyte-derived 
macrophage phagocytosis of apoptotic neutrophils produce anti-inflammatory mediators 
(including TGF-β) while downregulating pro-inflammatory cytokines (such as TNFα) in 
vitro (142).  Together these findings indicate that the resolution of inflammation not only 
requires the removal of apoptotic cells but also the active suppression of the inflammatory 
environment.  However, as these studies have been conducted in vitro, their relevance to 
the resolution of MSU-induced inflammation in vivo has yet to be demonstrated.   
 
In this study, the peak of neutrophil infiltration at 18 hours after MSU administration in 
vivo coincided with increased phagocytic ability of differentiated monocytes/macrophages 
ex vivo (chapter 3, section 3.2.9).  When MSU-recruited monocytes were isolated from the 
infiltrating neutrophils, monocytes produced increased levels of cytokines/chemokines 
(chapter 3, section 3.2.11).  This indicates that the phagocytosis of apoptotic neutrophils by 
recruited monocytes, may have switched them from a “pro”- to “non”-inflammatory 
phenotype ex vivo.   
 
In addition to neutrophil uptake, the resolution of inflammation in gout is also thought to 
involve the anti-inflammatory cytokine TGF-β (113, 167).  Previous studies have shown 
that administration of recombinant human TGF-β abrogated MSU-induced inflammation 
in a rat subcutaneous air pouch model (110).  In addition, Henson and colleagues have 
shown that anti-TGF-β antibody restores cytokine production in LPS-stimulated 
macrophages that had previously phagocytosed apoptotic cells (142).  This indicates a role 
for TGF-β in suppressing the pro-inflammatory capabilities of phagocytes involved in the 
uptake of apoptotic cells.  In this study, direct suppression of monocyte pro-inflammatory 
capabilities by neutrophil secreted soluble factors was shown when isolated, recruited 
monocytes were cultured in neutrophilic secretions; this resulted in the suppression of pro-
inflammatory cytokines/chemokines production by the recruited monocytes after MSU-
restimulation (chapter 3, section 3.2.12).  In addition, TGF-β was shown to play a role in 
the suppressive effects when TGF-β blocking antibody was added to neutrophil and 
monocyte co-cultures, resulting in the increased production of cytokines/chemokines from 
the mixed cultures (chapter 3, section 3.2.13).  Interestingly, this suppressive effect was 
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only observed in later stage recruited pro-inflammatory monocyte/macrophages.  However, 
as early recruited monocytes exhibit no response to MSU crystal restimulation, it is not 
surprising that TGF-β depletion has no real effect on this cell population; supporting the 
hypothesis that early monocytes may possess dysfunctional pathways in recognising MSU 
crystals.  
 
Therefore, this phenomenon needs to be examined in further detail, possibly by identifying 
what soluble factors neutrophils make and then adding each to recruited monocyte cultures 
to observe suppressive effects.  In addition, the importance of TGF-β in the initiation and 
resolution of MSU-induced inflammation could be investigated following the in vivo 
depletion of TGF-β.  Future research to investigate whether monocytes phagocytose 
apoptotic neutrophils, contributing to resolution in vivo could involve the i.p. injection of 
CFSE labelled neutrophils at the peak of MSU-induced inflammation and at different time-
points analysis of monocytes/macrophages for CFSE and monocyte marker co-localisation 
by flow cytometry. 
 
5.4 Impact of the inflammatory environment on recruited 
monocyte differentiation and function 
Until now, there has been very little research into the differentiation and function of 
monocytes recruited into an acute inflammatory environment (58, 175).  Even fewer 
studies have investigated the differences in differentiation and function of recruited 
monocytes in an abrogated inflammatory environment in vivo.  One of the novel findings 
of this study is the effect of an abrogated acute inflammatory environment on MSU-
recruited monocyte differentiation and function.  In this model, the process of monocyte to 
macrophage differentiation is delayed, resulting in functional deviations. 
 
In normal mice, the first 24 hours after monocytes are recruited into an MSU-induced 
inflammatory environment is characterised by the downregulation of the hemopoietic 
surface markers Gr-1 and 7/4 (chapter 3, section 3.2.7).  At this point, recruited monocytes 
begin to develop a macrophage-like morphology and upregulate the expression of 
macrophage surface phenotypes F4/80 and CD11b (macrophage markers), CD206 
(mannose receptor) and CD14 (TLR4 co-factor).  Although there were no observed 
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differences in these surface markers on monocytes isolated from macrophage-depleted 
compared to normal mice over time, monocytes recruited into the macrophage-depleted 
environment by MSU administration displayed a delayed development of macrophage 
morphological phenotypes compared to monocytes from normal mice.  Interestingly, there 
was also a notable decrease in the phagocytic function and capacity to produce pro-
inflammatory cytokines in monocytes isolated from macrophage-depleted compared to 
normal mice.  This indicated a fundamental difference that would have been missed if only 
cell surface markers were used to determine monocyte differentiation.   
 
Differentiation of recruited monocytes is driven by a variety of molecules; including the 
hemopoietic-cell growth factors GM-CSF/M-CSF that have been shown to play a key role 
in driving myeloid cell differentiation (151).  The different ratios of CSFs within the 
inflammatory environment may play a key role in directing the differentiation pathway of 
recruited monocytes.  For example, M-CSF within the tumour environment is believed to 
play a prominent role in driving the differentiation of recruited monocytes to TAMs by 
blocking their differentiation into DCs (96, 108).  Studies by Merad and colleagues has 
shown that CSF-receptor deficient mice failed to reconstitute the LC pool in inflamed skin 
in vivo (92).  In addition, GM-CSF levels within the bronchoalveolar lavage fluid has been 
proposed to contribute to monocytes differentiating into a unique DC-like macrophage 
population (109).  Furthermore, an inflammatory environment elicited by bacterial 
infection appears to preferentially programme recruited monocytes to differentiate into 
DCs (90).   
 
GM-CSF and M-CSF are two candidate cytokines that were evaluated for their possible 
effects on recruited monocyte differentiation in this study.  During the early phases of 
MSU-induced inflammation, GM-CSF decreased while M-CSF increased, indicating that 
the inflammatory microenvironment is positioned towards macrophage differentiation 
(chapter 3, section 3.2.10).  In macrophage-depleted mice, this ratio is altered whereby 
both GM-CSF and M-CSF levels are abrogated after MSU-stimulation; the decreased M-
CSF levels may have delayed the programming of monocyte differentiation to 
macrophages in vivo.  Further investigation into the ratios of CSFs within the inflammatory 
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environment could include profiling recruited monocyte differentiation in CSF-KO mice or 
following specific cytokine depletion in vivo. 
 
5.5 Summary 
The findings presented in this thesis extend the current model of MSU-induced acute 
inflammation by introducing novel insight into the impact of the microenvironment on the 
recruitment, differentiation and function of blood monocytes.  A schematic representation 
of my proposed model of MSU-induced inflammation incorporating my findings is 
presented in Diagram 5.1.   
 
The deposition of MSU crystals within the peritoneum induces the production of MCP-1 
from the local membrane.  This process may be augmented by the production of IL-1R 
agonists (such as IL-1β) produced by activated resident macrophages.  In addition, the 
process of leukocyte recruitment may be mediated by other chemoattractants such as M-
CSF.  As circulating monocytes transmigrate through the endothelium, they display altered 
expression of surface antigens and low phagocytic capacity, which correlates with a lack of 
responsiveness to MSU crystal restimulation.  The ratio of GM-CSF and M-CSF within the 
inflammatory environment appears to be responsible for programming monocyte to 
macrophage differentiation.  While not conclusively known, recruited monocytes may 
contribute to the resolution of acute inflammation by phagocytosing apoptotic neutrophils 
and producing anti-inflammatory cytokines (such as TGF-β).  Furthermore, TGF-β 
secreted by neutrophils appears to contribute to the suppression of overall inflammation.  
Over the course of a week, recruited monocytes developed phenotypes characteristic of 
resident macrophages such as phagocytic function and begin to respond to both MSU 
crystal and LPS restimulation.  This indicates that controlled clearance of the existing 
inflammation may be necessary before the local immune environment can be reset in 
preparation for future inflammatory insults.   
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Diagram 5.1: Proposed updates on the MSU-induced inflammation model.  1. Direct 
exposure of MSU crystals to the peritoneal membrane elicits the production of monocyte chemoattractants 
MCP-1 and M-CSF.  This process is augmented by the inflammatory environment, thereby further increasing 
chemokine production.  2. Blood monocytes undergo transmigration into the peritoneum and display lower 
phagocytic capacity and altered surface marker expression.  3. Uptake of MSU crystals by resident 
macrophages results in the production of inflammatory cytokines including IL-1β, IL-6, TNF-α and GM-
CSF.  This creates a highly pro-inflammatory environment into which the blood monocytes are recruited.  
Activated resident macrophages also produce the chemokine KC, which recruits neutrophils from the 
bloodstream into the peritoneum.  4. Monocytes recruited into the acute inflammatory environment are non-
responsive to MSU restimulation.  Phagocytosis of neutrophils by monocytes switches them into an “anti”-
inflammatory phenotype able to produce anti-inflammatory cytokines (such as TGF-β).  5. Infiltrating 
neutrophils amplify the inflammatory response by producing IL-8 and superoxide.  As neutrophils apoptose, 
they are able to contribute to the resolution of inflammation by secreting soluble factors (including TGF-β).  
6. Over the course of a week, recruited monocytes differentiate and develop macrophage-like phenotypes, 
eventually replenishing the resident macrophage population.   
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Appendix 
Appendix 1: GA+ cells in the blood show monocyte cell surface phenotype 
 
GA-A488 was injected intravenously to C57Bl/6J mice at a dose of 50µg/mouse.  CD11bhi cells were 
enriched from pooled blood of five mice by magnetic sorting one hour after the injections.  The cells were 
then stained for cell surface markers and analysed by flow cytometry.  Bottom right panel row shows the 
FSC/SSC profile of GA+ cells in comparison to total blood cells.  Data represents one of two experiments.  
Appendix 1 was provided by Aras Toker.   
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Appendix 2: Circulating monocytes display enhanced suppressor abilities of T cell 
expansion in vitro.   
 
 
 
Peripheral blood mononuclear cells were recovered from naïve C57Bl/6J mice and the CD11bhi monocytes 
enriched by magnetic sorting (>80% CD11bhi).  The monocytes were co-cultured with 5x104 C57Bl/6J 
splenocytes at the indicated ratios in the presence of DynaBead® CD3/CD28 T cell expander beads in 96 well 
round-bottom plates.  The cells were incubated fro 20 hours, and an additional eight hours in the presence of 
[3H]-thymidine.  T cell expansion was measured by [3H]-thymidine incorporation.  Measurements performed 
in triplicate.  Values represent mean S.E.M. * P < 0.01 as determined by two-tailed unpaired Student test.  
Results are representative of two independent experiments with five mice per group.  Appendix 2 was 
provided by Aras Toker.   
 
 
 
 
 
